WTO Expresses Optimism Over IP Waiver Agreement But Protestors Call for ‘Real TRIPS Waiver’ 07/06/2022 Kerry Cullinan Protestors in New York City. World Trade Organization (WTO) leaders are hopeful that an agreement could be reached on a waiver on intellectual property rights for COVID-19 vaccines at the Ministerial Council starting on Sunday – but the People’s Vaccine Alliance has organised global protests to demand “a real TRIPS waiver” ahead of the meeting. WTO Director-General Ngozi Okonjo-Iweala has expressed “cautious optimism” that agreement on the IP waiver is possible at the council, according to WTO spokesperson Daniel Pruzin. Speaking at a media briefing on Tuesday following a special meeting of the WTO General Council earlier in the day, Pruzin said that Ambassador Lansana Gberie, chair of the TRIPS Council, which is leading discussions on the waiver and the WTO’s response to the pandemic, was also optimistic. According to Gberie, delegations “entered into real negotiation mode [on Monday] in an effort to try to iron out their differences, particularly with regards to the waiver discussions,” said Pruzin. A small group meeting of the TRIPS Council on the waiver resumed negotiations on Tuesday evening. Too little, too late? On 3 May, Okonjo-Iweala put forward an “outcome document” on the waiver that had emerged from discussions with “the Quad” – the European Union, India, South Africa and the US. According to the WTO, the Quad adopted a “problem-solving approach aimed at identifying practical ways of clarifying, streamlining and simplifying how governments can override patent rights, under certain conditions, to enable diversification of production of COVID-19 vaccines”. However, there are still some sticking points on the proposal, even within the Quad, and the proposal has been widely condemned by health activists for being too little, too late. An IP waiver proposal for all COVID-related technology was first put on the table over 18 months ago by India and South Africa during the height of the pandemic when vaccines were in short supply. The current agreement is confined to COVID-19 vaccines, and it is being negotiated when there is a global glut of vaccines. The People’s Vaccine Alliance is planning global protests during the week aimed at pressuring US and European countries to “end COVID monopolies” and “deliver a real TRIPS waiver”, the global network announced on Tuesday. “The WTO is having its biggest meeting since the start of the pandemic. Feeling the pressure to do something on COVID, WTO leaders have introduced a bogus new proposal that not only fails to remove WTO barriers to COVID medicine accessibility, but actually introduces new obstacles,” according to the alliance. 🇪🇺🇩🇪🇨🇭🇬🇧World leaders, stop protecting Big Pharma and prolonging the global COVID pandemic! Lift Europe's block on a #TRIPSWaiver for COVID vaccines, tests & treatments and #EndCOVIDMonopolies #FightInequality pic.twitter.com/2ZJJsLanBA — #FightInequality (@FightInequality) June 7, 2022 Other big WTO agenda items Other big items on the agenda of the WTO Ministerial Council are a reduction in fishing subsidies, agricultural trade reform and reform of the WTO itself, including more regular ministerial meetings. Pruzin said the “significant progress” had been made on the fishing subsidies proposal, which has been negotiated for a number of years, and on possible ministerial declaration on WTO’s response to the pandemic, “There are still some very important differences which remain in the texts, and I think all the chairs recognise this, be it fisheries, be it agriculture, be in other areas as well,” said Pruzin. “But I think it’s fair to say that the atmosphere is much better than it has been in some time. I think there’s some good momentum going into the final preparations.” Image Credits: People's Vaccine Alliance. Moderna Doses First Participants in Phase 3 Study of mRNA Flu Vaccine 07/06/2022 Maayan Hoffman A medical assistant gives a flu vaccination. Moderna announced Tuesday that the first participants have been vaccinated in a Phase 3 study of its influenza (flu) vaccine, which is based on mRNA technology used in its COVID-19 vaccine. The vaccine, mRNA-1010, encodes for hemagglutinin (HA) glycoproteins of the four influenza strains recommended by the World Health Organization (WHO) for the prevention of influenza. Flu epidemics generally occur in the winter and some years can place a heavy burden on healthcare systems, with as many as 3 million to 5 million severe cases and, at its worst, as many as 650,000 deaths, according to WHO. The trial is expected to enroll approximately 6,000 adults in countries in the southern hemisphere. It is a randomized, observer-blind study that is meant to evaluate the safety and immunological efficacy of mRNA-1010 in comparison to a licensed seasonal influenza vaccine in adults 18 years and older. Participants will be randomly assigned on a 1:1 ratio to receive either a single dose of mRNA-1010 or a single dose of a licensed seasonal influenza vaccine as a comparator. The company aims to run a confirmatory efficacy study for mRNA-1010 as early as the 2022/2023 northern hemisphere influenza season. “mRNA-1010 is the first of several influenza vaccine candidates we are developing with the aim of iteratively improving traditional vaccines by inducing broad and robust immune responses,” Moderna CEO Stéphane Bancel said in a release. “We believe our mRNA platform, with the flexibility and speed of our manufacturing process, is well-positioned to address the significant unmet need in seasonal flu. Moderna was founded 12 years ago and became well-known two years ago with the development of its SARS-CoV2 mRNA vaccine. It was the second mRNA vaccine ever to be produced and was approved by the US Food and Drug Administration. The first mRNA vaccine was developed by Pfizer and BioNTech. Moderna is currently engaged in four Phase III studies, it said, including its SARS-CoV-2 booster, RSV, seasonal flu and CMV vaccine candidates. “Beginning in the fall of 2022, the company’s Phase III pipeline could lead to three respiratory commercial launches over the next two to three years,” Bancel said. Image Credits: Moderna, KEYSTONE/Gaetan Bally. ‘Monkeypox Begins – and Must be Resolved in – Endemic Countries’ 06/06/2022 Kerry Cullinan Dr Ibrahima Socé Fall, assistant general security for emergency response The first human case of monkeypox was recorded in 1970, yet the viral disease is only getting international attention since it has spread outside Africa to 27 non-endemic countries. The World Health Organization’s (WHO) Dr Ebrahima Socé Fall described monkeypox as a “neglected tropical disease” when he opened a two-day meeting called by the WHO’s R&D Blueprint to determine research priorities last Thursday. “We need to stop the chain of transmission and we believe at this stage we can still stop the chain of transmission in non-endemic countries by ensuring surveillance in certain population groups, cross investigation contact tracing, and maybe vaccination,” said Fall, WHO’s Assistant Director-General for Emergencies Response. However, WHO scientist Ana Maria Restrepo stressed at the meeting’s conclusion that the viral disease had to be addressed in the nine African countries where it is endemic. “The problem starts and has to be resolved at the level of the endemic countries,” said Restrepo, co-convenor of the R&D Blueprint that called the meeting, at the conclusion of the meeting. “There are researchers of high quality in these countries, and they are doing high-quality research despite the limitations, and our commitment is to support them.” Squirrel pox? The intention of the meeting – attended virtually by over 500 scientists – was to identify research priorities, and when it ended on Friday afternoon, the scientists had identified a long list of unknowns. One of the big questions is whether there is an “unknown animal reservoir” for monkeypox – with squirrels and rats being fingered as the most likely suspects. The Central African sun squirrel is particularly susceptible to monkeypox – and one researcher suggested the pox might have been more aptly named after it. “What was the first reservoir?” asked Dr Paul Fine of the London School of Hygiene and Tropical Medicine. “We think monkey because of the name monkeypox, but there were studies in a number of other species and it was found in several of them, in particular squirrels, particular the sun squirrel of Central Africa. So one might ask if this name is appropriate. Is it just monkeypox or are there other species very importantly, involved as reservoirs?” SARS Co-V2 comes from bats, while monkeypox could come from rats. Professor Jean-Jaques Muyembe Tamfum, director of the DRC’s Institute de Recherche Biomedicale, said that the majority of monkeypox cases in his country were children infected by hunting and handling rodents and squirrels. Adults were exposed to the virus by hunting monkeys. “The virus enters the body through the broken skin, and spreads in the mucous membranes and eyes, nose and the rest,” said Tamfum. Complications of monkeypox include bacterial conjunctivitis and even blindness. Scientists also raised whether rodents could be infected by “spillover” from human waste. The meeting resolved that a “comprehensive One Health approach” was needed to understand animal-to-human transmission and animal reservoirs. A ‘One Health’ approach is neeed for monkeypox Mutations and drivers Genomic sequencing of the current strain of monkeypox spreading internationally shows that it has 47 mutations when compared to a 2018 sample. This is surprisingly high, and one hypothesis is that the monkeypox virus has been mutating in an unknown animal – or perhaps more than one animal behind the two different clades – the Central African clade with a mortality rate of around 10% and the West African clade with a 2-3% fatality rate. Aside from the international spread of monkeypox, there has also been a dramatic increase in cases in endemic countries especially DRC and Nigeria. Nigeria’s Professor Dimie Ogoina told the meeting that his country was also seeing an increase in cases in areas where it had not previously been seen. Scientists thus want to unpack what is driving the transmission, as monkeypox is not known to be particularly infectious. In the past, infected people only passed the virus on to about 8-15% of the people living in the same house. The European outbreaks appear to stem from sexual contact at two events – in Berlin and on the Canary Islands, according to news reports. This is not typically how it has been transmitted, and the meeting raised a number of questions about sexual transmission – particularly whether it can be transmitted via semen and vaginal fluid, not just through contact with the infected lesions. “Monkeypox manifests in rashes. Would a person still engage in sex with these rashes? We need to look at asymptomatic transmission,” said Ogoina. Tricky diagnosis In Nigeria, men are significantly more likely to get monkeypox than women, raising questions about what makes them more vulnerable. Ogoina, from Niger Delta University, also revealed that people coinfected with HIV and monkeypox had “bigger lesions” and were more likely to have genital lesions – although only five such patients were examined. “It is very important just to recognise that the vast majority of recent cases, especially in DRC, are suspected cases or their probable cases or possible cases, they’re not confirmed,” stressed Fine. Some of the symptoms of monkeypox are similar to those of syphilis and chicken pox, and the meeting identified the need for better diagnostics. “WHO, through our regional offices, is working with African countries, regional institutions, technical and financial partners, to increase the ability to support disease surveillance laboratory diagnostics, readiness and response actions related to monkeypox,” said WHO epidemiologist Maria van Kerkhove. “We have to acknowledge the fact that this virus has been circulating for decades, and we now have attention to this. This unfortunately is a sad reality of the world that we live in. But we need to use this as an opportunity to advance our understanding of this virus to help everyone everywhere dealing with monkeypox,” said Van Kerkhove. Implementing COVID lessons Professor Helen Rees Professor Helen Rees, who moderated the two-day meeting, said that COVID-19 had shown the need for rapid global responses to emerging health threats. Rees called for “partnerships, collaboration, strategies that get us into the field quickly, antivirals and vaccines”. “We’re also seeing this interface with One Health, with environmental degradation and climate change. All of these things are coming to the fore. Just to underline this is not a pandemic, this is an outbreak that we are scratching our heads about. But the fact that we should respond now and rapidly is really excellent,” added Rees, a renowned scientist from South Africa’s University of Witwatersrand. WHO scientist Ana Maria Restrepo concluded the meeting by stressing that it was important to practice what had been preached during COVID-19. “We talked very much about the new health architecture for response to pandemics, and the lessons learned,” said Restrepo. “We are convinced that showing a good response for this multi-country outbreak is our best example of how we are going to be prepared for the next pandemic. “If we do when we all preach, we work together if we collaborate, we use master protocols, if we engage the countries; the communities – if we learn those lessons, and if we put equity at the centre of the discussions, then yes we have learned our lessons and we are moving forward towards being better prepared,” said Restrepo. Ana Maria Restrepo Expedited studies The meeting concluded with experts calling for expedited studies to better understand the disease epidemiology, clinical consequences, and modes of transmission. While the smallpox vaccine offers over 80% against monkeypox, it is unclear whether this protection endures – and smallpox vaccination was discontinued in the 1970s. The experts emphasized the need for clinical studies of vaccines and therapeutics to better document their efficacy and understand how to use them in this and future outbreaks. The meeting also called for immediate implementation of public health activities including communicating prevention information, enhanced disease surveillance, contact tracing, isolation of cases and optimized care of people with the virus. Self-Care Practices Can Save Millions and Alleviate Pressure on Health Systems 06/06/2022 Aishwarya Tendolkar In a world where health workers are scarce, self-care practices can drastically improve people’s quality of life and alleviate strain on health systems, but depend on a range of factors including patient literacy, fair prices and government stewardship. This is according to a one-of-a-kind global study demonstrating the value of self-care that was launched on the sidelines of recent World Health Assembly in Geneva. The World Health Organization (WHO) defines self-care as “the ability of individuals, families, and communities to promote health, prevent disease, maintain health, and to cope with illness and disability with or without the support of a healthcare provider.” Current self-care activities around the world are generating annual savings of approximately $119 billion, along with saving 11 billion patient hours worldwide, according to the study. The study was produced by the Swiss-based Global Self-Care Federation (GSCF), which represents manufacturers and distributors of non-prescription medicines on all continents. Self-care cost-saving (source: Global Self-Care Federation report). Low-income countries lagging But the low-income countries are still lagging in implementing and reaping the benefits of self-care. “In low-income countries, about 65% of households that could not obtain essential health services had financial constraints,” said Dr Ritu Sadana, WHO Head of Ageing and Health Division of Universal Health Coverge (UHC), one of the panelists at the launch of the report. “This is more than triple the proportion of households who lack access to health services because they are just unavailable, which is 20%.” High-income countries are reaping the most benefits of self-care practices while the low-and middle-income countries are playing catch-up. With increased adoption of self-care, we will be seeing an additional $19.5 billion in annual cost savings related to the increased adoption of self-care by 2030, said Ben Carrick, Johnson and Johnson’s senior director of consumer policy. “If we think about the welfare benefits, it could be leading to an annual increase of $312 billion per year globally. These are significant benefits that are worth chasing and grasping,” Carrick told the launch. To estimate the true #ValueofSelfCare, we must first understand how it operates across different global contexts. Our 3 country groupings allow us to unlock such insights. 🌏 Read the report to learn the full scope of benefits that can be achieved:https://t.co/h5gTOOsgUl pic.twitter.com/ZMrINWpIax — The Global Self-Care Federation (@Selfcarefed_org) June 6, 2022 The study grouped 155 countries based on their GDP levels, and then gauged the self-care effects. In the high-income countries (Group A), self-care is already making an indispensable contribution to relieving the burden on healthcare systems. But it is in the low-and middle-income countries (Group B and C), where self-care can enable a person to work and not depend on welfare. “We don’t need more GDP; we need more welfare and this is also what this project is about, this is what self-care is about… to generate more welfare and not just be focused on figures and economic factors,” said Professor Uwe May, Dean of Studies at Fresenius University. He added that currently if people practised self-care instead of doing nothing about their health issues, 41 billion productive days can be gained on a global level. Self-care ‘only option’ in poor countries The study also found that health economic and pharmacoeconomic approaches deployed to assess the value of self-care cannot be transferred to lower-income regions where the infrastructure, socio-economic factors, and awareness is different. In addition, lack of access to over-the-counter (OTC) medicine and the prevalence of traditional medicines also has an impact on self-care options. In regions like sub-Saharan Africa and South East Asia, self-care is not an alternative care option, but is often “the only possible access to treatment for most individuals”, according to the report. In these countries, self-care does not translate into saving on doctors’ and specialists’ time. “This is where the welfare benefits are really the main opportunity because it isn’t saving physicians’ time and people don’t have access to the physicians,” said Carrick. “But if it means that they’re productive, they’re back at work and they’re able to look after families, then it’s those welfare and productivity benefits that really come into play.”. In Latin America and the Caribbean, the practice of self-care and the use of OTC products leads to current welfare savings of $123 per capita per year. The more the OTC use increases, the greater the individual and societal benefits can be realised through self-care, according to the study “We estimated that at least 142 million older persons, about 14% of older persons worldwide, are unable to meet some of their basic needs. So the issues around self-care for themselves or by their families or care providers is extremely important,” said Carrick. What do we need now? The report highlights the need for private-public partnerships, digital and healthcare literacy in people living in low-and middle-income countries (LMICs) and better parameters to gauge healthcare outcomes in a country. “We need strong stewardship by government, and to have really strong capacities in government institutions…so that they can lead and shape how we actually get things done with the private sector, with multiple sectors across the government and also obviously, civil society and self-care demands with the active participation of people,” said Sadana. “Health literacy is a fundamental catalyst for change to ensure individuals comprehend and act on credible health information, becoming active self-managers of their own health,” said Carrick. Experts at the launch also highlighted the need for pharmacies to be more involved in developing better policies, and for governments to spend more on ensuring that self-care is delivered through, not only OTC and literacy, but also nutrition, lifestyle, and affordable healthcare. Sadana said that in India, 70% of all healthcare costs are paid out of pocket, and 70% of that was on drugs. “If we’re going to have a system which encourages self-care, using products that are evidence-based and quality-controlled, we still need to have a way to ensure that those are covered [by the health system] if we actually want a vast swathe of the population to use them.” Image Credits: Tbel Abuseridze/ Unsplash. Climate Crisis Poses Serious Risk to Mental Health – WHO 03/06/2022 Raisa Santos Climate change poses serious risks to mental health and well-being, concluded a new World Health Organization policy brief, launched on Friday at the Stockholm+50 conference. Natural disasters such as floods, heatwaves, storms, and drought can pose a threat to mental health and psychosocial well-being, exacerbating emotional distress, anxiety, depression, grief, and suicidal behavior. WHO is therefore urging countries to include mental health and psychosocial support in their response to climate change. “The impacts of climate change are increasingly part of our daily lives, and there is very little dedicated mental health support available for people and communities dealing with climate-related hazards and long-term risk,” said Dr Maria Neira, WHO’s Director of Environment, Climate Change, and Health. #ClimateChange poses serious risks to #MentalHealth and well-being – from emotional distress to anxiety, depression, grief, and suicidal behavior: new WHO policy brief https://t.co/ogdEP9iIG6 pic.twitter.com/VRqrMqoixr — World Health Organization (WHO) (@WHO) June 3, 2022 The findings concur with a report made by the Intergovernmental Panel on Climate Change (IPCC) published in February of this year, which revealed that half of the world’s populations live in climate ‘danger zones’ that place “people’s health, lives, and livelihoods” at risk, and this can also include people’s mental health. The two-day conference, hosted by the government of Sweden and convened by the United Nations General Assembly on 2 – 3 June, drew together thousands of participants across government, civil society, and the private sector in an effort to spur urgent action for a healthy planet. The meeting also commemorates 50 years since the 1972 UN Conference on the Human Environment, which made the environment a pressing issue for the first time. Climate change impact on mental health The mental health impacts of climate change are felt disproportionately around the world, with support services unequally distributed as well. While there are nearly 1 billion people living with mental health conditions, 3 out of 4 do not have access to needed services in low- and middle-income countries. A 2021 WHO survey found that out of 95 countries, only 9 have thus far included mental health and psychosocial support in their national health and climate change plans. Additionally, while the annual cost of common mental disorders is $1 trillion, only 2% of government health budgets are spent on mental health. These figures are all exacerbated by climate change. “The impact of climate change is compounding the already extremely challenging situation for mental health and health services globally,” said Devora Kestel, WHO Director of the Department of Mental Health and Substance Abuse. Examples of how climate change can impact mental health include the loss of personally important places, loss of autonomy and control, and exposure to pollution, which is associated with increased risk for mental health conditions. The new policy brief recommends five important approaches for governments to address the mental health impacts of climate change: Integrate climate considerations with mental health programs Integrate mental health support with climate action Build upon global commitments Development of community-based approaches to reduce vulnerabilities to climate change, and Close the funding gap for mental health and psychosocial support “By ramping up mental health and psychosocial support within disaster risk reduction and climate action, countries can do more to help protect those most at risk,” said Kestel. Image Credits: Clay Kaufmann/ Unsplash. After Many Missed Opportunities, Oral Health Gets Long Overdue Attention from WHO 03/06/2022 Ihsane Ben Yahya & Greg Chadwick Dental services, including regular check-ups, were among the most disrupted essential health services during the COVID-19 lockdowns. People´s reticence to visit a dentist during normal times was exacerbated by fear of venturing into an open clinic or simply not being able to, due to restrictions. Dental hesitancy has always been around but over two years into the pandemic, it´s now a lot worse. This hesitancy is also echoed at the policy level. Oral health has, until very recently, been considered the “ugly duckling” of global health efforts. The World Health Organization (WHO) has only ever passed a special resolution on oral health twice in its history: most recently, ironically, in the midst of the COVID-19 pandemic in 2021. The new global oral health strategy, approved by governments at 75th WHO World Health Assembly last week is a step in the right direction, and it is long overdue. 📣The WHO global #OralHealth strategy has officially been approved and adopted at the #WHA75 👏 FDI commends the strategy and tells @WHO that we are ready to support the development of the subsequent action plan and monitoring framework by 2023 ➡️ https://t.co/mTPgDRSB24 pic.twitter.com/MYf1nFap8e — FDI World Dental Federation (@fdiworlddental) May 28, 2022 Oral health is essential for overall health It´s a perfect time to double down on just why responding to the global oral health epidemic is in our broader (health) interests. Getting people back into dental clinics and protecting their oral health is essential to safeguarding their overall health, well-being, and quality of life. All those factors that can make people vulnerable to chronic non-communicable diseases (NCDs) such as cardiovascular disease, cancer, chronic respiratory disease, and diabetes are equally risky for one´s oral health. High sugar consumption, harmful alcohol use and tobacco are just as bad for our bodies as they are for our mouths. The impact in pure numbers is alarming: there were some 3.5 billion cases of oral diseases and other oral conditions in 2017. For the last three decades, the combined global prevalence of dental caries (tooth decay), periodontal (gum) disease and tooth loss has stood at 45% – higher than any other NCD. Ignoring the problem makes no sense, financial or otherwise. Worldwide, oral diseases accounted in 2015 for $ 357 billion in direct costs and US$ 188 billion in indirect costs. In the same year, $96.2 billion was spent on the treatment of oral diseases across the European Union, the third-highest total among NCDs, behind diabetes and cardiovascular diseases. “Without good oral health, you’re not healthy,” former US Surgeon-General David Satcher once said, and he was right. The largely siloed approach to dealing with oral health makes no policy sense either, especially when we consider the evidence. Junk food and tooth decay We know that bacteria and inflammation associated with periodontal disease are linked to cardiovascular disease, rheumatoid arthritis, and adverse effects in pregnancy. We also know that people living with diabetes experience improved blood glucose levels if their periodontal (gum) disease is managed correctly. Knowing what we know about poor oral health – that it is preventable and if addressed can help improve our overall health – only begs the question as to why more is not being done to integrate it into other NCD programmes? The pending ban on television and online advertising of junk food in the UK before 9pm is a great example of encouraging better diet. So too is the campaign by UK footballer Marcus Rashford to promote healthier school lunches. But they are missed opportunities. With forethought, both interventions could have included some key messages for children and parents around the connection between a healthy diet and good oral health. Future campaigns could better highlight the need to prioritize oral health promotion in schools, communities and workplaces as well as ensure access to the millions of people who cannot afford the basics, such as fluoridated toothpaste. We need to globally re-think how we talk about and tackle oral diseases. In the vast majority of countries, even essential oral health services are not part of universal health coverage. Oral diseases are noncommunicable diseases and need to be treated as such. Advocates have long argued that investment in prevention produces strong economic returns and saves millions of lives. COVID-19 has reinforced the huge economic and human cost of not doing so: people living with chronic diseases like diabetes, cancer and cardiovascular were at much higher risk of becoming seriously ill, hospitalized, or dying from SARS‑CoV‑2. At the same time, the pandemic is just a microcosm of the bigger picture: our past failure to address oral disease in a substantive way and to view it as an NCD like any other. Prof Ihsane Ben Yahya Prof Ihsane Ben Yahya is the President of the FDI World Dental Federation and professor at the Dental University in Casablanca, Morocco. Dr Greg Chadwick Dr Greg Chadwick is the President-elect of FDI World Dental Federation and Dean at East Carolina University, School of Dental Medicine, United States. Image Credits: Caroline LM/ Unsplash, FDI World Dental Federation. Shanghai Lockdown is Finally Relaxed But Stringent Testing Still Required 02/06/2022 Raisa Santos Shanghai eased its lockdown restrictions 1 June 2022, following continuous low cases reported. Sixty five days after one of the toughest lockdowns in the world, China has eased COVID-19 restrictions on its financial hub, Shanghai, on Wednesday – finally allowing the majority of its 25 million residents to move freely again. However, at least 890,000 residents are confined at home, in “quarantine” or “control zones”. The announcement to lift restrictions came as official figures showed on Sunday that daily new coronavirus cases fell from 170 to 122 in a 24-hour period. The city reported just 13 cases for Wednesday, and an additional 7 cases on Thursday. This is a marked turnaround from the beginning of April, when tens of thousands of cases were reported daily. “This is a day that we dreamed of for a very long time,” Shanghai government spokeswoman Yin Xin told the BBC. China to maintain ‘zero tolerance’ policy Shanghai residents will be required to hold a negative nucleic acid test result taken within 72 hours of entering public spaces or using public transportation from June But while China seems to have moved into the clear with COVID, the country is keen to maintain its “zero tolerance” policy, and is already preparing for future waves. Beijing municipal officials said Thursday that 12 of its planned 14 ‘transition hubs’ will be used to test and disinfect all imported frozen food before goods are distributed across the city. This follows China’s contention that frozen food could transmit COVID-19 in while the World Health Organization’s independent panel on the virus’s origins favour an unknown animal vector as the most likely cause, while others have pointed to laboratory accident for the spread of the coronavirus first found in bats in China. Tens of thousands of testing booths will also be set up across China’s largest cities, including Beijing, Shanghai, and technological hub Shenzhen, to require testing as often as every 48 hours. New rules in Shanghai will now require residents to show a green health code on their smartphone, with proof of a negative PCR test in the last 72 hours, to leave their residential compounds and enter most places, including banks, malls, and public transportation. However, cinemas, museums, and gyms remain closed, as well as in-person schooling. Restrictions on leaving the city still remain, with anyone traveling to another city facing a quarantine of seven to 14 days upon return. Beijing also lifted its restrictions earlier this week, following similar protocol with some of its public transportation system, malls, and other venues opening up. Shanghai testing centers tested by overcapacity and staff shortages Shanghai testing center Shanghai’s 72-hour rule has tested the capacity of its testing centers, as crowds flocked to the 15,000 stations. While some said their test took only a matter of minutes, others complained that they had to wait over an hour to test. Many testing booths are only open for about three hours each in the morning and afternoon, although some hospitals offer a 24-hour service. Shanghai resident Zhang Zehong told Sixth Tone that she was unable to test Wednesday as the station in her neighborhood closed two hours earlier than shown on the city’s health code app, which features all the testing centers. Instead, she went to a hospital with a 24-hour service Thursday morning, only to find no staff and a line that stretched on for over 100 meters. So many issues need to be fixed,” Zhang said. Chinese microblogging platform Weibo also featured complaints with the stations. “It’s been very hot recently, several people passed out when standing (in line),” one Weibo user wrote. “I visited five sites but each had long queues. This is not really humane enough. Don’t these mobile kiosks cause more people to gather?” another Weibo user wrote. Fifty-point plan to revive Shanghai economy A fifty-point plan has also been drawn up to support Shanghai’s economy, crippled in the wake of closures, quarantines, and lockdowns. New measures include reducing taxes for car buyers, speeding up the issuance of local government bonds, and fast-tracked approval of building projects. Drivers who also switch to an electric vehicle will also be able to claim a $1500 subsidy. Businesses may also be able to delay insurance and rent payments, with subsidies available for utility charges. Image Credits: Appriseug/Twitter , DA Trade Market Securities/Twitter , Don Weinland/Twitter. Eight Countries Compete to Host African Medicines Agency at Crucial African Union Meeting 02/06/2022 Paul Adepoju AMA headquarters host country is expected to be named at the end of an ongoing meeting in Addis Ababa A meeting to decide which African country will be the host country for the African Medicines Agency (AMA) is underway and at the last count, expressions of interest in hosting the agency have been received from Uganda, Algeria, Egypt, Morocco, Rwanda, Tanzania, Tunisia and Zimbabwe. The decision is expected to be one of the outcomes at the ongoing first Ordinary session of the Conference of State Parties (CoSP) of the AMA, in Addis Ababa, Ethiopia from 1 to 3 June 2022. The CoSP is reviewing the AMA assessment report and at the end of their meeting, it will make recommendations on the host country of the AMA Headquarters. A final decision on this recommendation will be made at the next assembly of the African Union. Uganda is one of the countries vying to host the AMA Headquarters and the country’s delegation to the CoSP meeting is led by the country’s Minister of Health, Dr Jane Aceng, and Dr Diana Atwine, a Permanent Secretary in the Ministry of Health. Zimbabwe’s team is a four-member delegation led by the country’s Health and Child Care deputy Minister, Dr John Mangwiro. Sierra Leone is also attending the session led by Minister of Health and Sanitation Dr Austin Demby. In his remark at the official launch of the Africa CDC’s Ministerial Executive Leadership Program (MELP), Dr John Nkengasong, Africa CDC’s outgoing Director General confirmed the CoSP’s outcome would play a critical role in deciding the future of the agency. “The launch of the AMA is really another landmark initiative of the African Union as part of the Agenda 63. I can’t wait to hear the outcome of the deliberations. It’s going to be transformational when the AMA and we are truly excited with that,” Nkengasong said. The three-day ministerial meeting will deliberate on the priorities and next steps to establish the AMA. From Geneva to Addis Ababa At last week’s World Health Assembly, Amref Health Africa’s Desta Lakew, on behalf of the African Medicines Agency Treaty Alliance (AMATA) described AMA as an initiative of the African Union aimed at strengthening the regulatory environment to guarantee access to quality, safe and efficacious medicines, medical products, and technologies on the continent. Countries that have signed the treaty, according to AMATA, are Algeria, Benin, Chad, Ghana, Madagascar, Mali, Morocco, Rwanda, Saharawi Arab Democratic Republic, Senegal, and Tunisia. But about four years after the AU Assembly adopted the AMA Treaty, Lakew noted that some Member States still haven’t given it the authority to fulfill its mandate. “The increased risk of disease outbreaks in the region and globally has made access to medical products a priority. Trade in locally produced medical products, including Personal Protective Equipment, across African countries will be hampered if we do not have a harmonized regulatory environment,” Lakew told WHA 75. At the CoSP meeting, the AU called on all member states to sign the Treaty to see improved regulation and easy flow of medical products and technologies, are expected to be reechoed. Lakew described the call as an urgent matter “for the sake of ensuring that there is equitable access to quality, safe, efficacious medicines and technologies for a healthy Africa”. Last month, Health Policy Watch reported Kenya was preparing to join the AMA alongside thirty-one other African Union member states following the Kenyan cabinet’s decision to approve the ratification of the African Union Treaty. See more about the African Medicines Agency on our special AMA Countdown page: African Medicines Agency Countdown Sex, War, Sustainability and the World Health Assembly – Last Week in Review 02/06/2022 Elaine Ruth Fletcher 75th World Health Assembly Health and peace, sex and war, money and management. Whether in chorus or cacophony – last week’s World Health Assembly of WHO member states played most of the notes in the symphony of global debate over strategies to tackle disease, epidemics and pandemics and bolster health systems. But the root causes of emerging disease threats – in modern environmental health threats and nature gone awry remained under-represented themes. From the opening notes of the WHA, on a health for peace theme, to Saturday’s late night closing and end-run charges over language on sexual orientation – this year’s WHA was a seesaw of successes and setbacks. Highs included the consensus vote Tuesday to increase member states contributions to WHO, followed by a resolution Friday to move ahead on the first real reforms to the International Health Regulations in almost 20 years. And at the same time, unprecedented polarization was evident during Thursday’s debate over a resolution condemning Russia’s invasion of Ukraine, which won approval by a vote of 88 to 12. That was followed by the dispute that emerged Friday and continued until nearly midnight Saturday over references to terms such as “sexual rights” and “men who have sex with men” (MSM) in a WHO strategy on HIV, hepatitis-B and sexually transmitted infections (STIs). That, too, was resolved only by a painful series of rollcall votes, leading to the strategy’s passage by just 60 member states, with twice as many delegates absent or abstaining. Like a bullet train ride Dr Hiroki Nakatani joins in the applause for the resolution’s passage on HIV, Hepatitis B and STIs Dr Hiroki Nakatani, who presided over the committee that faced the thorny final hours of WHA dealing with the clash among nations over sexual health terms that HIV professionals regard as the standard usage, compared this year’s WHA session to a ride on a bullet train. “The train ride was sometimes bumpy but we arrived at our destination,” he said of the first Assembly to be held in person in several years because of the pandemic. Perhaps so, even more so than the war in Ukraine, the exceptionally large number of abstentions in the vote on a new HIV, Hepatitis and STI strategy was a bitter pill to swallow for delegates on both sides of the debate. It highlighted the fact that the battles still being waged in Europe, the Middle East, Asia and Africa over the control of territory are not the only big issues dividing member states. Fissures over social norms shape and guide public health policies run just as deep. Sex & War – Global social divide as deep as territorial conflicts And among those norms, there remains a deep divide around health policies that interface with human sexuality – that other primordial urge that co-exists alongside the urge for power and territory. For WHA delegates, in fact, the series of votes Saturday over sexual terminology may have been even more unsettling than the votes over Russia’s invasion of Ukraine – precisely because they sit in Ministries of Health, not Defence, with day-to-day responsibility for designing and implementing policies on HIV and other STIs. As with the Ukraine conflict, the divide that emerged, however, was not strictly drawn along the lines of global North and South. Saudi delegate in heated WHA debate Saturday over sexual rights and terminology Rather, it was the oil-rich Saudi Arabia that led the charge in the quest to purge references to men who have sex with men from the strategy on HIV treatment, followed by emerging economies of Asia and Africa where conservative views about sexual expression are often protected by law as well as custom. Against that, was Europe, North America, much of Latin America and high-income Asia- where more new attitudes about gender identity and LGBTI terminology have taken root over the past few decades. There were also exceptions, such as South Africa, which voted in favour of the HIV strategy. And European Serbia abstained from the vote as did the Russian Federation. Respect for culture, versus respect for evidence In the aftermath, the abstaining countries pleaded for more understanding of norms guided by tradition and culture. Western delegates, meanwhile, referred to the compass of science – whereby recent research has revealed how oft-marginalized MSM groups often fall through the cracks of programmes for HIV/AIDS prevention, diagnosis and treatment. “We appreciate those member states acted in good faith as part of these deliberations. Unfortunately this has served as a painful reminder of the need to reinforce our focus on evidence, human dignity and decency,” said US Assistant Secretary of State for Global Health Loyce Pace just after the strategy was approved. Loyce Pace, Assistant Secretary of State for Global Health, USA “[But] we should not need to hold a vote on the existence of entire communities of people,” she added. “We have a strategy on critically important global health issues, yes. But at what cost to those we risk leaving behind? “So to gay, lesbian, bisexual, queer, intersex, transgender and gender non-conforming people around the world, the United States government sees you, and will continue to support you. Stay strong.” (Right) Denmark’s EB representative, Søren Brostrøm, Director-General, Danish Health Authority, at the WHO Executive Board meeting 30 May, (left) Loyce Pace Assistant Secretary of State for Global Health, USA Reviewing the issue at Monday’s Executive Board meeting, member states on both sides of the divide expressed concerns over the failure of the WHA to find consensus over such a flagship health strategy – and the “dangerous precedent” that the voting set. “It is important that this does not set a precedent for consideration and adoption of technical documents by the Health Assembly,” said Dr Edwin Dikoloti, Botswana’s Minister of Health and Wellness, speaking on behalf of the African group, saying that greater efforts need to be made to find consensus in future WHAs over such controversial issues. Money – landmark decision on WHO finance – but not a ‘done deal’ Members of the WHO Working Group on Sustainable Finance hammer out the final agreement on increasing member state contributions, Germany’s Björn Kümmel on far left. The holy grail of consensus was restored in other key moments – including around the WHA resolution to increase regular member state contributions to WHO – in a bid to stabilize the agency’s finances The agreement, the fruit of months of grinding backroom diplomacy led by Germany, saw member states commit to increase annual assessments to cover 50% of WHO’s core budget by the end of the decade. However, each stepwise increase up until 2030 will still need endorsement at future WHAs to go forward. And so the vote should not be seen as a blank check either, a senior official in the Department of Health and Human Services, told Health Policy Watch. “I would say that the US, as a big contributor to the WHO, is definitely committed to that [resolution], and we were very happy to join the consensus,” the official said. “But I hope it’s also been clear that that is not a done deal and neither for us as the administration or for Congress.” According to the resolution, final approval of each year’s increase is contingent on progress in WHO internal reforms that are supposed to make the organization more transparent, efficient and well-managed. Those demands include overhaul of WHO’s budget management system, said the senior US official: “The budgets that are adopted by the Health Assembly are not real budgets. They’re just budget space. And creating budgets that are aspirational is very different from programming and reporting on and demonstrating the impact of real budgets.” Management – following election Tedros faces new demands Applause just after WHA re-elects Dr Tedros Adhanom Ghebreyesus to serve a second five-year term as Director-General of the World Health Organization on 24 May. He ran un-opposed. But the expectations go beyond budget reform, pressing newly re-elected Dr Tedros Adhanom Ghebreyesus for changes in WHO’s management culture, including more merit-based appointments of senior WHO staff, such as those serving as heads of WHO country offices, and structural reforms in WHO’s internal justice system. “I think, from our perspective…. there’s a very significant culture change… that needs to happen within the organization,” the official told Health Policy Watch. Further related to that, are demands for a “full resolution” of the ongoing investigation of the cases of sexual harassment and abuse of women in the Democratic Republic of Congo by WHO staff and consultants, whose progress also was reviewed at last week’s WHA and Monday’s EB. Justice – WHO internal justice system lacks independence While the revelations of the DRC sex abuse scandal, which first came to light in 2020, and whose perpetrators have yet to be fully prosecuted, highlight failures of WHO internal justice to date, they also are evidence of a broader and more systematic problem, some WHO insiders maintain. One key problem, highlighted in multiple interviews with both past and present WHO staff, is the fact that WHO’s Internal Oversight Office (IOS) – the legal mechanism that manages staff and management complaints – is housed in the Director-General’s Office and effectively controlled by the Director General himself – rather than at arms length. Politically influential managers or staff with the ear of the DG, may receive different treatment than staff who do not, critics say. The flaws in the current process featured in a WHO Staff Association letter to Monday’s Executive Board. The Staff Association demanded that the WHO Global Board of Appeals, the three-member body that hears cases, and recommends disciplinary action to the Director General, be expanded and also include staff-appointed representatives. “The panel of the Global Board of Appeal (GBA) should have five-members,” stated the Staff Association. “A three-member panel – the current practice – is simply not reassuring staff that GBA deliberations are sufficiently robust,” the Staff Association letter stated.“Furthermore, the staff representatives on each of the GBA panels should be selected by the respective staff association rather than selected by the GBA Chair or Deputy-Chair.” The net result of the current system is that – short of a costly and lengthy appeal to the International Labour Organization – disciplinary cases are heard by a GBA board appointed by senior managers who report directly to Tedros, who also decides on the final outcome of the cases. Dr Boubacar Diallo with WHO Director-General, Dr Tedros Adhanom Ghebreyesus and then-WHO Emergency Response Team leader, Dr Michel Yao in DRC in June 2019; Diallo was among those accused of harassment and Yao was alleged to have ignored those and other reports. With regards to the DRC cases, allegations that high-ranking WHO managers or consultants with ties to Tedros may have turned a blind eye to the reports of abuses going on in the field, have never been publicly resolved. But the concerns extend beyond sexual harrassement, to the need to foster an institutional culture of professionalism free of political interference, critics also say, pointing to other episodes like the suppression of a 2020 WHO report on Italty’s pandemic response, which criticized another senior WHO advisor to Tedros. From a sustainable budget a sustainable planet? While WHO’s financial sustainability received considerable attention at this year’s WHA, there was comparatively little debate on the planet’s sustainability crisis – and how that may be fueling a cascading array of health impacts – from more noncommunicable diseases to emerging outbreaks, such as SARS-CoV2 and more recently a worldwide surge in monkeypox. A new roadmap to accelerate work on noncommunicable diseases fails to give more than a nod to air pollution as one of the leading causes of NCDs – responsible for some 7 million deaths a year from cancers, cardiovascular and lung diseases every year. And that doesn’t even include risks from chemicals exposures that make the total estimate of deaths from pollution closer to 9 million annually, according to a new Lancet Planetary Health Report released on 18 May. Deaths attributable to key “modern” and “traditional” pollution sources for which data is available In a debate over an NCD roadmap that aims to slash NCD risks by one third by 2030, France, speaking on behalf of some European Union member states,called for a more “integrated” approach that includes environmental health and climate change. So far, such approaches have been slow in coming. Despite the rhetoric about air pollution being a leading risk factor for NCDs, there are, as yet, no WHO “Best Buys” for environmental strategies that reduce deadly pollution risks – even if measures like clean public transport and compact cities, built around cycling and walking networks, are regarded by urban planners and transport managers as evidence-based solutions that have a record of demonstrated results. ‘One Health’ and food safety – some new approaches Caged animals held for sale and slaughter in unsanitary conditions at Wuhan’s Huanan Seafood Market, prior to the outbreak of COVID-19, including: (a) King rat snake (Elaphe carinata), (b) Chinese bamboo rat (Rhizomys sinensis), (c) Amur hedgehog (Erinaceus amurensis) (the finger points to a tick), (d) Raccoon dog (Nyctereutes procyonoides), (e) Marmot (Marmota himalayana) (beneath the marmots is a cage containing hedgehogs), and (f) Hog badger (Arctonyx albogularis). On the brigher side, a new WHO Global Strategy for Food Safety was approved by member states. For the first time ever, the strategy makes reference, at least in passing, to the need for a “One Health approach when addressing health risks emerging at the human-animal-ecosystems interface.” A companion decision asks WHO to also update its guidance on Reducing public health risks associated with the sale of live wild animals of mammalian species in traditional food markets. Such guidance emerges out of the SARS-CoV2 pandemic, where peoples’ exposure to SARS-CoV2 infected animals in the Wuhan, China live animal market is considered to be one of the most plausible routes by which SARS-CoV2 initially leaped from animal to human populations in Wuhan, China during 2019. But the caging and slaughter of live, wild animals in areas heavily trafficked by customers are practices common in thousands of traditional markets in Asia and Southeast Asia, as well as parts of Africa, leading to further risks of human exposure to pathogens the animals may harbour. Not nearly enough action to stop pandemics at source The unsafe handling of live animals that are sold for slaughter at traditional markets can risk the spread of foodborne and infectious diseases. Such “One Health” issues need far more deliberate and systematic WHO and member state attention than the nod that they have so far, a growing chorus of “Ecohealth” experts say. In a little-noticed press release issued during WHA, Dr Nigel Sizer, executive director of the consortium Preventing Pandemics at the Source called upon the WHA to do more to address ecosystem risks upstream that increase “spillover risks” of pathogen leap from animal to human populations: “Such actions include shutting down or strictly regulating wildlife trade and markets, stopping deforestation and forest degradation, and providing better health to communities in emerging infectious disease hotspots, as well as strengthened veterinary care and biosecurity in animal husbandry,” said Sizer, an internationally known conservationist, in his statement. “Overall throughout the WHA process and in the preparations for negotiation of a possible global instrument on pandemic prevention and preparedness there has been remarkably little attention given to true pandemic prevention,” Sizer later told Health Policy Watch. “We know where most pandemics come from and we know how to reduce the risk of zoonotic spillover of the vruses that cause them,” he added. “Governments in general and health agencies in particular should embrace these approaches, including One Health efforts. They should also work much more closely with environmental agencies to address spillover risk from tropical deforestation, wildlife exploitation and trade, and intensive animal agriculture. The public health return on investment in such activities would be enormous.” Health and Environment: WHO structures preserve a deep divide Researcher explores evidence around the wildlife-trade- pandemic nexus (Wildlife Conservation Society) There are parallel calls to better incorporate such concerns into any future “pandemic instrument” intended to have a broader scope than the International Health Regulations, and to be the focus of intense negotiations by a WHA Intergovernmental Board (INB) in coming months. However, the yawning chasm environmental groups encounter in trying to to interact with WHO and WHO member states over environmental health and One Health concerns, can sometimes appear as wide as the divide between member states on the terms around sexual health. “It has been exceedingly difficult to engage with the WHA or with the intergovernmental negotiating body’s (INB) process to draft and negotiate a new pandemic instrument,” Christine Franklin, of the Wildlife Conservation Society, another member of the Preventing Pandemics coalition, told Health Policy Watch. The club of non-state actors in ‘official relations’ “Only non-State actors in official relations with the WHO are invited to engage with the WHA,” she remarked. That status of ‘official relations’ not only allows civil society groups the privilege of expounding on their positions at the annual World Health Assembly, it gives them access to lengthy and detailed informal member state consultations and intergovernmental negotiating sessions that are closed to the general public and the media. Some 220 civil society actors hold that coveted status, mostly mainstream medical and health societies as well as pharma groups, but also agro-business foundations, such as CropLife International, as well as the outliers like the World Plumbing Council. A review by Health Policy Watch found nary an environmental or eco-health group on the list, as of February 2022. “So even though Wildlife Conservation Society has been working across the globe for more than 125 years; is the only international conservation organization with an embedded health program, works on the ground in more than 60 countries; and our health program is recognized as a One Health founder and a leader at the nexus of health and the environment, the INB’s public hearing has been the only opportunity we have had to provide input,” Franklin lamented. “Oral testimonies were limited to two minutes and written statements restricted to 250 words. In fact, there are no organizations from the conservation or environment communities in official relations with the WHO and the process to gain status is complex and lengthy.” Image Credits: Germany's UN Mission in Geneva , WHO, Lancet Planetary Health, Nature , Pierce Mill Media, Wildlife Conservation Society . Doubling of Monkeypox Cases Outside of Endemic Countries Raises New Alarm Bells at WHO 01/06/2022 Raisa Santos & Elaine Ruth Fletcher Monkeypox lesions In just a matter of three days, the number of monkeypox cases reported to WHO outside of central and west Africa has doubled – with reports Wednesday of some 550 cases in more than 30 countries outside of the countries where the disease is endemic, WHO Director General, Dr Tedros Adhanom Ghebreyesus told a press briefing on Wednesday. That, as compared to reports of 257 cases outside of Africa, as of Sunday, 30 May. The ‘sudden appearance’ of monkeypox in so many non-endemic countries is prompting new concerns that it could spread to more “vulnerable populations” in countries where it has suddenly emerged, including pregnant women and children, added WHO’s Maria Van Kerkhove, Health Emergencies technical lead. WHO Briefing, 1 June 2022 “Investigations are ongoing, but the sudden appearance of monkeypox in many countries at the same time suggests there may have been undetected transmission for some time,” said WHO Director-General Tedros Adhanom Ghebreyesus during a press briefing Wednesday. “WHO’s priority now is to first provide accurate information to those groups most at risk, and second to prevent further spread among at-risk groups, to advance our understanding of monkeypox.” WHO is organizing two R&D meetings of experts on Thursday and Friday of this week, to further discuss monkeypox and understand the current surge in cases. Ecological pressures prompting rapid disease emergence Gambian pouched rat – rodents are a common animal reservoir for monkeypox Monkeypox has long circulated in 12 countries of central and western Africa, with a rising incidence over time. Disease prevalence is highest in the Democratic Republic of Congo, which has reported several thousand cases a year, and where the monkeypox clade, or variant, in circulation is more deadly. The disease has been reported to have mortality rates of up to 10% in the DRC. Noone has yet reported to have died from the outbreak that has occurred abroad recently – which has been traced to the milder West African clade. Cases of monkeypox in endemic countries between 15 December 2021 to 1 May 2022 Increased circulation of the disease in Africa in recent years has been linked to deforestation – which put wild animals in closer contact with humans, as well as increased agro-food storage, and consequent infestation of food containers by infected rats. Additionally, human travelers as well as the trade in exotic animals has been linked to the appearance of some cases overseas in the past. But the appearance of so many cases abroad is a new phenomenon, where community transmission is now occurring, including among networks of men who have sex with men, WHO said. The changes in ecosystems, trade and travel have been exacerbated by a decline in human immunity to the disease, due to the discontinuation of smallpox vaccination in the 1970s, which was protective against monkeypox as well. Ecological pressures need to be addressed Michael Ryan, WHO Executive Director, Health Emergencies Beyond the immediate health system measures needed to track and trace the spiral of increasing human cases occurring daily, more attention needs to be given to the underlying drivers, and ‘ecological pressure’ that has caused disease outbreaks to expand in size and scope,WHO’s Executive Director of Health Emergencies Mike Ryan told the briefing. “Animals are changing their behavior, humans are changing their behavior. What we’re dealing with is a lot of ecological fragility,” said Ryan. “We’re dealing with the animal-human interface being quite unstable, and the number of times that these diseases cross into humans is increasing, [as well as] that ability to amplify the disease and move it within our communities.” But he did not elaborate on how WHO might address such drivers – beyond saying that they could be a topic of discussion at this week’s R&D meeting convened by the global health agency. Inequity of investment in monkeypox in Europe versus Africa already apparent The current outbreak also highlights once more, the boomerang effect of inequitable investments in health systems and disease control in Africa, where monkeypox has been circulating for decades in countries that lack the tools to track and tackle such infections, Ryan said. “There are thousands and thousands of cases of monkeypox every year in Africa, and there are deaths every year….. And now, we have a concern about this disease spreading in Europe, but I certainly haven’t heard that same level of concern over the last five or ten years.” “Are we in a position to collectively respond? Are we in a position to share resources in order to stop transmission of these diseases within human communities?,” Ryan asked. Already, countries such as the United Kingdom have vaccinated more than 1,000 people at risk of contracting the virus, and the European Union is in discussions to buy smallpox vaccines from Bavarian Nordic, the only maker of the vaccine licensed in Europe, according to media reports. Smallpox vaccines are estimated to be about 85% effective against monkeypox, which is in the same orthopox family of viruses – but there have been no such vaccination campaigns in monkeypox hotspots such as DRC for decades. “It’s a bit uncomfortable that we have a different attitude to the kinds of resources we deploy depending on where cases are,” said Dr Jimmy Whittworth, of the London School of Hygiene and Tropical Medicine, speaking to the Associated Press. “It exposes a moral failing when those interventions aren’t available for the millions of people in Africa who need them.” Stigma against disease may prevent care, increase transmission Tedros Adhanom Ghebreyesus, WHO Director-General Meanwhile, WHO’s Tedros urged people to fight against stigma associated with the transmission of monkeypox in networks of men who have sex with men (MSM) – and underlined that the disease can be transmitted in a range of ways. Those include through contact with: infected saliva and mouth lesions, bedding as well as transmission of pregnant women to their unborn children through the placenta, according to a WHO seminar on the issue Tuesday. Tedros said that MSM advocacy groups “are working hard to inform [members of their community] about the risks of monkeypox and prevent transmission. But all of us must work hard to fight stigma, which is not just wrong. It could also prevent infected individuals from seeking care, making it harder to stop transmission.” “Anyone can be infected with monkeypox if they have close physical contact with someone else who was infected,” he said. The virus was first identified in 1958 in a colony of captive African research monkeys. The first human case was identified in the DRC in 1970, during the period of smallpox elimination campaigns. Even before the current outbreak, there have been limited waves of cases reported in non-endemic countries through channels such as the export of exotic animals, such as infected mice, squirrels, and rats, from Ghana to the United States in 2003, as well as by infected travelers. Misinformation campaign to target monkeypox Maria van Kerkhove, WHO Technical Lead on COVID-19 WHO is also mounting a campaign on disinformation about the disease, said Gabby Stern, WHO Communications Director. WHO is currently working with both social media companies and tech companies, urging them to filter out the misinformation and push out accurate information through their channels and platforms, said She said that misinformation and disinformation was a ‘major priority’ for both WHO and the United Nations. “Misinformation kills, just as these viruses kill, misinformation kills as well,” added Dr Maria van Kerkhove, WHO technical Lead on COVID-19. “This remains a constant challenge, not only COVID-19 across the entire spectrum of interventions and the response that we have. It’s the attacks on science that undermine the effectiveness of our countermeasures.” Image Credits: Tessa Davis/Twitter , Laëtitia Dudous, WHO, Disease Outbreak News, 21 May 2022 . Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Moderna Doses First Participants in Phase 3 Study of mRNA Flu Vaccine 07/06/2022 Maayan Hoffman A medical assistant gives a flu vaccination. Moderna announced Tuesday that the first participants have been vaccinated in a Phase 3 study of its influenza (flu) vaccine, which is based on mRNA technology used in its COVID-19 vaccine. The vaccine, mRNA-1010, encodes for hemagglutinin (HA) glycoproteins of the four influenza strains recommended by the World Health Organization (WHO) for the prevention of influenza. Flu epidemics generally occur in the winter and some years can place a heavy burden on healthcare systems, with as many as 3 million to 5 million severe cases and, at its worst, as many as 650,000 deaths, according to WHO. The trial is expected to enroll approximately 6,000 adults in countries in the southern hemisphere. It is a randomized, observer-blind study that is meant to evaluate the safety and immunological efficacy of mRNA-1010 in comparison to a licensed seasonal influenza vaccine in adults 18 years and older. Participants will be randomly assigned on a 1:1 ratio to receive either a single dose of mRNA-1010 or a single dose of a licensed seasonal influenza vaccine as a comparator. The company aims to run a confirmatory efficacy study for mRNA-1010 as early as the 2022/2023 northern hemisphere influenza season. “mRNA-1010 is the first of several influenza vaccine candidates we are developing with the aim of iteratively improving traditional vaccines by inducing broad and robust immune responses,” Moderna CEO Stéphane Bancel said in a release. “We believe our mRNA platform, with the flexibility and speed of our manufacturing process, is well-positioned to address the significant unmet need in seasonal flu. Moderna was founded 12 years ago and became well-known two years ago with the development of its SARS-CoV2 mRNA vaccine. It was the second mRNA vaccine ever to be produced and was approved by the US Food and Drug Administration. The first mRNA vaccine was developed by Pfizer and BioNTech. Moderna is currently engaged in four Phase III studies, it said, including its SARS-CoV-2 booster, RSV, seasonal flu and CMV vaccine candidates. “Beginning in the fall of 2022, the company’s Phase III pipeline could lead to three respiratory commercial launches over the next two to three years,” Bancel said. Image Credits: Moderna, KEYSTONE/Gaetan Bally. ‘Monkeypox Begins – and Must be Resolved in – Endemic Countries’ 06/06/2022 Kerry Cullinan Dr Ibrahima Socé Fall, assistant general security for emergency response The first human case of monkeypox was recorded in 1970, yet the viral disease is only getting international attention since it has spread outside Africa to 27 non-endemic countries. The World Health Organization’s (WHO) Dr Ebrahima Socé Fall described monkeypox as a “neglected tropical disease” when he opened a two-day meeting called by the WHO’s R&D Blueprint to determine research priorities last Thursday. “We need to stop the chain of transmission and we believe at this stage we can still stop the chain of transmission in non-endemic countries by ensuring surveillance in certain population groups, cross investigation contact tracing, and maybe vaccination,” said Fall, WHO’s Assistant Director-General for Emergencies Response. However, WHO scientist Ana Maria Restrepo stressed at the meeting’s conclusion that the viral disease had to be addressed in the nine African countries where it is endemic. “The problem starts and has to be resolved at the level of the endemic countries,” said Restrepo, co-convenor of the R&D Blueprint that called the meeting, at the conclusion of the meeting. “There are researchers of high quality in these countries, and they are doing high-quality research despite the limitations, and our commitment is to support them.” Squirrel pox? The intention of the meeting – attended virtually by over 500 scientists – was to identify research priorities, and when it ended on Friday afternoon, the scientists had identified a long list of unknowns. One of the big questions is whether there is an “unknown animal reservoir” for monkeypox – with squirrels and rats being fingered as the most likely suspects. The Central African sun squirrel is particularly susceptible to monkeypox – and one researcher suggested the pox might have been more aptly named after it. “What was the first reservoir?” asked Dr Paul Fine of the London School of Hygiene and Tropical Medicine. “We think monkey because of the name monkeypox, but there were studies in a number of other species and it was found in several of them, in particular squirrels, particular the sun squirrel of Central Africa. So one might ask if this name is appropriate. Is it just monkeypox or are there other species very importantly, involved as reservoirs?” SARS Co-V2 comes from bats, while monkeypox could come from rats. Professor Jean-Jaques Muyembe Tamfum, director of the DRC’s Institute de Recherche Biomedicale, said that the majority of monkeypox cases in his country were children infected by hunting and handling rodents and squirrels. Adults were exposed to the virus by hunting monkeys. “The virus enters the body through the broken skin, and spreads in the mucous membranes and eyes, nose and the rest,” said Tamfum. Complications of monkeypox include bacterial conjunctivitis and even blindness. Scientists also raised whether rodents could be infected by “spillover” from human waste. The meeting resolved that a “comprehensive One Health approach” was needed to understand animal-to-human transmission and animal reservoirs. A ‘One Health’ approach is neeed for monkeypox Mutations and drivers Genomic sequencing of the current strain of monkeypox spreading internationally shows that it has 47 mutations when compared to a 2018 sample. This is surprisingly high, and one hypothesis is that the monkeypox virus has been mutating in an unknown animal – or perhaps more than one animal behind the two different clades – the Central African clade with a mortality rate of around 10% and the West African clade with a 2-3% fatality rate. Aside from the international spread of monkeypox, there has also been a dramatic increase in cases in endemic countries especially DRC and Nigeria. Nigeria’s Professor Dimie Ogoina told the meeting that his country was also seeing an increase in cases in areas where it had not previously been seen. Scientists thus want to unpack what is driving the transmission, as monkeypox is not known to be particularly infectious. In the past, infected people only passed the virus on to about 8-15% of the people living in the same house. The European outbreaks appear to stem from sexual contact at two events – in Berlin and on the Canary Islands, according to news reports. This is not typically how it has been transmitted, and the meeting raised a number of questions about sexual transmission – particularly whether it can be transmitted via semen and vaginal fluid, not just through contact with the infected lesions. “Monkeypox manifests in rashes. Would a person still engage in sex with these rashes? We need to look at asymptomatic transmission,” said Ogoina. Tricky diagnosis In Nigeria, men are significantly more likely to get monkeypox than women, raising questions about what makes them more vulnerable. Ogoina, from Niger Delta University, also revealed that people coinfected with HIV and monkeypox had “bigger lesions” and were more likely to have genital lesions – although only five such patients were examined. “It is very important just to recognise that the vast majority of recent cases, especially in DRC, are suspected cases or their probable cases or possible cases, they’re not confirmed,” stressed Fine. Some of the symptoms of monkeypox are similar to those of syphilis and chicken pox, and the meeting identified the need for better diagnostics. “WHO, through our regional offices, is working with African countries, regional institutions, technical and financial partners, to increase the ability to support disease surveillance laboratory diagnostics, readiness and response actions related to monkeypox,” said WHO epidemiologist Maria van Kerkhove. “We have to acknowledge the fact that this virus has been circulating for decades, and we now have attention to this. This unfortunately is a sad reality of the world that we live in. But we need to use this as an opportunity to advance our understanding of this virus to help everyone everywhere dealing with monkeypox,” said Van Kerkhove. Implementing COVID lessons Professor Helen Rees Professor Helen Rees, who moderated the two-day meeting, said that COVID-19 had shown the need for rapid global responses to emerging health threats. Rees called for “partnerships, collaboration, strategies that get us into the field quickly, antivirals and vaccines”. “We’re also seeing this interface with One Health, with environmental degradation and climate change. All of these things are coming to the fore. Just to underline this is not a pandemic, this is an outbreak that we are scratching our heads about. But the fact that we should respond now and rapidly is really excellent,” added Rees, a renowned scientist from South Africa’s University of Witwatersrand. WHO scientist Ana Maria Restrepo concluded the meeting by stressing that it was important to practice what had been preached during COVID-19. “We talked very much about the new health architecture for response to pandemics, and the lessons learned,” said Restrepo. “We are convinced that showing a good response for this multi-country outbreak is our best example of how we are going to be prepared for the next pandemic. “If we do when we all preach, we work together if we collaborate, we use master protocols, if we engage the countries; the communities – if we learn those lessons, and if we put equity at the centre of the discussions, then yes we have learned our lessons and we are moving forward towards being better prepared,” said Restrepo. Ana Maria Restrepo Expedited studies The meeting concluded with experts calling for expedited studies to better understand the disease epidemiology, clinical consequences, and modes of transmission. While the smallpox vaccine offers over 80% against monkeypox, it is unclear whether this protection endures – and smallpox vaccination was discontinued in the 1970s. The experts emphasized the need for clinical studies of vaccines and therapeutics to better document their efficacy and understand how to use them in this and future outbreaks. The meeting also called for immediate implementation of public health activities including communicating prevention information, enhanced disease surveillance, contact tracing, isolation of cases and optimized care of people with the virus. Self-Care Practices Can Save Millions and Alleviate Pressure on Health Systems 06/06/2022 Aishwarya Tendolkar In a world where health workers are scarce, self-care practices can drastically improve people’s quality of life and alleviate strain on health systems, but depend on a range of factors including patient literacy, fair prices and government stewardship. This is according to a one-of-a-kind global study demonstrating the value of self-care that was launched on the sidelines of recent World Health Assembly in Geneva. The World Health Organization (WHO) defines self-care as “the ability of individuals, families, and communities to promote health, prevent disease, maintain health, and to cope with illness and disability with or without the support of a healthcare provider.” Current self-care activities around the world are generating annual savings of approximately $119 billion, along with saving 11 billion patient hours worldwide, according to the study. The study was produced by the Swiss-based Global Self-Care Federation (GSCF), which represents manufacturers and distributors of non-prescription medicines on all continents. Self-care cost-saving (source: Global Self-Care Federation report). Low-income countries lagging But the low-income countries are still lagging in implementing and reaping the benefits of self-care. “In low-income countries, about 65% of households that could not obtain essential health services had financial constraints,” said Dr Ritu Sadana, WHO Head of Ageing and Health Division of Universal Health Coverge (UHC), one of the panelists at the launch of the report. “This is more than triple the proportion of households who lack access to health services because they are just unavailable, which is 20%.” High-income countries are reaping the most benefits of self-care practices while the low-and middle-income countries are playing catch-up. With increased adoption of self-care, we will be seeing an additional $19.5 billion in annual cost savings related to the increased adoption of self-care by 2030, said Ben Carrick, Johnson and Johnson’s senior director of consumer policy. “If we think about the welfare benefits, it could be leading to an annual increase of $312 billion per year globally. These are significant benefits that are worth chasing and grasping,” Carrick told the launch. To estimate the true #ValueofSelfCare, we must first understand how it operates across different global contexts. Our 3 country groupings allow us to unlock such insights. 🌏 Read the report to learn the full scope of benefits that can be achieved:https://t.co/h5gTOOsgUl pic.twitter.com/ZMrINWpIax — The Global Self-Care Federation (@Selfcarefed_org) June 6, 2022 The study grouped 155 countries based on their GDP levels, and then gauged the self-care effects. In the high-income countries (Group A), self-care is already making an indispensable contribution to relieving the burden on healthcare systems. But it is in the low-and middle-income countries (Group B and C), where self-care can enable a person to work and not depend on welfare. “We don’t need more GDP; we need more welfare and this is also what this project is about, this is what self-care is about… to generate more welfare and not just be focused on figures and economic factors,” said Professor Uwe May, Dean of Studies at Fresenius University. He added that currently if people practised self-care instead of doing nothing about their health issues, 41 billion productive days can be gained on a global level. Self-care ‘only option’ in poor countries The study also found that health economic and pharmacoeconomic approaches deployed to assess the value of self-care cannot be transferred to lower-income regions where the infrastructure, socio-economic factors, and awareness is different. In addition, lack of access to over-the-counter (OTC) medicine and the prevalence of traditional medicines also has an impact on self-care options. In regions like sub-Saharan Africa and South East Asia, self-care is not an alternative care option, but is often “the only possible access to treatment for most individuals”, according to the report. In these countries, self-care does not translate into saving on doctors’ and specialists’ time. “This is where the welfare benefits are really the main opportunity because it isn’t saving physicians’ time and people don’t have access to the physicians,” said Carrick. “But if it means that they’re productive, they’re back at work and they’re able to look after families, then it’s those welfare and productivity benefits that really come into play.”. In Latin America and the Caribbean, the practice of self-care and the use of OTC products leads to current welfare savings of $123 per capita per year. The more the OTC use increases, the greater the individual and societal benefits can be realised through self-care, according to the study “We estimated that at least 142 million older persons, about 14% of older persons worldwide, are unable to meet some of their basic needs. So the issues around self-care for themselves or by their families or care providers is extremely important,” said Carrick. What do we need now? The report highlights the need for private-public partnerships, digital and healthcare literacy in people living in low-and middle-income countries (LMICs) and better parameters to gauge healthcare outcomes in a country. “We need strong stewardship by government, and to have really strong capacities in government institutions…so that they can lead and shape how we actually get things done with the private sector, with multiple sectors across the government and also obviously, civil society and self-care demands with the active participation of people,” said Sadana. “Health literacy is a fundamental catalyst for change to ensure individuals comprehend and act on credible health information, becoming active self-managers of their own health,” said Carrick. Experts at the launch also highlighted the need for pharmacies to be more involved in developing better policies, and for governments to spend more on ensuring that self-care is delivered through, not only OTC and literacy, but also nutrition, lifestyle, and affordable healthcare. Sadana said that in India, 70% of all healthcare costs are paid out of pocket, and 70% of that was on drugs. “If we’re going to have a system which encourages self-care, using products that are evidence-based and quality-controlled, we still need to have a way to ensure that those are covered [by the health system] if we actually want a vast swathe of the population to use them.” Image Credits: Tbel Abuseridze/ Unsplash. Climate Crisis Poses Serious Risk to Mental Health – WHO 03/06/2022 Raisa Santos Climate change poses serious risks to mental health and well-being, concluded a new World Health Organization policy brief, launched on Friday at the Stockholm+50 conference. Natural disasters such as floods, heatwaves, storms, and drought can pose a threat to mental health and psychosocial well-being, exacerbating emotional distress, anxiety, depression, grief, and suicidal behavior. WHO is therefore urging countries to include mental health and psychosocial support in their response to climate change. “The impacts of climate change are increasingly part of our daily lives, and there is very little dedicated mental health support available for people and communities dealing with climate-related hazards and long-term risk,” said Dr Maria Neira, WHO’s Director of Environment, Climate Change, and Health. #ClimateChange poses serious risks to #MentalHealth and well-being – from emotional distress to anxiety, depression, grief, and suicidal behavior: new WHO policy brief https://t.co/ogdEP9iIG6 pic.twitter.com/VRqrMqoixr — World Health Organization (WHO) (@WHO) June 3, 2022 The findings concur with a report made by the Intergovernmental Panel on Climate Change (IPCC) published in February of this year, which revealed that half of the world’s populations live in climate ‘danger zones’ that place “people’s health, lives, and livelihoods” at risk, and this can also include people’s mental health. The two-day conference, hosted by the government of Sweden and convened by the United Nations General Assembly on 2 – 3 June, drew together thousands of participants across government, civil society, and the private sector in an effort to spur urgent action for a healthy planet. The meeting also commemorates 50 years since the 1972 UN Conference on the Human Environment, which made the environment a pressing issue for the first time. Climate change impact on mental health The mental health impacts of climate change are felt disproportionately around the world, with support services unequally distributed as well. While there are nearly 1 billion people living with mental health conditions, 3 out of 4 do not have access to needed services in low- and middle-income countries. A 2021 WHO survey found that out of 95 countries, only 9 have thus far included mental health and psychosocial support in their national health and climate change plans. Additionally, while the annual cost of common mental disorders is $1 trillion, only 2% of government health budgets are spent on mental health. These figures are all exacerbated by climate change. “The impact of climate change is compounding the already extremely challenging situation for mental health and health services globally,” said Devora Kestel, WHO Director of the Department of Mental Health and Substance Abuse. Examples of how climate change can impact mental health include the loss of personally important places, loss of autonomy and control, and exposure to pollution, which is associated with increased risk for mental health conditions. The new policy brief recommends five important approaches for governments to address the mental health impacts of climate change: Integrate climate considerations with mental health programs Integrate mental health support with climate action Build upon global commitments Development of community-based approaches to reduce vulnerabilities to climate change, and Close the funding gap for mental health and psychosocial support “By ramping up mental health and psychosocial support within disaster risk reduction and climate action, countries can do more to help protect those most at risk,” said Kestel. Image Credits: Clay Kaufmann/ Unsplash. After Many Missed Opportunities, Oral Health Gets Long Overdue Attention from WHO 03/06/2022 Ihsane Ben Yahya & Greg Chadwick Dental services, including regular check-ups, were among the most disrupted essential health services during the COVID-19 lockdowns. People´s reticence to visit a dentist during normal times was exacerbated by fear of venturing into an open clinic or simply not being able to, due to restrictions. Dental hesitancy has always been around but over two years into the pandemic, it´s now a lot worse. This hesitancy is also echoed at the policy level. Oral health has, until very recently, been considered the “ugly duckling” of global health efforts. The World Health Organization (WHO) has only ever passed a special resolution on oral health twice in its history: most recently, ironically, in the midst of the COVID-19 pandemic in 2021. The new global oral health strategy, approved by governments at 75th WHO World Health Assembly last week is a step in the right direction, and it is long overdue. 📣The WHO global #OralHealth strategy has officially been approved and adopted at the #WHA75 👏 FDI commends the strategy and tells @WHO that we are ready to support the development of the subsequent action plan and monitoring framework by 2023 ➡️ https://t.co/mTPgDRSB24 pic.twitter.com/MYf1nFap8e — FDI World Dental Federation (@fdiworlddental) May 28, 2022 Oral health is essential for overall health It´s a perfect time to double down on just why responding to the global oral health epidemic is in our broader (health) interests. Getting people back into dental clinics and protecting their oral health is essential to safeguarding their overall health, well-being, and quality of life. All those factors that can make people vulnerable to chronic non-communicable diseases (NCDs) such as cardiovascular disease, cancer, chronic respiratory disease, and diabetes are equally risky for one´s oral health. High sugar consumption, harmful alcohol use and tobacco are just as bad for our bodies as they are for our mouths. The impact in pure numbers is alarming: there were some 3.5 billion cases of oral diseases and other oral conditions in 2017. For the last three decades, the combined global prevalence of dental caries (tooth decay), periodontal (gum) disease and tooth loss has stood at 45% – higher than any other NCD. Ignoring the problem makes no sense, financial or otherwise. Worldwide, oral diseases accounted in 2015 for $ 357 billion in direct costs and US$ 188 billion in indirect costs. In the same year, $96.2 billion was spent on the treatment of oral diseases across the European Union, the third-highest total among NCDs, behind diabetes and cardiovascular diseases. “Without good oral health, you’re not healthy,” former US Surgeon-General David Satcher once said, and he was right. The largely siloed approach to dealing with oral health makes no policy sense either, especially when we consider the evidence. Junk food and tooth decay We know that bacteria and inflammation associated with periodontal disease are linked to cardiovascular disease, rheumatoid arthritis, and adverse effects in pregnancy. We also know that people living with diabetes experience improved blood glucose levels if their periodontal (gum) disease is managed correctly. Knowing what we know about poor oral health – that it is preventable and if addressed can help improve our overall health – only begs the question as to why more is not being done to integrate it into other NCD programmes? The pending ban on television and online advertising of junk food in the UK before 9pm is a great example of encouraging better diet. So too is the campaign by UK footballer Marcus Rashford to promote healthier school lunches. But they are missed opportunities. With forethought, both interventions could have included some key messages for children and parents around the connection between a healthy diet and good oral health. Future campaigns could better highlight the need to prioritize oral health promotion in schools, communities and workplaces as well as ensure access to the millions of people who cannot afford the basics, such as fluoridated toothpaste. We need to globally re-think how we talk about and tackle oral diseases. In the vast majority of countries, even essential oral health services are not part of universal health coverage. Oral diseases are noncommunicable diseases and need to be treated as such. Advocates have long argued that investment in prevention produces strong economic returns and saves millions of lives. COVID-19 has reinforced the huge economic and human cost of not doing so: people living with chronic diseases like diabetes, cancer and cardiovascular were at much higher risk of becoming seriously ill, hospitalized, or dying from SARS‑CoV‑2. At the same time, the pandemic is just a microcosm of the bigger picture: our past failure to address oral disease in a substantive way and to view it as an NCD like any other. Prof Ihsane Ben Yahya Prof Ihsane Ben Yahya is the President of the FDI World Dental Federation and professor at the Dental University in Casablanca, Morocco. Dr Greg Chadwick Dr Greg Chadwick is the President-elect of FDI World Dental Federation and Dean at East Carolina University, School of Dental Medicine, United States. Image Credits: Caroline LM/ Unsplash, FDI World Dental Federation. Shanghai Lockdown is Finally Relaxed But Stringent Testing Still Required 02/06/2022 Raisa Santos Shanghai eased its lockdown restrictions 1 June 2022, following continuous low cases reported. Sixty five days after one of the toughest lockdowns in the world, China has eased COVID-19 restrictions on its financial hub, Shanghai, on Wednesday – finally allowing the majority of its 25 million residents to move freely again. However, at least 890,000 residents are confined at home, in “quarantine” or “control zones”. The announcement to lift restrictions came as official figures showed on Sunday that daily new coronavirus cases fell from 170 to 122 in a 24-hour period. The city reported just 13 cases for Wednesday, and an additional 7 cases on Thursday. This is a marked turnaround from the beginning of April, when tens of thousands of cases were reported daily. “This is a day that we dreamed of for a very long time,” Shanghai government spokeswoman Yin Xin told the BBC. China to maintain ‘zero tolerance’ policy Shanghai residents will be required to hold a negative nucleic acid test result taken within 72 hours of entering public spaces or using public transportation from June But while China seems to have moved into the clear with COVID, the country is keen to maintain its “zero tolerance” policy, and is already preparing for future waves. Beijing municipal officials said Thursday that 12 of its planned 14 ‘transition hubs’ will be used to test and disinfect all imported frozen food before goods are distributed across the city. This follows China’s contention that frozen food could transmit COVID-19 in while the World Health Organization’s independent panel on the virus’s origins favour an unknown animal vector as the most likely cause, while others have pointed to laboratory accident for the spread of the coronavirus first found in bats in China. Tens of thousands of testing booths will also be set up across China’s largest cities, including Beijing, Shanghai, and technological hub Shenzhen, to require testing as often as every 48 hours. New rules in Shanghai will now require residents to show a green health code on their smartphone, with proof of a negative PCR test in the last 72 hours, to leave their residential compounds and enter most places, including banks, malls, and public transportation. However, cinemas, museums, and gyms remain closed, as well as in-person schooling. Restrictions on leaving the city still remain, with anyone traveling to another city facing a quarantine of seven to 14 days upon return. Beijing also lifted its restrictions earlier this week, following similar protocol with some of its public transportation system, malls, and other venues opening up. Shanghai testing centers tested by overcapacity and staff shortages Shanghai testing center Shanghai’s 72-hour rule has tested the capacity of its testing centers, as crowds flocked to the 15,000 stations. While some said their test took only a matter of minutes, others complained that they had to wait over an hour to test. Many testing booths are only open for about three hours each in the morning and afternoon, although some hospitals offer a 24-hour service. Shanghai resident Zhang Zehong told Sixth Tone that she was unable to test Wednesday as the station in her neighborhood closed two hours earlier than shown on the city’s health code app, which features all the testing centers. Instead, she went to a hospital with a 24-hour service Thursday morning, only to find no staff and a line that stretched on for over 100 meters. So many issues need to be fixed,” Zhang said. Chinese microblogging platform Weibo also featured complaints with the stations. “It’s been very hot recently, several people passed out when standing (in line),” one Weibo user wrote. “I visited five sites but each had long queues. This is not really humane enough. Don’t these mobile kiosks cause more people to gather?” another Weibo user wrote. Fifty-point plan to revive Shanghai economy A fifty-point plan has also been drawn up to support Shanghai’s economy, crippled in the wake of closures, quarantines, and lockdowns. New measures include reducing taxes for car buyers, speeding up the issuance of local government bonds, and fast-tracked approval of building projects. Drivers who also switch to an electric vehicle will also be able to claim a $1500 subsidy. Businesses may also be able to delay insurance and rent payments, with subsidies available for utility charges. Image Credits: Appriseug/Twitter , DA Trade Market Securities/Twitter , Don Weinland/Twitter. Eight Countries Compete to Host African Medicines Agency at Crucial African Union Meeting 02/06/2022 Paul Adepoju AMA headquarters host country is expected to be named at the end of an ongoing meeting in Addis Ababa A meeting to decide which African country will be the host country for the African Medicines Agency (AMA) is underway and at the last count, expressions of interest in hosting the agency have been received from Uganda, Algeria, Egypt, Morocco, Rwanda, Tanzania, Tunisia and Zimbabwe. The decision is expected to be one of the outcomes at the ongoing first Ordinary session of the Conference of State Parties (CoSP) of the AMA, in Addis Ababa, Ethiopia from 1 to 3 June 2022. The CoSP is reviewing the AMA assessment report and at the end of their meeting, it will make recommendations on the host country of the AMA Headquarters. A final decision on this recommendation will be made at the next assembly of the African Union. Uganda is one of the countries vying to host the AMA Headquarters and the country’s delegation to the CoSP meeting is led by the country’s Minister of Health, Dr Jane Aceng, and Dr Diana Atwine, a Permanent Secretary in the Ministry of Health. Zimbabwe’s team is a four-member delegation led by the country’s Health and Child Care deputy Minister, Dr John Mangwiro. Sierra Leone is also attending the session led by Minister of Health and Sanitation Dr Austin Demby. In his remark at the official launch of the Africa CDC’s Ministerial Executive Leadership Program (MELP), Dr John Nkengasong, Africa CDC’s outgoing Director General confirmed the CoSP’s outcome would play a critical role in deciding the future of the agency. “The launch of the AMA is really another landmark initiative of the African Union as part of the Agenda 63. I can’t wait to hear the outcome of the deliberations. It’s going to be transformational when the AMA and we are truly excited with that,” Nkengasong said. The three-day ministerial meeting will deliberate on the priorities and next steps to establish the AMA. From Geneva to Addis Ababa At last week’s World Health Assembly, Amref Health Africa’s Desta Lakew, on behalf of the African Medicines Agency Treaty Alliance (AMATA) described AMA as an initiative of the African Union aimed at strengthening the regulatory environment to guarantee access to quality, safe and efficacious medicines, medical products, and technologies on the continent. Countries that have signed the treaty, according to AMATA, are Algeria, Benin, Chad, Ghana, Madagascar, Mali, Morocco, Rwanda, Saharawi Arab Democratic Republic, Senegal, and Tunisia. But about four years after the AU Assembly adopted the AMA Treaty, Lakew noted that some Member States still haven’t given it the authority to fulfill its mandate. “The increased risk of disease outbreaks in the region and globally has made access to medical products a priority. Trade in locally produced medical products, including Personal Protective Equipment, across African countries will be hampered if we do not have a harmonized regulatory environment,” Lakew told WHA 75. At the CoSP meeting, the AU called on all member states to sign the Treaty to see improved regulation and easy flow of medical products and technologies, are expected to be reechoed. Lakew described the call as an urgent matter “for the sake of ensuring that there is equitable access to quality, safe, efficacious medicines and technologies for a healthy Africa”. Last month, Health Policy Watch reported Kenya was preparing to join the AMA alongside thirty-one other African Union member states following the Kenyan cabinet’s decision to approve the ratification of the African Union Treaty. See more about the African Medicines Agency on our special AMA Countdown page: African Medicines Agency Countdown Sex, War, Sustainability and the World Health Assembly – Last Week in Review 02/06/2022 Elaine Ruth Fletcher 75th World Health Assembly Health and peace, sex and war, money and management. Whether in chorus or cacophony – last week’s World Health Assembly of WHO member states played most of the notes in the symphony of global debate over strategies to tackle disease, epidemics and pandemics and bolster health systems. But the root causes of emerging disease threats – in modern environmental health threats and nature gone awry remained under-represented themes. From the opening notes of the WHA, on a health for peace theme, to Saturday’s late night closing and end-run charges over language on sexual orientation – this year’s WHA was a seesaw of successes and setbacks. Highs included the consensus vote Tuesday to increase member states contributions to WHO, followed by a resolution Friday to move ahead on the first real reforms to the International Health Regulations in almost 20 years. And at the same time, unprecedented polarization was evident during Thursday’s debate over a resolution condemning Russia’s invasion of Ukraine, which won approval by a vote of 88 to 12. That was followed by the dispute that emerged Friday and continued until nearly midnight Saturday over references to terms such as “sexual rights” and “men who have sex with men” (MSM) in a WHO strategy on HIV, hepatitis-B and sexually transmitted infections (STIs). That, too, was resolved only by a painful series of rollcall votes, leading to the strategy’s passage by just 60 member states, with twice as many delegates absent or abstaining. Like a bullet train ride Dr Hiroki Nakatani joins in the applause for the resolution’s passage on HIV, Hepatitis B and STIs Dr Hiroki Nakatani, who presided over the committee that faced the thorny final hours of WHA dealing with the clash among nations over sexual health terms that HIV professionals regard as the standard usage, compared this year’s WHA session to a ride on a bullet train. “The train ride was sometimes bumpy but we arrived at our destination,” he said of the first Assembly to be held in person in several years because of the pandemic. Perhaps so, even more so than the war in Ukraine, the exceptionally large number of abstentions in the vote on a new HIV, Hepatitis and STI strategy was a bitter pill to swallow for delegates on both sides of the debate. It highlighted the fact that the battles still being waged in Europe, the Middle East, Asia and Africa over the control of territory are not the only big issues dividing member states. Fissures over social norms shape and guide public health policies run just as deep. Sex & War – Global social divide as deep as territorial conflicts And among those norms, there remains a deep divide around health policies that interface with human sexuality – that other primordial urge that co-exists alongside the urge for power and territory. For WHA delegates, in fact, the series of votes Saturday over sexual terminology may have been even more unsettling than the votes over Russia’s invasion of Ukraine – precisely because they sit in Ministries of Health, not Defence, with day-to-day responsibility for designing and implementing policies on HIV and other STIs. As with the Ukraine conflict, the divide that emerged, however, was not strictly drawn along the lines of global North and South. Saudi delegate in heated WHA debate Saturday over sexual rights and terminology Rather, it was the oil-rich Saudi Arabia that led the charge in the quest to purge references to men who have sex with men from the strategy on HIV treatment, followed by emerging economies of Asia and Africa where conservative views about sexual expression are often protected by law as well as custom. Against that, was Europe, North America, much of Latin America and high-income Asia- where more new attitudes about gender identity and LGBTI terminology have taken root over the past few decades. There were also exceptions, such as South Africa, which voted in favour of the HIV strategy. And European Serbia abstained from the vote as did the Russian Federation. Respect for culture, versus respect for evidence In the aftermath, the abstaining countries pleaded for more understanding of norms guided by tradition and culture. Western delegates, meanwhile, referred to the compass of science – whereby recent research has revealed how oft-marginalized MSM groups often fall through the cracks of programmes for HIV/AIDS prevention, diagnosis and treatment. “We appreciate those member states acted in good faith as part of these deliberations. Unfortunately this has served as a painful reminder of the need to reinforce our focus on evidence, human dignity and decency,” said US Assistant Secretary of State for Global Health Loyce Pace just after the strategy was approved. Loyce Pace, Assistant Secretary of State for Global Health, USA “[But] we should not need to hold a vote on the existence of entire communities of people,” she added. “We have a strategy on critically important global health issues, yes. But at what cost to those we risk leaving behind? “So to gay, lesbian, bisexual, queer, intersex, transgender and gender non-conforming people around the world, the United States government sees you, and will continue to support you. Stay strong.” (Right) Denmark’s EB representative, Søren Brostrøm, Director-General, Danish Health Authority, at the WHO Executive Board meeting 30 May, (left) Loyce Pace Assistant Secretary of State for Global Health, USA Reviewing the issue at Monday’s Executive Board meeting, member states on both sides of the divide expressed concerns over the failure of the WHA to find consensus over such a flagship health strategy – and the “dangerous precedent” that the voting set. “It is important that this does not set a precedent for consideration and adoption of technical documents by the Health Assembly,” said Dr Edwin Dikoloti, Botswana’s Minister of Health and Wellness, speaking on behalf of the African group, saying that greater efforts need to be made to find consensus in future WHAs over such controversial issues. Money – landmark decision on WHO finance – but not a ‘done deal’ Members of the WHO Working Group on Sustainable Finance hammer out the final agreement on increasing member state contributions, Germany’s Björn Kümmel on far left. The holy grail of consensus was restored in other key moments – including around the WHA resolution to increase regular member state contributions to WHO – in a bid to stabilize the agency’s finances The agreement, the fruit of months of grinding backroom diplomacy led by Germany, saw member states commit to increase annual assessments to cover 50% of WHO’s core budget by the end of the decade. However, each stepwise increase up until 2030 will still need endorsement at future WHAs to go forward. And so the vote should not be seen as a blank check either, a senior official in the Department of Health and Human Services, told Health Policy Watch. “I would say that the US, as a big contributor to the WHO, is definitely committed to that [resolution], and we were very happy to join the consensus,” the official said. “But I hope it’s also been clear that that is not a done deal and neither for us as the administration or for Congress.” According to the resolution, final approval of each year’s increase is contingent on progress in WHO internal reforms that are supposed to make the organization more transparent, efficient and well-managed. Those demands include overhaul of WHO’s budget management system, said the senior US official: “The budgets that are adopted by the Health Assembly are not real budgets. They’re just budget space. And creating budgets that are aspirational is very different from programming and reporting on and demonstrating the impact of real budgets.” Management – following election Tedros faces new demands Applause just after WHA re-elects Dr Tedros Adhanom Ghebreyesus to serve a second five-year term as Director-General of the World Health Organization on 24 May. He ran un-opposed. But the expectations go beyond budget reform, pressing newly re-elected Dr Tedros Adhanom Ghebreyesus for changes in WHO’s management culture, including more merit-based appointments of senior WHO staff, such as those serving as heads of WHO country offices, and structural reforms in WHO’s internal justice system. “I think, from our perspective…. there’s a very significant culture change… that needs to happen within the organization,” the official told Health Policy Watch. Further related to that, are demands for a “full resolution” of the ongoing investigation of the cases of sexual harassment and abuse of women in the Democratic Republic of Congo by WHO staff and consultants, whose progress also was reviewed at last week’s WHA and Monday’s EB. Justice – WHO internal justice system lacks independence While the revelations of the DRC sex abuse scandal, which first came to light in 2020, and whose perpetrators have yet to be fully prosecuted, highlight failures of WHO internal justice to date, they also are evidence of a broader and more systematic problem, some WHO insiders maintain. One key problem, highlighted in multiple interviews with both past and present WHO staff, is the fact that WHO’s Internal Oversight Office (IOS) – the legal mechanism that manages staff and management complaints – is housed in the Director-General’s Office and effectively controlled by the Director General himself – rather than at arms length. Politically influential managers or staff with the ear of the DG, may receive different treatment than staff who do not, critics say. The flaws in the current process featured in a WHO Staff Association letter to Monday’s Executive Board. The Staff Association demanded that the WHO Global Board of Appeals, the three-member body that hears cases, and recommends disciplinary action to the Director General, be expanded and also include staff-appointed representatives. “The panel of the Global Board of Appeal (GBA) should have five-members,” stated the Staff Association. “A three-member panel – the current practice – is simply not reassuring staff that GBA deliberations are sufficiently robust,” the Staff Association letter stated.“Furthermore, the staff representatives on each of the GBA panels should be selected by the respective staff association rather than selected by the GBA Chair or Deputy-Chair.” The net result of the current system is that – short of a costly and lengthy appeal to the International Labour Organization – disciplinary cases are heard by a GBA board appointed by senior managers who report directly to Tedros, who also decides on the final outcome of the cases. Dr Boubacar Diallo with WHO Director-General, Dr Tedros Adhanom Ghebreyesus and then-WHO Emergency Response Team leader, Dr Michel Yao in DRC in June 2019; Diallo was among those accused of harassment and Yao was alleged to have ignored those and other reports. With regards to the DRC cases, allegations that high-ranking WHO managers or consultants with ties to Tedros may have turned a blind eye to the reports of abuses going on in the field, have never been publicly resolved. But the concerns extend beyond sexual harrassement, to the need to foster an institutional culture of professionalism free of political interference, critics also say, pointing to other episodes like the suppression of a 2020 WHO report on Italty’s pandemic response, which criticized another senior WHO advisor to Tedros. From a sustainable budget a sustainable planet? While WHO’s financial sustainability received considerable attention at this year’s WHA, there was comparatively little debate on the planet’s sustainability crisis – and how that may be fueling a cascading array of health impacts – from more noncommunicable diseases to emerging outbreaks, such as SARS-CoV2 and more recently a worldwide surge in monkeypox. A new roadmap to accelerate work on noncommunicable diseases fails to give more than a nod to air pollution as one of the leading causes of NCDs – responsible for some 7 million deaths a year from cancers, cardiovascular and lung diseases every year. And that doesn’t even include risks from chemicals exposures that make the total estimate of deaths from pollution closer to 9 million annually, according to a new Lancet Planetary Health Report released on 18 May. Deaths attributable to key “modern” and “traditional” pollution sources for which data is available In a debate over an NCD roadmap that aims to slash NCD risks by one third by 2030, France, speaking on behalf of some European Union member states,called for a more “integrated” approach that includes environmental health and climate change. So far, such approaches have been slow in coming. Despite the rhetoric about air pollution being a leading risk factor for NCDs, there are, as yet, no WHO “Best Buys” for environmental strategies that reduce deadly pollution risks – even if measures like clean public transport and compact cities, built around cycling and walking networks, are regarded by urban planners and transport managers as evidence-based solutions that have a record of demonstrated results. ‘One Health’ and food safety – some new approaches Caged animals held for sale and slaughter in unsanitary conditions at Wuhan’s Huanan Seafood Market, prior to the outbreak of COVID-19, including: (a) King rat snake (Elaphe carinata), (b) Chinese bamboo rat (Rhizomys sinensis), (c) Amur hedgehog (Erinaceus amurensis) (the finger points to a tick), (d) Raccoon dog (Nyctereutes procyonoides), (e) Marmot (Marmota himalayana) (beneath the marmots is a cage containing hedgehogs), and (f) Hog badger (Arctonyx albogularis). On the brigher side, a new WHO Global Strategy for Food Safety was approved by member states. For the first time ever, the strategy makes reference, at least in passing, to the need for a “One Health approach when addressing health risks emerging at the human-animal-ecosystems interface.” A companion decision asks WHO to also update its guidance on Reducing public health risks associated with the sale of live wild animals of mammalian species in traditional food markets. Such guidance emerges out of the SARS-CoV2 pandemic, where peoples’ exposure to SARS-CoV2 infected animals in the Wuhan, China live animal market is considered to be one of the most plausible routes by which SARS-CoV2 initially leaped from animal to human populations in Wuhan, China during 2019. But the caging and slaughter of live, wild animals in areas heavily trafficked by customers are practices common in thousands of traditional markets in Asia and Southeast Asia, as well as parts of Africa, leading to further risks of human exposure to pathogens the animals may harbour. Not nearly enough action to stop pandemics at source The unsafe handling of live animals that are sold for slaughter at traditional markets can risk the spread of foodborne and infectious diseases. Such “One Health” issues need far more deliberate and systematic WHO and member state attention than the nod that they have so far, a growing chorus of “Ecohealth” experts say. In a little-noticed press release issued during WHA, Dr Nigel Sizer, executive director of the consortium Preventing Pandemics at the Source called upon the WHA to do more to address ecosystem risks upstream that increase “spillover risks” of pathogen leap from animal to human populations: “Such actions include shutting down or strictly regulating wildlife trade and markets, stopping deforestation and forest degradation, and providing better health to communities in emerging infectious disease hotspots, as well as strengthened veterinary care and biosecurity in animal husbandry,” said Sizer, an internationally known conservationist, in his statement. “Overall throughout the WHA process and in the preparations for negotiation of a possible global instrument on pandemic prevention and preparedness there has been remarkably little attention given to true pandemic prevention,” Sizer later told Health Policy Watch. “We know where most pandemics come from and we know how to reduce the risk of zoonotic spillover of the vruses that cause them,” he added. “Governments in general and health agencies in particular should embrace these approaches, including One Health efforts. They should also work much more closely with environmental agencies to address spillover risk from tropical deforestation, wildlife exploitation and trade, and intensive animal agriculture. The public health return on investment in such activities would be enormous.” Health and Environment: WHO structures preserve a deep divide Researcher explores evidence around the wildlife-trade- pandemic nexus (Wildlife Conservation Society) There are parallel calls to better incorporate such concerns into any future “pandemic instrument” intended to have a broader scope than the International Health Regulations, and to be the focus of intense negotiations by a WHA Intergovernmental Board (INB) in coming months. However, the yawning chasm environmental groups encounter in trying to to interact with WHO and WHO member states over environmental health and One Health concerns, can sometimes appear as wide as the divide between member states on the terms around sexual health. “It has been exceedingly difficult to engage with the WHA or with the intergovernmental negotiating body’s (INB) process to draft and negotiate a new pandemic instrument,” Christine Franklin, of the Wildlife Conservation Society, another member of the Preventing Pandemics coalition, told Health Policy Watch. The club of non-state actors in ‘official relations’ “Only non-State actors in official relations with the WHO are invited to engage with the WHA,” she remarked. That status of ‘official relations’ not only allows civil society groups the privilege of expounding on their positions at the annual World Health Assembly, it gives them access to lengthy and detailed informal member state consultations and intergovernmental negotiating sessions that are closed to the general public and the media. Some 220 civil society actors hold that coveted status, mostly mainstream medical and health societies as well as pharma groups, but also agro-business foundations, such as CropLife International, as well as the outliers like the World Plumbing Council. A review by Health Policy Watch found nary an environmental or eco-health group on the list, as of February 2022. “So even though Wildlife Conservation Society has been working across the globe for more than 125 years; is the only international conservation organization with an embedded health program, works on the ground in more than 60 countries; and our health program is recognized as a One Health founder and a leader at the nexus of health and the environment, the INB’s public hearing has been the only opportunity we have had to provide input,” Franklin lamented. “Oral testimonies were limited to two minutes and written statements restricted to 250 words. In fact, there are no organizations from the conservation or environment communities in official relations with the WHO and the process to gain status is complex and lengthy.” Image Credits: Germany's UN Mission in Geneva , WHO, Lancet Planetary Health, Nature , Pierce Mill Media, Wildlife Conservation Society . Doubling of Monkeypox Cases Outside of Endemic Countries Raises New Alarm Bells at WHO 01/06/2022 Raisa Santos & Elaine Ruth Fletcher Monkeypox lesions In just a matter of three days, the number of monkeypox cases reported to WHO outside of central and west Africa has doubled – with reports Wednesday of some 550 cases in more than 30 countries outside of the countries where the disease is endemic, WHO Director General, Dr Tedros Adhanom Ghebreyesus told a press briefing on Wednesday. That, as compared to reports of 257 cases outside of Africa, as of Sunday, 30 May. The ‘sudden appearance’ of monkeypox in so many non-endemic countries is prompting new concerns that it could spread to more “vulnerable populations” in countries where it has suddenly emerged, including pregnant women and children, added WHO’s Maria Van Kerkhove, Health Emergencies technical lead. WHO Briefing, 1 June 2022 “Investigations are ongoing, but the sudden appearance of monkeypox in many countries at the same time suggests there may have been undetected transmission for some time,” said WHO Director-General Tedros Adhanom Ghebreyesus during a press briefing Wednesday. “WHO’s priority now is to first provide accurate information to those groups most at risk, and second to prevent further spread among at-risk groups, to advance our understanding of monkeypox.” WHO is organizing two R&D meetings of experts on Thursday and Friday of this week, to further discuss monkeypox and understand the current surge in cases. Ecological pressures prompting rapid disease emergence Gambian pouched rat – rodents are a common animal reservoir for monkeypox Monkeypox has long circulated in 12 countries of central and western Africa, with a rising incidence over time. Disease prevalence is highest in the Democratic Republic of Congo, which has reported several thousand cases a year, and where the monkeypox clade, or variant, in circulation is more deadly. The disease has been reported to have mortality rates of up to 10% in the DRC. Noone has yet reported to have died from the outbreak that has occurred abroad recently – which has been traced to the milder West African clade. Cases of monkeypox in endemic countries between 15 December 2021 to 1 May 2022 Increased circulation of the disease in Africa in recent years has been linked to deforestation – which put wild animals in closer contact with humans, as well as increased agro-food storage, and consequent infestation of food containers by infected rats. Additionally, human travelers as well as the trade in exotic animals has been linked to the appearance of some cases overseas in the past. But the appearance of so many cases abroad is a new phenomenon, where community transmission is now occurring, including among networks of men who have sex with men, WHO said. The changes in ecosystems, trade and travel have been exacerbated by a decline in human immunity to the disease, due to the discontinuation of smallpox vaccination in the 1970s, which was protective against monkeypox as well. Ecological pressures need to be addressed Michael Ryan, WHO Executive Director, Health Emergencies Beyond the immediate health system measures needed to track and trace the spiral of increasing human cases occurring daily, more attention needs to be given to the underlying drivers, and ‘ecological pressure’ that has caused disease outbreaks to expand in size and scope,WHO’s Executive Director of Health Emergencies Mike Ryan told the briefing. “Animals are changing their behavior, humans are changing their behavior. What we’re dealing with is a lot of ecological fragility,” said Ryan. “We’re dealing with the animal-human interface being quite unstable, and the number of times that these diseases cross into humans is increasing, [as well as] that ability to amplify the disease and move it within our communities.” But he did not elaborate on how WHO might address such drivers – beyond saying that they could be a topic of discussion at this week’s R&D meeting convened by the global health agency. Inequity of investment in monkeypox in Europe versus Africa already apparent The current outbreak also highlights once more, the boomerang effect of inequitable investments in health systems and disease control in Africa, where monkeypox has been circulating for decades in countries that lack the tools to track and tackle such infections, Ryan said. “There are thousands and thousands of cases of monkeypox every year in Africa, and there are deaths every year….. And now, we have a concern about this disease spreading in Europe, but I certainly haven’t heard that same level of concern over the last five or ten years.” “Are we in a position to collectively respond? Are we in a position to share resources in order to stop transmission of these diseases within human communities?,” Ryan asked. Already, countries such as the United Kingdom have vaccinated more than 1,000 people at risk of contracting the virus, and the European Union is in discussions to buy smallpox vaccines from Bavarian Nordic, the only maker of the vaccine licensed in Europe, according to media reports. Smallpox vaccines are estimated to be about 85% effective against monkeypox, which is in the same orthopox family of viruses – but there have been no such vaccination campaigns in monkeypox hotspots such as DRC for decades. “It’s a bit uncomfortable that we have a different attitude to the kinds of resources we deploy depending on where cases are,” said Dr Jimmy Whittworth, of the London School of Hygiene and Tropical Medicine, speaking to the Associated Press. “It exposes a moral failing when those interventions aren’t available for the millions of people in Africa who need them.” Stigma against disease may prevent care, increase transmission Tedros Adhanom Ghebreyesus, WHO Director-General Meanwhile, WHO’s Tedros urged people to fight against stigma associated with the transmission of monkeypox in networks of men who have sex with men (MSM) – and underlined that the disease can be transmitted in a range of ways. Those include through contact with: infected saliva and mouth lesions, bedding as well as transmission of pregnant women to their unborn children through the placenta, according to a WHO seminar on the issue Tuesday. Tedros said that MSM advocacy groups “are working hard to inform [members of their community] about the risks of monkeypox and prevent transmission. But all of us must work hard to fight stigma, which is not just wrong. It could also prevent infected individuals from seeking care, making it harder to stop transmission.” “Anyone can be infected with monkeypox if they have close physical contact with someone else who was infected,” he said. The virus was first identified in 1958 in a colony of captive African research monkeys. The first human case was identified in the DRC in 1970, during the period of smallpox elimination campaigns. Even before the current outbreak, there have been limited waves of cases reported in non-endemic countries through channels such as the export of exotic animals, such as infected mice, squirrels, and rats, from Ghana to the United States in 2003, as well as by infected travelers. Misinformation campaign to target monkeypox Maria van Kerkhove, WHO Technical Lead on COVID-19 WHO is also mounting a campaign on disinformation about the disease, said Gabby Stern, WHO Communications Director. WHO is currently working with both social media companies and tech companies, urging them to filter out the misinformation and push out accurate information through their channels and platforms, said She said that misinformation and disinformation was a ‘major priority’ for both WHO and the United Nations. “Misinformation kills, just as these viruses kill, misinformation kills as well,” added Dr Maria van Kerkhove, WHO technical Lead on COVID-19. “This remains a constant challenge, not only COVID-19 across the entire spectrum of interventions and the response that we have. It’s the attacks on science that undermine the effectiveness of our countermeasures.” Image Credits: Tessa Davis/Twitter , Laëtitia Dudous, WHO, Disease Outbreak News, 21 May 2022 . Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
‘Monkeypox Begins – and Must be Resolved in – Endemic Countries’ 06/06/2022 Kerry Cullinan Dr Ibrahima Socé Fall, assistant general security for emergency response The first human case of monkeypox was recorded in 1970, yet the viral disease is only getting international attention since it has spread outside Africa to 27 non-endemic countries. The World Health Organization’s (WHO) Dr Ebrahima Socé Fall described monkeypox as a “neglected tropical disease” when he opened a two-day meeting called by the WHO’s R&D Blueprint to determine research priorities last Thursday. “We need to stop the chain of transmission and we believe at this stage we can still stop the chain of transmission in non-endemic countries by ensuring surveillance in certain population groups, cross investigation contact tracing, and maybe vaccination,” said Fall, WHO’s Assistant Director-General for Emergencies Response. However, WHO scientist Ana Maria Restrepo stressed at the meeting’s conclusion that the viral disease had to be addressed in the nine African countries where it is endemic. “The problem starts and has to be resolved at the level of the endemic countries,” said Restrepo, co-convenor of the R&D Blueprint that called the meeting, at the conclusion of the meeting. “There are researchers of high quality in these countries, and they are doing high-quality research despite the limitations, and our commitment is to support them.” Squirrel pox? The intention of the meeting – attended virtually by over 500 scientists – was to identify research priorities, and when it ended on Friday afternoon, the scientists had identified a long list of unknowns. One of the big questions is whether there is an “unknown animal reservoir” for monkeypox – with squirrels and rats being fingered as the most likely suspects. The Central African sun squirrel is particularly susceptible to monkeypox – and one researcher suggested the pox might have been more aptly named after it. “What was the first reservoir?” asked Dr Paul Fine of the London School of Hygiene and Tropical Medicine. “We think monkey because of the name monkeypox, but there were studies in a number of other species and it was found in several of them, in particular squirrels, particular the sun squirrel of Central Africa. So one might ask if this name is appropriate. Is it just monkeypox or are there other species very importantly, involved as reservoirs?” SARS Co-V2 comes from bats, while monkeypox could come from rats. Professor Jean-Jaques Muyembe Tamfum, director of the DRC’s Institute de Recherche Biomedicale, said that the majority of monkeypox cases in his country were children infected by hunting and handling rodents and squirrels. Adults were exposed to the virus by hunting monkeys. “The virus enters the body through the broken skin, and spreads in the mucous membranes and eyes, nose and the rest,” said Tamfum. Complications of monkeypox include bacterial conjunctivitis and even blindness. Scientists also raised whether rodents could be infected by “spillover” from human waste. The meeting resolved that a “comprehensive One Health approach” was needed to understand animal-to-human transmission and animal reservoirs. A ‘One Health’ approach is neeed for monkeypox Mutations and drivers Genomic sequencing of the current strain of monkeypox spreading internationally shows that it has 47 mutations when compared to a 2018 sample. This is surprisingly high, and one hypothesis is that the monkeypox virus has been mutating in an unknown animal – or perhaps more than one animal behind the two different clades – the Central African clade with a mortality rate of around 10% and the West African clade with a 2-3% fatality rate. Aside from the international spread of monkeypox, there has also been a dramatic increase in cases in endemic countries especially DRC and Nigeria. Nigeria’s Professor Dimie Ogoina told the meeting that his country was also seeing an increase in cases in areas where it had not previously been seen. Scientists thus want to unpack what is driving the transmission, as monkeypox is not known to be particularly infectious. In the past, infected people only passed the virus on to about 8-15% of the people living in the same house. The European outbreaks appear to stem from sexual contact at two events – in Berlin and on the Canary Islands, according to news reports. This is not typically how it has been transmitted, and the meeting raised a number of questions about sexual transmission – particularly whether it can be transmitted via semen and vaginal fluid, not just through contact with the infected lesions. “Monkeypox manifests in rashes. Would a person still engage in sex with these rashes? We need to look at asymptomatic transmission,” said Ogoina. Tricky diagnosis In Nigeria, men are significantly more likely to get monkeypox than women, raising questions about what makes them more vulnerable. Ogoina, from Niger Delta University, also revealed that people coinfected with HIV and monkeypox had “bigger lesions” and were more likely to have genital lesions – although only five such patients were examined. “It is very important just to recognise that the vast majority of recent cases, especially in DRC, are suspected cases or their probable cases or possible cases, they’re not confirmed,” stressed Fine. Some of the symptoms of monkeypox are similar to those of syphilis and chicken pox, and the meeting identified the need for better diagnostics. “WHO, through our regional offices, is working with African countries, regional institutions, technical and financial partners, to increase the ability to support disease surveillance laboratory diagnostics, readiness and response actions related to monkeypox,” said WHO epidemiologist Maria van Kerkhove. “We have to acknowledge the fact that this virus has been circulating for decades, and we now have attention to this. This unfortunately is a sad reality of the world that we live in. But we need to use this as an opportunity to advance our understanding of this virus to help everyone everywhere dealing with monkeypox,” said Van Kerkhove. Implementing COVID lessons Professor Helen Rees Professor Helen Rees, who moderated the two-day meeting, said that COVID-19 had shown the need for rapid global responses to emerging health threats. Rees called for “partnerships, collaboration, strategies that get us into the field quickly, antivirals and vaccines”. “We’re also seeing this interface with One Health, with environmental degradation and climate change. All of these things are coming to the fore. Just to underline this is not a pandemic, this is an outbreak that we are scratching our heads about. But the fact that we should respond now and rapidly is really excellent,” added Rees, a renowned scientist from South Africa’s University of Witwatersrand. WHO scientist Ana Maria Restrepo concluded the meeting by stressing that it was important to practice what had been preached during COVID-19. “We talked very much about the new health architecture for response to pandemics, and the lessons learned,” said Restrepo. “We are convinced that showing a good response for this multi-country outbreak is our best example of how we are going to be prepared for the next pandemic. “If we do when we all preach, we work together if we collaborate, we use master protocols, if we engage the countries; the communities – if we learn those lessons, and if we put equity at the centre of the discussions, then yes we have learned our lessons and we are moving forward towards being better prepared,” said Restrepo. Ana Maria Restrepo Expedited studies The meeting concluded with experts calling for expedited studies to better understand the disease epidemiology, clinical consequences, and modes of transmission. While the smallpox vaccine offers over 80% against monkeypox, it is unclear whether this protection endures – and smallpox vaccination was discontinued in the 1970s. The experts emphasized the need for clinical studies of vaccines and therapeutics to better document their efficacy and understand how to use them in this and future outbreaks. The meeting also called for immediate implementation of public health activities including communicating prevention information, enhanced disease surveillance, contact tracing, isolation of cases and optimized care of people with the virus. Self-Care Practices Can Save Millions and Alleviate Pressure on Health Systems 06/06/2022 Aishwarya Tendolkar In a world where health workers are scarce, self-care practices can drastically improve people’s quality of life and alleviate strain on health systems, but depend on a range of factors including patient literacy, fair prices and government stewardship. This is according to a one-of-a-kind global study demonstrating the value of self-care that was launched on the sidelines of recent World Health Assembly in Geneva. The World Health Organization (WHO) defines self-care as “the ability of individuals, families, and communities to promote health, prevent disease, maintain health, and to cope with illness and disability with or without the support of a healthcare provider.” Current self-care activities around the world are generating annual savings of approximately $119 billion, along with saving 11 billion patient hours worldwide, according to the study. The study was produced by the Swiss-based Global Self-Care Federation (GSCF), which represents manufacturers and distributors of non-prescription medicines on all continents. Self-care cost-saving (source: Global Self-Care Federation report). Low-income countries lagging But the low-income countries are still lagging in implementing and reaping the benefits of self-care. “In low-income countries, about 65% of households that could not obtain essential health services had financial constraints,” said Dr Ritu Sadana, WHO Head of Ageing and Health Division of Universal Health Coverge (UHC), one of the panelists at the launch of the report. “This is more than triple the proportion of households who lack access to health services because they are just unavailable, which is 20%.” High-income countries are reaping the most benefits of self-care practices while the low-and middle-income countries are playing catch-up. With increased adoption of self-care, we will be seeing an additional $19.5 billion in annual cost savings related to the increased adoption of self-care by 2030, said Ben Carrick, Johnson and Johnson’s senior director of consumer policy. “If we think about the welfare benefits, it could be leading to an annual increase of $312 billion per year globally. These are significant benefits that are worth chasing and grasping,” Carrick told the launch. To estimate the true #ValueofSelfCare, we must first understand how it operates across different global contexts. Our 3 country groupings allow us to unlock such insights. 🌏 Read the report to learn the full scope of benefits that can be achieved:https://t.co/h5gTOOsgUl pic.twitter.com/ZMrINWpIax — The Global Self-Care Federation (@Selfcarefed_org) June 6, 2022 The study grouped 155 countries based on their GDP levels, and then gauged the self-care effects. In the high-income countries (Group A), self-care is already making an indispensable contribution to relieving the burden on healthcare systems. But it is in the low-and middle-income countries (Group B and C), where self-care can enable a person to work and not depend on welfare. “We don’t need more GDP; we need more welfare and this is also what this project is about, this is what self-care is about… to generate more welfare and not just be focused on figures and economic factors,” said Professor Uwe May, Dean of Studies at Fresenius University. He added that currently if people practised self-care instead of doing nothing about their health issues, 41 billion productive days can be gained on a global level. Self-care ‘only option’ in poor countries The study also found that health economic and pharmacoeconomic approaches deployed to assess the value of self-care cannot be transferred to lower-income regions where the infrastructure, socio-economic factors, and awareness is different. In addition, lack of access to over-the-counter (OTC) medicine and the prevalence of traditional medicines also has an impact on self-care options. In regions like sub-Saharan Africa and South East Asia, self-care is not an alternative care option, but is often “the only possible access to treatment for most individuals”, according to the report. In these countries, self-care does not translate into saving on doctors’ and specialists’ time. “This is where the welfare benefits are really the main opportunity because it isn’t saving physicians’ time and people don’t have access to the physicians,” said Carrick. “But if it means that they’re productive, they’re back at work and they’re able to look after families, then it’s those welfare and productivity benefits that really come into play.”. In Latin America and the Caribbean, the practice of self-care and the use of OTC products leads to current welfare savings of $123 per capita per year. The more the OTC use increases, the greater the individual and societal benefits can be realised through self-care, according to the study “We estimated that at least 142 million older persons, about 14% of older persons worldwide, are unable to meet some of their basic needs. So the issues around self-care for themselves or by their families or care providers is extremely important,” said Carrick. What do we need now? The report highlights the need for private-public partnerships, digital and healthcare literacy in people living in low-and middle-income countries (LMICs) and better parameters to gauge healthcare outcomes in a country. “We need strong stewardship by government, and to have really strong capacities in government institutions…so that they can lead and shape how we actually get things done with the private sector, with multiple sectors across the government and also obviously, civil society and self-care demands with the active participation of people,” said Sadana. “Health literacy is a fundamental catalyst for change to ensure individuals comprehend and act on credible health information, becoming active self-managers of their own health,” said Carrick. Experts at the launch also highlighted the need for pharmacies to be more involved in developing better policies, and for governments to spend more on ensuring that self-care is delivered through, not only OTC and literacy, but also nutrition, lifestyle, and affordable healthcare. Sadana said that in India, 70% of all healthcare costs are paid out of pocket, and 70% of that was on drugs. “If we’re going to have a system which encourages self-care, using products that are evidence-based and quality-controlled, we still need to have a way to ensure that those are covered [by the health system] if we actually want a vast swathe of the population to use them.” Image Credits: Tbel Abuseridze/ Unsplash. Climate Crisis Poses Serious Risk to Mental Health – WHO 03/06/2022 Raisa Santos Climate change poses serious risks to mental health and well-being, concluded a new World Health Organization policy brief, launched on Friday at the Stockholm+50 conference. Natural disasters such as floods, heatwaves, storms, and drought can pose a threat to mental health and psychosocial well-being, exacerbating emotional distress, anxiety, depression, grief, and suicidal behavior. WHO is therefore urging countries to include mental health and psychosocial support in their response to climate change. “The impacts of climate change are increasingly part of our daily lives, and there is very little dedicated mental health support available for people and communities dealing with climate-related hazards and long-term risk,” said Dr Maria Neira, WHO’s Director of Environment, Climate Change, and Health. #ClimateChange poses serious risks to #MentalHealth and well-being – from emotional distress to anxiety, depression, grief, and suicidal behavior: new WHO policy brief https://t.co/ogdEP9iIG6 pic.twitter.com/VRqrMqoixr — World Health Organization (WHO) (@WHO) June 3, 2022 The findings concur with a report made by the Intergovernmental Panel on Climate Change (IPCC) published in February of this year, which revealed that half of the world’s populations live in climate ‘danger zones’ that place “people’s health, lives, and livelihoods” at risk, and this can also include people’s mental health. The two-day conference, hosted by the government of Sweden and convened by the United Nations General Assembly on 2 – 3 June, drew together thousands of participants across government, civil society, and the private sector in an effort to spur urgent action for a healthy planet. The meeting also commemorates 50 years since the 1972 UN Conference on the Human Environment, which made the environment a pressing issue for the first time. Climate change impact on mental health The mental health impacts of climate change are felt disproportionately around the world, with support services unequally distributed as well. While there are nearly 1 billion people living with mental health conditions, 3 out of 4 do not have access to needed services in low- and middle-income countries. A 2021 WHO survey found that out of 95 countries, only 9 have thus far included mental health and psychosocial support in their national health and climate change plans. Additionally, while the annual cost of common mental disorders is $1 trillion, only 2% of government health budgets are spent on mental health. These figures are all exacerbated by climate change. “The impact of climate change is compounding the already extremely challenging situation for mental health and health services globally,” said Devora Kestel, WHO Director of the Department of Mental Health and Substance Abuse. Examples of how climate change can impact mental health include the loss of personally important places, loss of autonomy and control, and exposure to pollution, which is associated with increased risk for mental health conditions. The new policy brief recommends five important approaches for governments to address the mental health impacts of climate change: Integrate climate considerations with mental health programs Integrate mental health support with climate action Build upon global commitments Development of community-based approaches to reduce vulnerabilities to climate change, and Close the funding gap for mental health and psychosocial support “By ramping up mental health and psychosocial support within disaster risk reduction and climate action, countries can do more to help protect those most at risk,” said Kestel. Image Credits: Clay Kaufmann/ Unsplash. After Many Missed Opportunities, Oral Health Gets Long Overdue Attention from WHO 03/06/2022 Ihsane Ben Yahya & Greg Chadwick Dental services, including regular check-ups, were among the most disrupted essential health services during the COVID-19 lockdowns. People´s reticence to visit a dentist during normal times was exacerbated by fear of venturing into an open clinic or simply not being able to, due to restrictions. Dental hesitancy has always been around but over two years into the pandemic, it´s now a lot worse. This hesitancy is also echoed at the policy level. Oral health has, until very recently, been considered the “ugly duckling” of global health efforts. The World Health Organization (WHO) has only ever passed a special resolution on oral health twice in its history: most recently, ironically, in the midst of the COVID-19 pandemic in 2021. The new global oral health strategy, approved by governments at 75th WHO World Health Assembly last week is a step in the right direction, and it is long overdue. 📣The WHO global #OralHealth strategy has officially been approved and adopted at the #WHA75 👏 FDI commends the strategy and tells @WHO that we are ready to support the development of the subsequent action plan and monitoring framework by 2023 ➡️ https://t.co/mTPgDRSB24 pic.twitter.com/MYf1nFap8e — FDI World Dental Federation (@fdiworlddental) May 28, 2022 Oral health is essential for overall health It´s a perfect time to double down on just why responding to the global oral health epidemic is in our broader (health) interests. Getting people back into dental clinics and protecting their oral health is essential to safeguarding their overall health, well-being, and quality of life. All those factors that can make people vulnerable to chronic non-communicable diseases (NCDs) such as cardiovascular disease, cancer, chronic respiratory disease, and diabetes are equally risky for one´s oral health. High sugar consumption, harmful alcohol use and tobacco are just as bad for our bodies as they are for our mouths. The impact in pure numbers is alarming: there were some 3.5 billion cases of oral diseases and other oral conditions in 2017. For the last three decades, the combined global prevalence of dental caries (tooth decay), periodontal (gum) disease and tooth loss has stood at 45% – higher than any other NCD. Ignoring the problem makes no sense, financial or otherwise. Worldwide, oral diseases accounted in 2015 for $ 357 billion in direct costs and US$ 188 billion in indirect costs. In the same year, $96.2 billion was spent on the treatment of oral diseases across the European Union, the third-highest total among NCDs, behind diabetes and cardiovascular diseases. “Without good oral health, you’re not healthy,” former US Surgeon-General David Satcher once said, and he was right. The largely siloed approach to dealing with oral health makes no policy sense either, especially when we consider the evidence. Junk food and tooth decay We know that bacteria and inflammation associated with periodontal disease are linked to cardiovascular disease, rheumatoid arthritis, and adverse effects in pregnancy. We also know that people living with diabetes experience improved blood glucose levels if their periodontal (gum) disease is managed correctly. Knowing what we know about poor oral health – that it is preventable and if addressed can help improve our overall health – only begs the question as to why more is not being done to integrate it into other NCD programmes? The pending ban on television and online advertising of junk food in the UK before 9pm is a great example of encouraging better diet. So too is the campaign by UK footballer Marcus Rashford to promote healthier school lunches. But they are missed opportunities. With forethought, both interventions could have included some key messages for children and parents around the connection between a healthy diet and good oral health. Future campaigns could better highlight the need to prioritize oral health promotion in schools, communities and workplaces as well as ensure access to the millions of people who cannot afford the basics, such as fluoridated toothpaste. We need to globally re-think how we talk about and tackle oral diseases. In the vast majority of countries, even essential oral health services are not part of universal health coverage. Oral diseases are noncommunicable diseases and need to be treated as such. Advocates have long argued that investment in prevention produces strong economic returns and saves millions of lives. COVID-19 has reinforced the huge economic and human cost of not doing so: people living with chronic diseases like diabetes, cancer and cardiovascular were at much higher risk of becoming seriously ill, hospitalized, or dying from SARS‑CoV‑2. At the same time, the pandemic is just a microcosm of the bigger picture: our past failure to address oral disease in a substantive way and to view it as an NCD like any other. Prof Ihsane Ben Yahya Prof Ihsane Ben Yahya is the President of the FDI World Dental Federation and professor at the Dental University in Casablanca, Morocco. Dr Greg Chadwick Dr Greg Chadwick is the President-elect of FDI World Dental Federation and Dean at East Carolina University, School of Dental Medicine, United States. Image Credits: Caroline LM/ Unsplash, FDI World Dental Federation. Shanghai Lockdown is Finally Relaxed But Stringent Testing Still Required 02/06/2022 Raisa Santos Shanghai eased its lockdown restrictions 1 June 2022, following continuous low cases reported. Sixty five days after one of the toughest lockdowns in the world, China has eased COVID-19 restrictions on its financial hub, Shanghai, on Wednesday – finally allowing the majority of its 25 million residents to move freely again. However, at least 890,000 residents are confined at home, in “quarantine” or “control zones”. The announcement to lift restrictions came as official figures showed on Sunday that daily new coronavirus cases fell from 170 to 122 in a 24-hour period. The city reported just 13 cases for Wednesday, and an additional 7 cases on Thursday. This is a marked turnaround from the beginning of April, when tens of thousands of cases were reported daily. “This is a day that we dreamed of for a very long time,” Shanghai government spokeswoman Yin Xin told the BBC. China to maintain ‘zero tolerance’ policy Shanghai residents will be required to hold a negative nucleic acid test result taken within 72 hours of entering public spaces or using public transportation from June But while China seems to have moved into the clear with COVID, the country is keen to maintain its “zero tolerance” policy, and is already preparing for future waves. Beijing municipal officials said Thursday that 12 of its planned 14 ‘transition hubs’ will be used to test and disinfect all imported frozen food before goods are distributed across the city. This follows China’s contention that frozen food could transmit COVID-19 in while the World Health Organization’s independent panel on the virus’s origins favour an unknown animal vector as the most likely cause, while others have pointed to laboratory accident for the spread of the coronavirus first found in bats in China. Tens of thousands of testing booths will also be set up across China’s largest cities, including Beijing, Shanghai, and technological hub Shenzhen, to require testing as often as every 48 hours. New rules in Shanghai will now require residents to show a green health code on their smartphone, with proof of a negative PCR test in the last 72 hours, to leave their residential compounds and enter most places, including banks, malls, and public transportation. However, cinemas, museums, and gyms remain closed, as well as in-person schooling. Restrictions on leaving the city still remain, with anyone traveling to another city facing a quarantine of seven to 14 days upon return. Beijing also lifted its restrictions earlier this week, following similar protocol with some of its public transportation system, malls, and other venues opening up. Shanghai testing centers tested by overcapacity and staff shortages Shanghai testing center Shanghai’s 72-hour rule has tested the capacity of its testing centers, as crowds flocked to the 15,000 stations. While some said their test took only a matter of minutes, others complained that they had to wait over an hour to test. Many testing booths are only open for about three hours each in the morning and afternoon, although some hospitals offer a 24-hour service. Shanghai resident Zhang Zehong told Sixth Tone that she was unable to test Wednesday as the station in her neighborhood closed two hours earlier than shown on the city’s health code app, which features all the testing centers. Instead, she went to a hospital with a 24-hour service Thursday morning, only to find no staff and a line that stretched on for over 100 meters. So many issues need to be fixed,” Zhang said. Chinese microblogging platform Weibo also featured complaints with the stations. “It’s been very hot recently, several people passed out when standing (in line),” one Weibo user wrote. “I visited five sites but each had long queues. This is not really humane enough. Don’t these mobile kiosks cause more people to gather?” another Weibo user wrote. Fifty-point plan to revive Shanghai economy A fifty-point plan has also been drawn up to support Shanghai’s economy, crippled in the wake of closures, quarantines, and lockdowns. New measures include reducing taxes for car buyers, speeding up the issuance of local government bonds, and fast-tracked approval of building projects. Drivers who also switch to an electric vehicle will also be able to claim a $1500 subsidy. Businesses may also be able to delay insurance and rent payments, with subsidies available for utility charges. Image Credits: Appriseug/Twitter , DA Trade Market Securities/Twitter , Don Weinland/Twitter. Eight Countries Compete to Host African Medicines Agency at Crucial African Union Meeting 02/06/2022 Paul Adepoju AMA headquarters host country is expected to be named at the end of an ongoing meeting in Addis Ababa A meeting to decide which African country will be the host country for the African Medicines Agency (AMA) is underway and at the last count, expressions of interest in hosting the agency have been received from Uganda, Algeria, Egypt, Morocco, Rwanda, Tanzania, Tunisia and Zimbabwe. The decision is expected to be one of the outcomes at the ongoing first Ordinary session of the Conference of State Parties (CoSP) of the AMA, in Addis Ababa, Ethiopia from 1 to 3 June 2022. The CoSP is reviewing the AMA assessment report and at the end of their meeting, it will make recommendations on the host country of the AMA Headquarters. A final decision on this recommendation will be made at the next assembly of the African Union. Uganda is one of the countries vying to host the AMA Headquarters and the country’s delegation to the CoSP meeting is led by the country’s Minister of Health, Dr Jane Aceng, and Dr Diana Atwine, a Permanent Secretary in the Ministry of Health. Zimbabwe’s team is a four-member delegation led by the country’s Health and Child Care deputy Minister, Dr John Mangwiro. Sierra Leone is also attending the session led by Minister of Health and Sanitation Dr Austin Demby. In his remark at the official launch of the Africa CDC’s Ministerial Executive Leadership Program (MELP), Dr John Nkengasong, Africa CDC’s outgoing Director General confirmed the CoSP’s outcome would play a critical role in deciding the future of the agency. “The launch of the AMA is really another landmark initiative of the African Union as part of the Agenda 63. I can’t wait to hear the outcome of the deliberations. It’s going to be transformational when the AMA and we are truly excited with that,” Nkengasong said. The three-day ministerial meeting will deliberate on the priorities and next steps to establish the AMA. From Geneva to Addis Ababa At last week’s World Health Assembly, Amref Health Africa’s Desta Lakew, on behalf of the African Medicines Agency Treaty Alliance (AMATA) described AMA as an initiative of the African Union aimed at strengthening the regulatory environment to guarantee access to quality, safe and efficacious medicines, medical products, and technologies on the continent. Countries that have signed the treaty, according to AMATA, are Algeria, Benin, Chad, Ghana, Madagascar, Mali, Morocco, Rwanda, Saharawi Arab Democratic Republic, Senegal, and Tunisia. But about four years after the AU Assembly adopted the AMA Treaty, Lakew noted that some Member States still haven’t given it the authority to fulfill its mandate. “The increased risk of disease outbreaks in the region and globally has made access to medical products a priority. Trade in locally produced medical products, including Personal Protective Equipment, across African countries will be hampered if we do not have a harmonized regulatory environment,” Lakew told WHA 75. At the CoSP meeting, the AU called on all member states to sign the Treaty to see improved regulation and easy flow of medical products and technologies, are expected to be reechoed. Lakew described the call as an urgent matter “for the sake of ensuring that there is equitable access to quality, safe, efficacious medicines and technologies for a healthy Africa”. Last month, Health Policy Watch reported Kenya was preparing to join the AMA alongside thirty-one other African Union member states following the Kenyan cabinet’s decision to approve the ratification of the African Union Treaty. See more about the African Medicines Agency on our special AMA Countdown page: African Medicines Agency Countdown Sex, War, Sustainability and the World Health Assembly – Last Week in Review 02/06/2022 Elaine Ruth Fletcher 75th World Health Assembly Health and peace, sex and war, money and management. Whether in chorus or cacophony – last week’s World Health Assembly of WHO member states played most of the notes in the symphony of global debate over strategies to tackle disease, epidemics and pandemics and bolster health systems. But the root causes of emerging disease threats – in modern environmental health threats and nature gone awry remained under-represented themes. From the opening notes of the WHA, on a health for peace theme, to Saturday’s late night closing and end-run charges over language on sexual orientation – this year’s WHA was a seesaw of successes and setbacks. Highs included the consensus vote Tuesday to increase member states contributions to WHO, followed by a resolution Friday to move ahead on the first real reforms to the International Health Regulations in almost 20 years. And at the same time, unprecedented polarization was evident during Thursday’s debate over a resolution condemning Russia’s invasion of Ukraine, which won approval by a vote of 88 to 12. That was followed by the dispute that emerged Friday and continued until nearly midnight Saturday over references to terms such as “sexual rights” and “men who have sex with men” (MSM) in a WHO strategy on HIV, hepatitis-B and sexually transmitted infections (STIs). That, too, was resolved only by a painful series of rollcall votes, leading to the strategy’s passage by just 60 member states, with twice as many delegates absent or abstaining. Like a bullet train ride Dr Hiroki Nakatani joins in the applause for the resolution’s passage on HIV, Hepatitis B and STIs Dr Hiroki Nakatani, who presided over the committee that faced the thorny final hours of WHA dealing with the clash among nations over sexual health terms that HIV professionals regard as the standard usage, compared this year’s WHA session to a ride on a bullet train. “The train ride was sometimes bumpy but we arrived at our destination,” he said of the first Assembly to be held in person in several years because of the pandemic. Perhaps so, even more so than the war in Ukraine, the exceptionally large number of abstentions in the vote on a new HIV, Hepatitis and STI strategy was a bitter pill to swallow for delegates on both sides of the debate. It highlighted the fact that the battles still being waged in Europe, the Middle East, Asia and Africa over the control of territory are not the only big issues dividing member states. Fissures over social norms shape and guide public health policies run just as deep. Sex & War – Global social divide as deep as territorial conflicts And among those norms, there remains a deep divide around health policies that interface with human sexuality – that other primordial urge that co-exists alongside the urge for power and territory. For WHA delegates, in fact, the series of votes Saturday over sexual terminology may have been even more unsettling than the votes over Russia’s invasion of Ukraine – precisely because they sit in Ministries of Health, not Defence, with day-to-day responsibility for designing and implementing policies on HIV and other STIs. As with the Ukraine conflict, the divide that emerged, however, was not strictly drawn along the lines of global North and South. Saudi delegate in heated WHA debate Saturday over sexual rights and terminology Rather, it was the oil-rich Saudi Arabia that led the charge in the quest to purge references to men who have sex with men from the strategy on HIV treatment, followed by emerging economies of Asia and Africa where conservative views about sexual expression are often protected by law as well as custom. Against that, was Europe, North America, much of Latin America and high-income Asia- where more new attitudes about gender identity and LGBTI terminology have taken root over the past few decades. There were also exceptions, such as South Africa, which voted in favour of the HIV strategy. And European Serbia abstained from the vote as did the Russian Federation. Respect for culture, versus respect for evidence In the aftermath, the abstaining countries pleaded for more understanding of norms guided by tradition and culture. Western delegates, meanwhile, referred to the compass of science – whereby recent research has revealed how oft-marginalized MSM groups often fall through the cracks of programmes for HIV/AIDS prevention, diagnosis and treatment. “We appreciate those member states acted in good faith as part of these deliberations. Unfortunately this has served as a painful reminder of the need to reinforce our focus on evidence, human dignity and decency,” said US Assistant Secretary of State for Global Health Loyce Pace just after the strategy was approved. Loyce Pace, Assistant Secretary of State for Global Health, USA “[But] we should not need to hold a vote on the existence of entire communities of people,” she added. “We have a strategy on critically important global health issues, yes. But at what cost to those we risk leaving behind? “So to gay, lesbian, bisexual, queer, intersex, transgender and gender non-conforming people around the world, the United States government sees you, and will continue to support you. Stay strong.” (Right) Denmark’s EB representative, Søren Brostrøm, Director-General, Danish Health Authority, at the WHO Executive Board meeting 30 May, (left) Loyce Pace Assistant Secretary of State for Global Health, USA Reviewing the issue at Monday’s Executive Board meeting, member states on both sides of the divide expressed concerns over the failure of the WHA to find consensus over such a flagship health strategy – and the “dangerous precedent” that the voting set. “It is important that this does not set a precedent for consideration and adoption of technical documents by the Health Assembly,” said Dr Edwin Dikoloti, Botswana’s Minister of Health and Wellness, speaking on behalf of the African group, saying that greater efforts need to be made to find consensus in future WHAs over such controversial issues. Money – landmark decision on WHO finance – but not a ‘done deal’ Members of the WHO Working Group on Sustainable Finance hammer out the final agreement on increasing member state contributions, Germany’s Björn Kümmel on far left. The holy grail of consensus was restored in other key moments – including around the WHA resolution to increase regular member state contributions to WHO – in a bid to stabilize the agency’s finances The agreement, the fruit of months of grinding backroom diplomacy led by Germany, saw member states commit to increase annual assessments to cover 50% of WHO’s core budget by the end of the decade. However, each stepwise increase up until 2030 will still need endorsement at future WHAs to go forward. And so the vote should not be seen as a blank check either, a senior official in the Department of Health and Human Services, told Health Policy Watch. “I would say that the US, as a big contributor to the WHO, is definitely committed to that [resolution], and we were very happy to join the consensus,” the official said. “But I hope it’s also been clear that that is not a done deal and neither for us as the administration or for Congress.” According to the resolution, final approval of each year’s increase is contingent on progress in WHO internal reforms that are supposed to make the organization more transparent, efficient and well-managed. Those demands include overhaul of WHO’s budget management system, said the senior US official: “The budgets that are adopted by the Health Assembly are not real budgets. They’re just budget space. And creating budgets that are aspirational is very different from programming and reporting on and demonstrating the impact of real budgets.” Management – following election Tedros faces new demands Applause just after WHA re-elects Dr Tedros Adhanom Ghebreyesus to serve a second five-year term as Director-General of the World Health Organization on 24 May. He ran un-opposed. But the expectations go beyond budget reform, pressing newly re-elected Dr Tedros Adhanom Ghebreyesus for changes in WHO’s management culture, including more merit-based appointments of senior WHO staff, such as those serving as heads of WHO country offices, and structural reforms in WHO’s internal justice system. “I think, from our perspective…. there’s a very significant culture change… that needs to happen within the organization,” the official told Health Policy Watch. Further related to that, are demands for a “full resolution” of the ongoing investigation of the cases of sexual harassment and abuse of women in the Democratic Republic of Congo by WHO staff and consultants, whose progress also was reviewed at last week’s WHA and Monday’s EB. Justice – WHO internal justice system lacks independence While the revelations of the DRC sex abuse scandal, which first came to light in 2020, and whose perpetrators have yet to be fully prosecuted, highlight failures of WHO internal justice to date, they also are evidence of a broader and more systematic problem, some WHO insiders maintain. One key problem, highlighted in multiple interviews with both past and present WHO staff, is the fact that WHO’s Internal Oversight Office (IOS) – the legal mechanism that manages staff and management complaints – is housed in the Director-General’s Office and effectively controlled by the Director General himself – rather than at arms length. Politically influential managers or staff with the ear of the DG, may receive different treatment than staff who do not, critics say. The flaws in the current process featured in a WHO Staff Association letter to Monday’s Executive Board. The Staff Association demanded that the WHO Global Board of Appeals, the three-member body that hears cases, and recommends disciplinary action to the Director General, be expanded and also include staff-appointed representatives. “The panel of the Global Board of Appeal (GBA) should have five-members,” stated the Staff Association. “A three-member panel – the current practice – is simply not reassuring staff that GBA deliberations are sufficiently robust,” the Staff Association letter stated.“Furthermore, the staff representatives on each of the GBA panels should be selected by the respective staff association rather than selected by the GBA Chair or Deputy-Chair.” The net result of the current system is that – short of a costly and lengthy appeal to the International Labour Organization – disciplinary cases are heard by a GBA board appointed by senior managers who report directly to Tedros, who also decides on the final outcome of the cases. Dr Boubacar Diallo with WHO Director-General, Dr Tedros Adhanom Ghebreyesus and then-WHO Emergency Response Team leader, Dr Michel Yao in DRC in June 2019; Diallo was among those accused of harassment and Yao was alleged to have ignored those and other reports. With regards to the DRC cases, allegations that high-ranking WHO managers or consultants with ties to Tedros may have turned a blind eye to the reports of abuses going on in the field, have never been publicly resolved. But the concerns extend beyond sexual harrassement, to the need to foster an institutional culture of professionalism free of political interference, critics also say, pointing to other episodes like the suppression of a 2020 WHO report on Italty’s pandemic response, which criticized another senior WHO advisor to Tedros. From a sustainable budget a sustainable planet? While WHO’s financial sustainability received considerable attention at this year’s WHA, there was comparatively little debate on the planet’s sustainability crisis – and how that may be fueling a cascading array of health impacts – from more noncommunicable diseases to emerging outbreaks, such as SARS-CoV2 and more recently a worldwide surge in monkeypox. A new roadmap to accelerate work on noncommunicable diseases fails to give more than a nod to air pollution as one of the leading causes of NCDs – responsible for some 7 million deaths a year from cancers, cardiovascular and lung diseases every year. And that doesn’t even include risks from chemicals exposures that make the total estimate of deaths from pollution closer to 9 million annually, according to a new Lancet Planetary Health Report released on 18 May. Deaths attributable to key “modern” and “traditional” pollution sources for which data is available In a debate over an NCD roadmap that aims to slash NCD risks by one third by 2030, France, speaking on behalf of some European Union member states,called for a more “integrated” approach that includes environmental health and climate change. So far, such approaches have been slow in coming. Despite the rhetoric about air pollution being a leading risk factor for NCDs, there are, as yet, no WHO “Best Buys” for environmental strategies that reduce deadly pollution risks – even if measures like clean public transport and compact cities, built around cycling and walking networks, are regarded by urban planners and transport managers as evidence-based solutions that have a record of demonstrated results. ‘One Health’ and food safety – some new approaches Caged animals held for sale and slaughter in unsanitary conditions at Wuhan’s Huanan Seafood Market, prior to the outbreak of COVID-19, including: (a) King rat snake (Elaphe carinata), (b) Chinese bamboo rat (Rhizomys sinensis), (c) Amur hedgehog (Erinaceus amurensis) (the finger points to a tick), (d) Raccoon dog (Nyctereutes procyonoides), (e) Marmot (Marmota himalayana) (beneath the marmots is a cage containing hedgehogs), and (f) Hog badger (Arctonyx albogularis). On the brigher side, a new WHO Global Strategy for Food Safety was approved by member states. For the first time ever, the strategy makes reference, at least in passing, to the need for a “One Health approach when addressing health risks emerging at the human-animal-ecosystems interface.” A companion decision asks WHO to also update its guidance on Reducing public health risks associated with the sale of live wild animals of mammalian species in traditional food markets. Such guidance emerges out of the SARS-CoV2 pandemic, where peoples’ exposure to SARS-CoV2 infected animals in the Wuhan, China live animal market is considered to be one of the most plausible routes by which SARS-CoV2 initially leaped from animal to human populations in Wuhan, China during 2019. But the caging and slaughter of live, wild animals in areas heavily trafficked by customers are practices common in thousands of traditional markets in Asia and Southeast Asia, as well as parts of Africa, leading to further risks of human exposure to pathogens the animals may harbour. Not nearly enough action to stop pandemics at source The unsafe handling of live animals that are sold for slaughter at traditional markets can risk the spread of foodborne and infectious diseases. Such “One Health” issues need far more deliberate and systematic WHO and member state attention than the nod that they have so far, a growing chorus of “Ecohealth” experts say. In a little-noticed press release issued during WHA, Dr Nigel Sizer, executive director of the consortium Preventing Pandemics at the Source called upon the WHA to do more to address ecosystem risks upstream that increase “spillover risks” of pathogen leap from animal to human populations: “Such actions include shutting down or strictly regulating wildlife trade and markets, stopping deforestation and forest degradation, and providing better health to communities in emerging infectious disease hotspots, as well as strengthened veterinary care and biosecurity in animal husbandry,” said Sizer, an internationally known conservationist, in his statement. “Overall throughout the WHA process and in the preparations for negotiation of a possible global instrument on pandemic prevention and preparedness there has been remarkably little attention given to true pandemic prevention,” Sizer later told Health Policy Watch. “We know where most pandemics come from and we know how to reduce the risk of zoonotic spillover of the vruses that cause them,” he added. “Governments in general and health agencies in particular should embrace these approaches, including One Health efforts. They should also work much more closely with environmental agencies to address spillover risk from tropical deforestation, wildlife exploitation and trade, and intensive animal agriculture. The public health return on investment in such activities would be enormous.” Health and Environment: WHO structures preserve a deep divide Researcher explores evidence around the wildlife-trade- pandemic nexus (Wildlife Conservation Society) There are parallel calls to better incorporate such concerns into any future “pandemic instrument” intended to have a broader scope than the International Health Regulations, and to be the focus of intense negotiations by a WHA Intergovernmental Board (INB) in coming months. However, the yawning chasm environmental groups encounter in trying to to interact with WHO and WHO member states over environmental health and One Health concerns, can sometimes appear as wide as the divide between member states on the terms around sexual health. “It has been exceedingly difficult to engage with the WHA or with the intergovernmental negotiating body’s (INB) process to draft and negotiate a new pandemic instrument,” Christine Franklin, of the Wildlife Conservation Society, another member of the Preventing Pandemics coalition, told Health Policy Watch. The club of non-state actors in ‘official relations’ “Only non-State actors in official relations with the WHO are invited to engage with the WHA,” she remarked. That status of ‘official relations’ not only allows civil society groups the privilege of expounding on their positions at the annual World Health Assembly, it gives them access to lengthy and detailed informal member state consultations and intergovernmental negotiating sessions that are closed to the general public and the media. Some 220 civil society actors hold that coveted status, mostly mainstream medical and health societies as well as pharma groups, but also agro-business foundations, such as CropLife International, as well as the outliers like the World Plumbing Council. A review by Health Policy Watch found nary an environmental or eco-health group on the list, as of February 2022. “So even though Wildlife Conservation Society has been working across the globe for more than 125 years; is the only international conservation organization with an embedded health program, works on the ground in more than 60 countries; and our health program is recognized as a One Health founder and a leader at the nexus of health and the environment, the INB’s public hearing has been the only opportunity we have had to provide input,” Franklin lamented. “Oral testimonies were limited to two minutes and written statements restricted to 250 words. In fact, there are no organizations from the conservation or environment communities in official relations with the WHO and the process to gain status is complex and lengthy.” Image Credits: Germany's UN Mission in Geneva , WHO, Lancet Planetary Health, Nature , Pierce Mill Media, Wildlife Conservation Society . Doubling of Monkeypox Cases Outside of Endemic Countries Raises New Alarm Bells at WHO 01/06/2022 Raisa Santos & Elaine Ruth Fletcher Monkeypox lesions In just a matter of three days, the number of monkeypox cases reported to WHO outside of central and west Africa has doubled – with reports Wednesday of some 550 cases in more than 30 countries outside of the countries where the disease is endemic, WHO Director General, Dr Tedros Adhanom Ghebreyesus told a press briefing on Wednesday. That, as compared to reports of 257 cases outside of Africa, as of Sunday, 30 May. The ‘sudden appearance’ of monkeypox in so many non-endemic countries is prompting new concerns that it could spread to more “vulnerable populations” in countries where it has suddenly emerged, including pregnant women and children, added WHO’s Maria Van Kerkhove, Health Emergencies technical lead. WHO Briefing, 1 June 2022 “Investigations are ongoing, but the sudden appearance of monkeypox in many countries at the same time suggests there may have been undetected transmission for some time,” said WHO Director-General Tedros Adhanom Ghebreyesus during a press briefing Wednesday. “WHO’s priority now is to first provide accurate information to those groups most at risk, and second to prevent further spread among at-risk groups, to advance our understanding of monkeypox.” WHO is organizing two R&D meetings of experts on Thursday and Friday of this week, to further discuss monkeypox and understand the current surge in cases. Ecological pressures prompting rapid disease emergence Gambian pouched rat – rodents are a common animal reservoir for monkeypox Monkeypox has long circulated in 12 countries of central and western Africa, with a rising incidence over time. Disease prevalence is highest in the Democratic Republic of Congo, which has reported several thousand cases a year, and where the monkeypox clade, or variant, in circulation is more deadly. The disease has been reported to have mortality rates of up to 10% in the DRC. Noone has yet reported to have died from the outbreak that has occurred abroad recently – which has been traced to the milder West African clade. Cases of monkeypox in endemic countries between 15 December 2021 to 1 May 2022 Increased circulation of the disease in Africa in recent years has been linked to deforestation – which put wild animals in closer contact with humans, as well as increased agro-food storage, and consequent infestation of food containers by infected rats. Additionally, human travelers as well as the trade in exotic animals has been linked to the appearance of some cases overseas in the past. But the appearance of so many cases abroad is a new phenomenon, where community transmission is now occurring, including among networks of men who have sex with men, WHO said. The changes in ecosystems, trade and travel have been exacerbated by a decline in human immunity to the disease, due to the discontinuation of smallpox vaccination in the 1970s, which was protective against monkeypox as well. Ecological pressures need to be addressed Michael Ryan, WHO Executive Director, Health Emergencies Beyond the immediate health system measures needed to track and trace the spiral of increasing human cases occurring daily, more attention needs to be given to the underlying drivers, and ‘ecological pressure’ that has caused disease outbreaks to expand in size and scope,WHO’s Executive Director of Health Emergencies Mike Ryan told the briefing. “Animals are changing their behavior, humans are changing their behavior. What we’re dealing with is a lot of ecological fragility,” said Ryan. “We’re dealing with the animal-human interface being quite unstable, and the number of times that these diseases cross into humans is increasing, [as well as] that ability to amplify the disease and move it within our communities.” But he did not elaborate on how WHO might address such drivers – beyond saying that they could be a topic of discussion at this week’s R&D meeting convened by the global health agency. Inequity of investment in monkeypox in Europe versus Africa already apparent The current outbreak also highlights once more, the boomerang effect of inequitable investments in health systems and disease control in Africa, where monkeypox has been circulating for decades in countries that lack the tools to track and tackle such infections, Ryan said. “There are thousands and thousands of cases of monkeypox every year in Africa, and there are deaths every year….. And now, we have a concern about this disease spreading in Europe, but I certainly haven’t heard that same level of concern over the last five or ten years.” “Are we in a position to collectively respond? Are we in a position to share resources in order to stop transmission of these diseases within human communities?,” Ryan asked. Already, countries such as the United Kingdom have vaccinated more than 1,000 people at risk of contracting the virus, and the European Union is in discussions to buy smallpox vaccines from Bavarian Nordic, the only maker of the vaccine licensed in Europe, according to media reports. Smallpox vaccines are estimated to be about 85% effective against monkeypox, which is in the same orthopox family of viruses – but there have been no such vaccination campaigns in monkeypox hotspots such as DRC for decades. “It’s a bit uncomfortable that we have a different attitude to the kinds of resources we deploy depending on where cases are,” said Dr Jimmy Whittworth, of the London School of Hygiene and Tropical Medicine, speaking to the Associated Press. “It exposes a moral failing when those interventions aren’t available for the millions of people in Africa who need them.” Stigma against disease may prevent care, increase transmission Tedros Adhanom Ghebreyesus, WHO Director-General Meanwhile, WHO’s Tedros urged people to fight against stigma associated with the transmission of monkeypox in networks of men who have sex with men (MSM) – and underlined that the disease can be transmitted in a range of ways. Those include through contact with: infected saliva and mouth lesions, bedding as well as transmission of pregnant women to their unborn children through the placenta, according to a WHO seminar on the issue Tuesday. Tedros said that MSM advocacy groups “are working hard to inform [members of their community] about the risks of monkeypox and prevent transmission. But all of us must work hard to fight stigma, which is not just wrong. It could also prevent infected individuals from seeking care, making it harder to stop transmission.” “Anyone can be infected with monkeypox if they have close physical contact with someone else who was infected,” he said. The virus was first identified in 1958 in a colony of captive African research monkeys. The first human case was identified in the DRC in 1970, during the period of smallpox elimination campaigns. Even before the current outbreak, there have been limited waves of cases reported in non-endemic countries through channels such as the export of exotic animals, such as infected mice, squirrels, and rats, from Ghana to the United States in 2003, as well as by infected travelers. Misinformation campaign to target monkeypox Maria van Kerkhove, WHO Technical Lead on COVID-19 WHO is also mounting a campaign on disinformation about the disease, said Gabby Stern, WHO Communications Director. WHO is currently working with both social media companies and tech companies, urging them to filter out the misinformation and push out accurate information through their channels and platforms, said She said that misinformation and disinformation was a ‘major priority’ for both WHO and the United Nations. “Misinformation kills, just as these viruses kill, misinformation kills as well,” added Dr Maria van Kerkhove, WHO technical Lead on COVID-19. “This remains a constant challenge, not only COVID-19 across the entire spectrum of interventions and the response that we have. It’s the attacks on science that undermine the effectiveness of our countermeasures.” Image Credits: Tessa Davis/Twitter , Laëtitia Dudous, WHO, Disease Outbreak News, 21 May 2022 . Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Self-Care Practices Can Save Millions and Alleviate Pressure on Health Systems 06/06/2022 Aishwarya Tendolkar In a world where health workers are scarce, self-care practices can drastically improve people’s quality of life and alleviate strain on health systems, but depend on a range of factors including patient literacy, fair prices and government stewardship. This is according to a one-of-a-kind global study demonstrating the value of self-care that was launched on the sidelines of recent World Health Assembly in Geneva. The World Health Organization (WHO) defines self-care as “the ability of individuals, families, and communities to promote health, prevent disease, maintain health, and to cope with illness and disability with or without the support of a healthcare provider.” Current self-care activities around the world are generating annual savings of approximately $119 billion, along with saving 11 billion patient hours worldwide, according to the study. The study was produced by the Swiss-based Global Self-Care Federation (GSCF), which represents manufacturers and distributors of non-prescription medicines on all continents. Self-care cost-saving (source: Global Self-Care Federation report). Low-income countries lagging But the low-income countries are still lagging in implementing and reaping the benefits of self-care. “In low-income countries, about 65% of households that could not obtain essential health services had financial constraints,” said Dr Ritu Sadana, WHO Head of Ageing and Health Division of Universal Health Coverge (UHC), one of the panelists at the launch of the report. “This is more than triple the proportion of households who lack access to health services because they are just unavailable, which is 20%.” High-income countries are reaping the most benefits of self-care practices while the low-and middle-income countries are playing catch-up. With increased adoption of self-care, we will be seeing an additional $19.5 billion in annual cost savings related to the increased adoption of self-care by 2030, said Ben Carrick, Johnson and Johnson’s senior director of consumer policy. “If we think about the welfare benefits, it could be leading to an annual increase of $312 billion per year globally. These are significant benefits that are worth chasing and grasping,” Carrick told the launch. To estimate the true #ValueofSelfCare, we must first understand how it operates across different global contexts. Our 3 country groupings allow us to unlock such insights. 🌏 Read the report to learn the full scope of benefits that can be achieved:https://t.co/h5gTOOsgUl pic.twitter.com/ZMrINWpIax — The Global Self-Care Federation (@Selfcarefed_org) June 6, 2022 The study grouped 155 countries based on their GDP levels, and then gauged the self-care effects. In the high-income countries (Group A), self-care is already making an indispensable contribution to relieving the burden on healthcare systems. But it is in the low-and middle-income countries (Group B and C), where self-care can enable a person to work and not depend on welfare. “We don’t need more GDP; we need more welfare and this is also what this project is about, this is what self-care is about… to generate more welfare and not just be focused on figures and economic factors,” said Professor Uwe May, Dean of Studies at Fresenius University. He added that currently if people practised self-care instead of doing nothing about their health issues, 41 billion productive days can be gained on a global level. Self-care ‘only option’ in poor countries The study also found that health economic and pharmacoeconomic approaches deployed to assess the value of self-care cannot be transferred to lower-income regions where the infrastructure, socio-economic factors, and awareness is different. In addition, lack of access to over-the-counter (OTC) medicine and the prevalence of traditional medicines also has an impact on self-care options. In regions like sub-Saharan Africa and South East Asia, self-care is not an alternative care option, but is often “the only possible access to treatment for most individuals”, according to the report. In these countries, self-care does not translate into saving on doctors’ and specialists’ time. “This is where the welfare benefits are really the main opportunity because it isn’t saving physicians’ time and people don’t have access to the physicians,” said Carrick. “But if it means that they’re productive, they’re back at work and they’re able to look after families, then it’s those welfare and productivity benefits that really come into play.”. In Latin America and the Caribbean, the practice of self-care and the use of OTC products leads to current welfare savings of $123 per capita per year. The more the OTC use increases, the greater the individual and societal benefits can be realised through self-care, according to the study “We estimated that at least 142 million older persons, about 14% of older persons worldwide, are unable to meet some of their basic needs. So the issues around self-care for themselves or by their families or care providers is extremely important,” said Carrick. What do we need now? The report highlights the need for private-public partnerships, digital and healthcare literacy in people living in low-and middle-income countries (LMICs) and better parameters to gauge healthcare outcomes in a country. “We need strong stewardship by government, and to have really strong capacities in government institutions…so that they can lead and shape how we actually get things done with the private sector, with multiple sectors across the government and also obviously, civil society and self-care demands with the active participation of people,” said Sadana. “Health literacy is a fundamental catalyst for change to ensure individuals comprehend and act on credible health information, becoming active self-managers of their own health,” said Carrick. Experts at the launch also highlighted the need for pharmacies to be more involved in developing better policies, and for governments to spend more on ensuring that self-care is delivered through, not only OTC and literacy, but also nutrition, lifestyle, and affordable healthcare. Sadana said that in India, 70% of all healthcare costs are paid out of pocket, and 70% of that was on drugs. “If we’re going to have a system which encourages self-care, using products that are evidence-based and quality-controlled, we still need to have a way to ensure that those are covered [by the health system] if we actually want a vast swathe of the population to use them.” Image Credits: Tbel Abuseridze/ Unsplash. Climate Crisis Poses Serious Risk to Mental Health – WHO 03/06/2022 Raisa Santos Climate change poses serious risks to mental health and well-being, concluded a new World Health Organization policy brief, launched on Friday at the Stockholm+50 conference. Natural disasters such as floods, heatwaves, storms, and drought can pose a threat to mental health and psychosocial well-being, exacerbating emotional distress, anxiety, depression, grief, and suicidal behavior. WHO is therefore urging countries to include mental health and psychosocial support in their response to climate change. “The impacts of climate change are increasingly part of our daily lives, and there is very little dedicated mental health support available for people and communities dealing with climate-related hazards and long-term risk,” said Dr Maria Neira, WHO’s Director of Environment, Climate Change, and Health. #ClimateChange poses serious risks to #MentalHealth and well-being – from emotional distress to anxiety, depression, grief, and suicidal behavior: new WHO policy brief https://t.co/ogdEP9iIG6 pic.twitter.com/VRqrMqoixr — World Health Organization (WHO) (@WHO) June 3, 2022 The findings concur with a report made by the Intergovernmental Panel on Climate Change (IPCC) published in February of this year, which revealed that half of the world’s populations live in climate ‘danger zones’ that place “people’s health, lives, and livelihoods” at risk, and this can also include people’s mental health. The two-day conference, hosted by the government of Sweden and convened by the United Nations General Assembly on 2 – 3 June, drew together thousands of participants across government, civil society, and the private sector in an effort to spur urgent action for a healthy planet. The meeting also commemorates 50 years since the 1972 UN Conference on the Human Environment, which made the environment a pressing issue for the first time. Climate change impact on mental health The mental health impacts of climate change are felt disproportionately around the world, with support services unequally distributed as well. While there are nearly 1 billion people living with mental health conditions, 3 out of 4 do not have access to needed services in low- and middle-income countries. A 2021 WHO survey found that out of 95 countries, only 9 have thus far included mental health and psychosocial support in their national health and climate change plans. Additionally, while the annual cost of common mental disorders is $1 trillion, only 2% of government health budgets are spent on mental health. These figures are all exacerbated by climate change. “The impact of climate change is compounding the already extremely challenging situation for mental health and health services globally,” said Devora Kestel, WHO Director of the Department of Mental Health and Substance Abuse. Examples of how climate change can impact mental health include the loss of personally important places, loss of autonomy and control, and exposure to pollution, which is associated with increased risk for mental health conditions. The new policy brief recommends five important approaches for governments to address the mental health impacts of climate change: Integrate climate considerations with mental health programs Integrate mental health support with climate action Build upon global commitments Development of community-based approaches to reduce vulnerabilities to climate change, and Close the funding gap for mental health and psychosocial support “By ramping up mental health and psychosocial support within disaster risk reduction and climate action, countries can do more to help protect those most at risk,” said Kestel. Image Credits: Clay Kaufmann/ Unsplash. After Many Missed Opportunities, Oral Health Gets Long Overdue Attention from WHO 03/06/2022 Ihsane Ben Yahya & Greg Chadwick Dental services, including regular check-ups, were among the most disrupted essential health services during the COVID-19 lockdowns. People´s reticence to visit a dentist during normal times was exacerbated by fear of venturing into an open clinic or simply not being able to, due to restrictions. Dental hesitancy has always been around but over two years into the pandemic, it´s now a lot worse. This hesitancy is also echoed at the policy level. Oral health has, until very recently, been considered the “ugly duckling” of global health efforts. The World Health Organization (WHO) has only ever passed a special resolution on oral health twice in its history: most recently, ironically, in the midst of the COVID-19 pandemic in 2021. The new global oral health strategy, approved by governments at 75th WHO World Health Assembly last week is a step in the right direction, and it is long overdue. 📣The WHO global #OralHealth strategy has officially been approved and adopted at the #WHA75 👏 FDI commends the strategy and tells @WHO that we are ready to support the development of the subsequent action plan and monitoring framework by 2023 ➡️ https://t.co/mTPgDRSB24 pic.twitter.com/MYf1nFap8e — FDI World Dental Federation (@fdiworlddental) May 28, 2022 Oral health is essential for overall health It´s a perfect time to double down on just why responding to the global oral health epidemic is in our broader (health) interests. Getting people back into dental clinics and protecting their oral health is essential to safeguarding their overall health, well-being, and quality of life. All those factors that can make people vulnerable to chronic non-communicable diseases (NCDs) such as cardiovascular disease, cancer, chronic respiratory disease, and diabetes are equally risky for one´s oral health. High sugar consumption, harmful alcohol use and tobacco are just as bad for our bodies as they are for our mouths. The impact in pure numbers is alarming: there were some 3.5 billion cases of oral diseases and other oral conditions in 2017. For the last three decades, the combined global prevalence of dental caries (tooth decay), periodontal (gum) disease and tooth loss has stood at 45% – higher than any other NCD. Ignoring the problem makes no sense, financial or otherwise. Worldwide, oral diseases accounted in 2015 for $ 357 billion in direct costs and US$ 188 billion in indirect costs. In the same year, $96.2 billion was spent on the treatment of oral diseases across the European Union, the third-highest total among NCDs, behind diabetes and cardiovascular diseases. “Without good oral health, you’re not healthy,” former US Surgeon-General David Satcher once said, and he was right. The largely siloed approach to dealing with oral health makes no policy sense either, especially when we consider the evidence. Junk food and tooth decay We know that bacteria and inflammation associated with periodontal disease are linked to cardiovascular disease, rheumatoid arthritis, and adverse effects in pregnancy. We also know that people living with diabetes experience improved blood glucose levels if their periodontal (gum) disease is managed correctly. Knowing what we know about poor oral health – that it is preventable and if addressed can help improve our overall health – only begs the question as to why more is not being done to integrate it into other NCD programmes? The pending ban on television and online advertising of junk food in the UK before 9pm is a great example of encouraging better diet. So too is the campaign by UK footballer Marcus Rashford to promote healthier school lunches. But they are missed opportunities. With forethought, both interventions could have included some key messages for children and parents around the connection between a healthy diet and good oral health. Future campaigns could better highlight the need to prioritize oral health promotion in schools, communities and workplaces as well as ensure access to the millions of people who cannot afford the basics, such as fluoridated toothpaste. We need to globally re-think how we talk about and tackle oral diseases. In the vast majority of countries, even essential oral health services are not part of universal health coverage. Oral diseases are noncommunicable diseases and need to be treated as such. Advocates have long argued that investment in prevention produces strong economic returns and saves millions of lives. COVID-19 has reinforced the huge economic and human cost of not doing so: people living with chronic diseases like diabetes, cancer and cardiovascular were at much higher risk of becoming seriously ill, hospitalized, or dying from SARS‑CoV‑2. At the same time, the pandemic is just a microcosm of the bigger picture: our past failure to address oral disease in a substantive way and to view it as an NCD like any other. Prof Ihsane Ben Yahya Prof Ihsane Ben Yahya is the President of the FDI World Dental Federation and professor at the Dental University in Casablanca, Morocco. Dr Greg Chadwick Dr Greg Chadwick is the President-elect of FDI World Dental Federation and Dean at East Carolina University, School of Dental Medicine, United States. Image Credits: Caroline LM/ Unsplash, FDI World Dental Federation. Shanghai Lockdown is Finally Relaxed But Stringent Testing Still Required 02/06/2022 Raisa Santos Shanghai eased its lockdown restrictions 1 June 2022, following continuous low cases reported. Sixty five days after one of the toughest lockdowns in the world, China has eased COVID-19 restrictions on its financial hub, Shanghai, on Wednesday – finally allowing the majority of its 25 million residents to move freely again. However, at least 890,000 residents are confined at home, in “quarantine” or “control zones”. The announcement to lift restrictions came as official figures showed on Sunday that daily new coronavirus cases fell from 170 to 122 in a 24-hour period. The city reported just 13 cases for Wednesday, and an additional 7 cases on Thursday. This is a marked turnaround from the beginning of April, when tens of thousands of cases were reported daily. “This is a day that we dreamed of for a very long time,” Shanghai government spokeswoman Yin Xin told the BBC. China to maintain ‘zero tolerance’ policy Shanghai residents will be required to hold a negative nucleic acid test result taken within 72 hours of entering public spaces or using public transportation from June But while China seems to have moved into the clear with COVID, the country is keen to maintain its “zero tolerance” policy, and is already preparing for future waves. Beijing municipal officials said Thursday that 12 of its planned 14 ‘transition hubs’ will be used to test and disinfect all imported frozen food before goods are distributed across the city. This follows China’s contention that frozen food could transmit COVID-19 in while the World Health Organization’s independent panel on the virus’s origins favour an unknown animal vector as the most likely cause, while others have pointed to laboratory accident for the spread of the coronavirus first found in bats in China. Tens of thousands of testing booths will also be set up across China’s largest cities, including Beijing, Shanghai, and technological hub Shenzhen, to require testing as often as every 48 hours. New rules in Shanghai will now require residents to show a green health code on their smartphone, with proof of a negative PCR test in the last 72 hours, to leave their residential compounds and enter most places, including banks, malls, and public transportation. However, cinemas, museums, and gyms remain closed, as well as in-person schooling. Restrictions on leaving the city still remain, with anyone traveling to another city facing a quarantine of seven to 14 days upon return. Beijing also lifted its restrictions earlier this week, following similar protocol with some of its public transportation system, malls, and other venues opening up. Shanghai testing centers tested by overcapacity and staff shortages Shanghai testing center Shanghai’s 72-hour rule has tested the capacity of its testing centers, as crowds flocked to the 15,000 stations. While some said their test took only a matter of minutes, others complained that they had to wait over an hour to test. Many testing booths are only open for about three hours each in the morning and afternoon, although some hospitals offer a 24-hour service. Shanghai resident Zhang Zehong told Sixth Tone that she was unable to test Wednesday as the station in her neighborhood closed two hours earlier than shown on the city’s health code app, which features all the testing centers. Instead, she went to a hospital with a 24-hour service Thursday morning, only to find no staff and a line that stretched on for over 100 meters. So many issues need to be fixed,” Zhang said. Chinese microblogging platform Weibo also featured complaints with the stations. “It’s been very hot recently, several people passed out when standing (in line),” one Weibo user wrote. “I visited five sites but each had long queues. This is not really humane enough. Don’t these mobile kiosks cause more people to gather?” another Weibo user wrote. Fifty-point plan to revive Shanghai economy A fifty-point plan has also been drawn up to support Shanghai’s economy, crippled in the wake of closures, quarantines, and lockdowns. New measures include reducing taxes for car buyers, speeding up the issuance of local government bonds, and fast-tracked approval of building projects. Drivers who also switch to an electric vehicle will also be able to claim a $1500 subsidy. Businesses may also be able to delay insurance and rent payments, with subsidies available for utility charges. Image Credits: Appriseug/Twitter , DA Trade Market Securities/Twitter , Don Weinland/Twitter. Eight Countries Compete to Host African Medicines Agency at Crucial African Union Meeting 02/06/2022 Paul Adepoju AMA headquarters host country is expected to be named at the end of an ongoing meeting in Addis Ababa A meeting to decide which African country will be the host country for the African Medicines Agency (AMA) is underway and at the last count, expressions of interest in hosting the agency have been received from Uganda, Algeria, Egypt, Morocco, Rwanda, Tanzania, Tunisia and Zimbabwe. The decision is expected to be one of the outcomes at the ongoing first Ordinary session of the Conference of State Parties (CoSP) of the AMA, in Addis Ababa, Ethiopia from 1 to 3 June 2022. The CoSP is reviewing the AMA assessment report and at the end of their meeting, it will make recommendations on the host country of the AMA Headquarters. A final decision on this recommendation will be made at the next assembly of the African Union. Uganda is one of the countries vying to host the AMA Headquarters and the country’s delegation to the CoSP meeting is led by the country’s Minister of Health, Dr Jane Aceng, and Dr Diana Atwine, a Permanent Secretary in the Ministry of Health. Zimbabwe’s team is a four-member delegation led by the country’s Health and Child Care deputy Minister, Dr John Mangwiro. Sierra Leone is also attending the session led by Minister of Health and Sanitation Dr Austin Demby. In his remark at the official launch of the Africa CDC’s Ministerial Executive Leadership Program (MELP), Dr John Nkengasong, Africa CDC’s outgoing Director General confirmed the CoSP’s outcome would play a critical role in deciding the future of the agency. “The launch of the AMA is really another landmark initiative of the African Union as part of the Agenda 63. I can’t wait to hear the outcome of the deliberations. It’s going to be transformational when the AMA and we are truly excited with that,” Nkengasong said. The three-day ministerial meeting will deliberate on the priorities and next steps to establish the AMA. From Geneva to Addis Ababa At last week’s World Health Assembly, Amref Health Africa’s Desta Lakew, on behalf of the African Medicines Agency Treaty Alliance (AMATA) described AMA as an initiative of the African Union aimed at strengthening the regulatory environment to guarantee access to quality, safe and efficacious medicines, medical products, and technologies on the continent. Countries that have signed the treaty, according to AMATA, are Algeria, Benin, Chad, Ghana, Madagascar, Mali, Morocco, Rwanda, Saharawi Arab Democratic Republic, Senegal, and Tunisia. But about four years after the AU Assembly adopted the AMA Treaty, Lakew noted that some Member States still haven’t given it the authority to fulfill its mandate. “The increased risk of disease outbreaks in the region and globally has made access to medical products a priority. Trade in locally produced medical products, including Personal Protective Equipment, across African countries will be hampered if we do not have a harmonized regulatory environment,” Lakew told WHA 75. At the CoSP meeting, the AU called on all member states to sign the Treaty to see improved regulation and easy flow of medical products and technologies, are expected to be reechoed. Lakew described the call as an urgent matter “for the sake of ensuring that there is equitable access to quality, safe, efficacious medicines and technologies for a healthy Africa”. Last month, Health Policy Watch reported Kenya was preparing to join the AMA alongside thirty-one other African Union member states following the Kenyan cabinet’s decision to approve the ratification of the African Union Treaty. See more about the African Medicines Agency on our special AMA Countdown page: African Medicines Agency Countdown Sex, War, Sustainability and the World Health Assembly – Last Week in Review 02/06/2022 Elaine Ruth Fletcher 75th World Health Assembly Health and peace, sex and war, money and management. Whether in chorus or cacophony – last week’s World Health Assembly of WHO member states played most of the notes in the symphony of global debate over strategies to tackle disease, epidemics and pandemics and bolster health systems. But the root causes of emerging disease threats – in modern environmental health threats and nature gone awry remained under-represented themes. From the opening notes of the WHA, on a health for peace theme, to Saturday’s late night closing and end-run charges over language on sexual orientation – this year’s WHA was a seesaw of successes and setbacks. Highs included the consensus vote Tuesday to increase member states contributions to WHO, followed by a resolution Friday to move ahead on the first real reforms to the International Health Regulations in almost 20 years. And at the same time, unprecedented polarization was evident during Thursday’s debate over a resolution condemning Russia’s invasion of Ukraine, which won approval by a vote of 88 to 12. That was followed by the dispute that emerged Friday and continued until nearly midnight Saturday over references to terms such as “sexual rights” and “men who have sex with men” (MSM) in a WHO strategy on HIV, hepatitis-B and sexually transmitted infections (STIs). That, too, was resolved only by a painful series of rollcall votes, leading to the strategy’s passage by just 60 member states, with twice as many delegates absent or abstaining. Like a bullet train ride Dr Hiroki Nakatani joins in the applause for the resolution’s passage on HIV, Hepatitis B and STIs Dr Hiroki Nakatani, who presided over the committee that faced the thorny final hours of WHA dealing with the clash among nations over sexual health terms that HIV professionals regard as the standard usage, compared this year’s WHA session to a ride on a bullet train. “The train ride was sometimes bumpy but we arrived at our destination,” he said of the first Assembly to be held in person in several years because of the pandemic. Perhaps so, even more so than the war in Ukraine, the exceptionally large number of abstentions in the vote on a new HIV, Hepatitis and STI strategy was a bitter pill to swallow for delegates on both sides of the debate. It highlighted the fact that the battles still being waged in Europe, the Middle East, Asia and Africa over the control of territory are not the only big issues dividing member states. Fissures over social norms shape and guide public health policies run just as deep. Sex & War – Global social divide as deep as territorial conflicts And among those norms, there remains a deep divide around health policies that interface with human sexuality – that other primordial urge that co-exists alongside the urge for power and territory. For WHA delegates, in fact, the series of votes Saturday over sexual terminology may have been even more unsettling than the votes over Russia’s invasion of Ukraine – precisely because they sit in Ministries of Health, not Defence, with day-to-day responsibility for designing and implementing policies on HIV and other STIs. As with the Ukraine conflict, the divide that emerged, however, was not strictly drawn along the lines of global North and South. Saudi delegate in heated WHA debate Saturday over sexual rights and terminology Rather, it was the oil-rich Saudi Arabia that led the charge in the quest to purge references to men who have sex with men from the strategy on HIV treatment, followed by emerging economies of Asia and Africa where conservative views about sexual expression are often protected by law as well as custom. Against that, was Europe, North America, much of Latin America and high-income Asia- where more new attitudes about gender identity and LGBTI terminology have taken root over the past few decades. There were also exceptions, such as South Africa, which voted in favour of the HIV strategy. And European Serbia abstained from the vote as did the Russian Federation. Respect for culture, versus respect for evidence In the aftermath, the abstaining countries pleaded for more understanding of norms guided by tradition and culture. Western delegates, meanwhile, referred to the compass of science – whereby recent research has revealed how oft-marginalized MSM groups often fall through the cracks of programmes for HIV/AIDS prevention, diagnosis and treatment. “We appreciate those member states acted in good faith as part of these deliberations. Unfortunately this has served as a painful reminder of the need to reinforce our focus on evidence, human dignity and decency,” said US Assistant Secretary of State for Global Health Loyce Pace just after the strategy was approved. Loyce Pace, Assistant Secretary of State for Global Health, USA “[But] we should not need to hold a vote on the existence of entire communities of people,” she added. “We have a strategy on critically important global health issues, yes. But at what cost to those we risk leaving behind? “So to gay, lesbian, bisexual, queer, intersex, transgender and gender non-conforming people around the world, the United States government sees you, and will continue to support you. Stay strong.” (Right) Denmark’s EB representative, Søren Brostrøm, Director-General, Danish Health Authority, at the WHO Executive Board meeting 30 May, (left) Loyce Pace Assistant Secretary of State for Global Health, USA Reviewing the issue at Monday’s Executive Board meeting, member states on both sides of the divide expressed concerns over the failure of the WHA to find consensus over such a flagship health strategy – and the “dangerous precedent” that the voting set. “It is important that this does not set a precedent for consideration and adoption of technical documents by the Health Assembly,” said Dr Edwin Dikoloti, Botswana’s Minister of Health and Wellness, speaking on behalf of the African group, saying that greater efforts need to be made to find consensus in future WHAs over such controversial issues. Money – landmark decision on WHO finance – but not a ‘done deal’ Members of the WHO Working Group on Sustainable Finance hammer out the final agreement on increasing member state contributions, Germany’s Björn Kümmel on far left. The holy grail of consensus was restored in other key moments – including around the WHA resolution to increase regular member state contributions to WHO – in a bid to stabilize the agency’s finances The agreement, the fruit of months of grinding backroom diplomacy led by Germany, saw member states commit to increase annual assessments to cover 50% of WHO’s core budget by the end of the decade. However, each stepwise increase up until 2030 will still need endorsement at future WHAs to go forward. And so the vote should not be seen as a blank check either, a senior official in the Department of Health and Human Services, told Health Policy Watch. “I would say that the US, as a big contributor to the WHO, is definitely committed to that [resolution], and we were very happy to join the consensus,” the official said. “But I hope it’s also been clear that that is not a done deal and neither for us as the administration or for Congress.” According to the resolution, final approval of each year’s increase is contingent on progress in WHO internal reforms that are supposed to make the organization more transparent, efficient and well-managed. Those demands include overhaul of WHO’s budget management system, said the senior US official: “The budgets that are adopted by the Health Assembly are not real budgets. They’re just budget space. And creating budgets that are aspirational is very different from programming and reporting on and demonstrating the impact of real budgets.” Management – following election Tedros faces new demands Applause just after WHA re-elects Dr Tedros Adhanom Ghebreyesus to serve a second five-year term as Director-General of the World Health Organization on 24 May. He ran un-opposed. But the expectations go beyond budget reform, pressing newly re-elected Dr Tedros Adhanom Ghebreyesus for changes in WHO’s management culture, including more merit-based appointments of senior WHO staff, such as those serving as heads of WHO country offices, and structural reforms in WHO’s internal justice system. “I think, from our perspective…. there’s a very significant culture change… that needs to happen within the organization,” the official told Health Policy Watch. Further related to that, are demands for a “full resolution” of the ongoing investigation of the cases of sexual harassment and abuse of women in the Democratic Republic of Congo by WHO staff and consultants, whose progress also was reviewed at last week’s WHA and Monday’s EB. Justice – WHO internal justice system lacks independence While the revelations of the DRC sex abuse scandal, which first came to light in 2020, and whose perpetrators have yet to be fully prosecuted, highlight failures of WHO internal justice to date, they also are evidence of a broader and more systematic problem, some WHO insiders maintain. One key problem, highlighted in multiple interviews with both past and present WHO staff, is the fact that WHO’s Internal Oversight Office (IOS) – the legal mechanism that manages staff and management complaints – is housed in the Director-General’s Office and effectively controlled by the Director General himself – rather than at arms length. Politically influential managers or staff with the ear of the DG, may receive different treatment than staff who do not, critics say. The flaws in the current process featured in a WHO Staff Association letter to Monday’s Executive Board. The Staff Association demanded that the WHO Global Board of Appeals, the three-member body that hears cases, and recommends disciplinary action to the Director General, be expanded and also include staff-appointed representatives. “The panel of the Global Board of Appeal (GBA) should have five-members,” stated the Staff Association. “A three-member panel – the current practice – is simply not reassuring staff that GBA deliberations are sufficiently robust,” the Staff Association letter stated.“Furthermore, the staff representatives on each of the GBA panels should be selected by the respective staff association rather than selected by the GBA Chair or Deputy-Chair.” The net result of the current system is that – short of a costly and lengthy appeal to the International Labour Organization – disciplinary cases are heard by a GBA board appointed by senior managers who report directly to Tedros, who also decides on the final outcome of the cases. Dr Boubacar Diallo with WHO Director-General, Dr Tedros Adhanom Ghebreyesus and then-WHO Emergency Response Team leader, Dr Michel Yao in DRC in June 2019; Diallo was among those accused of harassment and Yao was alleged to have ignored those and other reports. With regards to the DRC cases, allegations that high-ranking WHO managers or consultants with ties to Tedros may have turned a blind eye to the reports of abuses going on in the field, have never been publicly resolved. But the concerns extend beyond sexual harrassement, to the need to foster an institutional culture of professionalism free of political interference, critics also say, pointing to other episodes like the suppression of a 2020 WHO report on Italty’s pandemic response, which criticized another senior WHO advisor to Tedros. From a sustainable budget a sustainable planet? While WHO’s financial sustainability received considerable attention at this year’s WHA, there was comparatively little debate on the planet’s sustainability crisis – and how that may be fueling a cascading array of health impacts – from more noncommunicable diseases to emerging outbreaks, such as SARS-CoV2 and more recently a worldwide surge in monkeypox. A new roadmap to accelerate work on noncommunicable diseases fails to give more than a nod to air pollution as one of the leading causes of NCDs – responsible for some 7 million deaths a year from cancers, cardiovascular and lung diseases every year. And that doesn’t even include risks from chemicals exposures that make the total estimate of deaths from pollution closer to 9 million annually, according to a new Lancet Planetary Health Report released on 18 May. Deaths attributable to key “modern” and “traditional” pollution sources for which data is available In a debate over an NCD roadmap that aims to slash NCD risks by one third by 2030, France, speaking on behalf of some European Union member states,called for a more “integrated” approach that includes environmental health and climate change. So far, such approaches have been slow in coming. Despite the rhetoric about air pollution being a leading risk factor for NCDs, there are, as yet, no WHO “Best Buys” for environmental strategies that reduce deadly pollution risks – even if measures like clean public transport and compact cities, built around cycling and walking networks, are regarded by urban planners and transport managers as evidence-based solutions that have a record of demonstrated results. ‘One Health’ and food safety – some new approaches Caged animals held for sale and slaughter in unsanitary conditions at Wuhan’s Huanan Seafood Market, prior to the outbreak of COVID-19, including: (a) King rat snake (Elaphe carinata), (b) Chinese bamboo rat (Rhizomys sinensis), (c) Amur hedgehog (Erinaceus amurensis) (the finger points to a tick), (d) Raccoon dog (Nyctereutes procyonoides), (e) Marmot (Marmota himalayana) (beneath the marmots is a cage containing hedgehogs), and (f) Hog badger (Arctonyx albogularis). On the brigher side, a new WHO Global Strategy for Food Safety was approved by member states. For the first time ever, the strategy makes reference, at least in passing, to the need for a “One Health approach when addressing health risks emerging at the human-animal-ecosystems interface.” A companion decision asks WHO to also update its guidance on Reducing public health risks associated with the sale of live wild animals of mammalian species in traditional food markets. Such guidance emerges out of the SARS-CoV2 pandemic, where peoples’ exposure to SARS-CoV2 infected animals in the Wuhan, China live animal market is considered to be one of the most plausible routes by which SARS-CoV2 initially leaped from animal to human populations in Wuhan, China during 2019. But the caging and slaughter of live, wild animals in areas heavily trafficked by customers are practices common in thousands of traditional markets in Asia and Southeast Asia, as well as parts of Africa, leading to further risks of human exposure to pathogens the animals may harbour. Not nearly enough action to stop pandemics at source The unsafe handling of live animals that are sold for slaughter at traditional markets can risk the spread of foodborne and infectious diseases. Such “One Health” issues need far more deliberate and systematic WHO and member state attention than the nod that they have so far, a growing chorus of “Ecohealth” experts say. In a little-noticed press release issued during WHA, Dr Nigel Sizer, executive director of the consortium Preventing Pandemics at the Source called upon the WHA to do more to address ecosystem risks upstream that increase “spillover risks” of pathogen leap from animal to human populations: “Such actions include shutting down or strictly regulating wildlife trade and markets, stopping deforestation and forest degradation, and providing better health to communities in emerging infectious disease hotspots, as well as strengthened veterinary care and biosecurity in animal husbandry,” said Sizer, an internationally known conservationist, in his statement. “Overall throughout the WHA process and in the preparations for negotiation of a possible global instrument on pandemic prevention and preparedness there has been remarkably little attention given to true pandemic prevention,” Sizer later told Health Policy Watch. “We know where most pandemics come from and we know how to reduce the risk of zoonotic spillover of the vruses that cause them,” he added. “Governments in general and health agencies in particular should embrace these approaches, including One Health efforts. They should also work much more closely with environmental agencies to address spillover risk from tropical deforestation, wildlife exploitation and trade, and intensive animal agriculture. The public health return on investment in such activities would be enormous.” Health and Environment: WHO structures preserve a deep divide Researcher explores evidence around the wildlife-trade- pandemic nexus (Wildlife Conservation Society) There are parallel calls to better incorporate such concerns into any future “pandemic instrument” intended to have a broader scope than the International Health Regulations, and to be the focus of intense negotiations by a WHA Intergovernmental Board (INB) in coming months. However, the yawning chasm environmental groups encounter in trying to to interact with WHO and WHO member states over environmental health and One Health concerns, can sometimes appear as wide as the divide between member states on the terms around sexual health. “It has been exceedingly difficult to engage with the WHA or with the intergovernmental negotiating body’s (INB) process to draft and negotiate a new pandemic instrument,” Christine Franklin, of the Wildlife Conservation Society, another member of the Preventing Pandemics coalition, told Health Policy Watch. The club of non-state actors in ‘official relations’ “Only non-State actors in official relations with the WHO are invited to engage with the WHA,” she remarked. That status of ‘official relations’ not only allows civil society groups the privilege of expounding on their positions at the annual World Health Assembly, it gives them access to lengthy and detailed informal member state consultations and intergovernmental negotiating sessions that are closed to the general public and the media. Some 220 civil society actors hold that coveted status, mostly mainstream medical and health societies as well as pharma groups, but also agro-business foundations, such as CropLife International, as well as the outliers like the World Plumbing Council. A review by Health Policy Watch found nary an environmental or eco-health group on the list, as of February 2022. “So even though Wildlife Conservation Society has been working across the globe for more than 125 years; is the only international conservation organization with an embedded health program, works on the ground in more than 60 countries; and our health program is recognized as a One Health founder and a leader at the nexus of health and the environment, the INB’s public hearing has been the only opportunity we have had to provide input,” Franklin lamented. “Oral testimonies were limited to two minutes and written statements restricted to 250 words. In fact, there are no organizations from the conservation or environment communities in official relations with the WHO and the process to gain status is complex and lengthy.” Image Credits: Germany's UN Mission in Geneva , WHO, Lancet Planetary Health, Nature , Pierce Mill Media, Wildlife Conservation Society . Doubling of Monkeypox Cases Outside of Endemic Countries Raises New Alarm Bells at WHO 01/06/2022 Raisa Santos & Elaine Ruth Fletcher Monkeypox lesions In just a matter of three days, the number of monkeypox cases reported to WHO outside of central and west Africa has doubled – with reports Wednesday of some 550 cases in more than 30 countries outside of the countries where the disease is endemic, WHO Director General, Dr Tedros Adhanom Ghebreyesus told a press briefing on Wednesday. That, as compared to reports of 257 cases outside of Africa, as of Sunday, 30 May. The ‘sudden appearance’ of monkeypox in so many non-endemic countries is prompting new concerns that it could spread to more “vulnerable populations” in countries where it has suddenly emerged, including pregnant women and children, added WHO’s Maria Van Kerkhove, Health Emergencies technical lead. WHO Briefing, 1 June 2022 “Investigations are ongoing, but the sudden appearance of monkeypox in many countries at the same time suggests there may have been undetected transmission for some time,” said WHO Director-General Tedros Adhanom Ghebreyesus during a press briefing Wednesday. “WHO’s priority now is to first provide accurate information to those groups most at risk, and second to prevent further spread among at-risk groups, to advance our understanding of monkeypox.” WHO is organizing two R&D meetings of experts on Thursday and Friday of this week, to further discuss monkeypox and understand the current surge in cases. Ecological pressures prompting rapid disease emergence Gambian pouched rat – rodents are a common animal reservoir for monkeypox Monkeypox has long circulated in 12 countries of central and western Africa, with a rising incidence over time. Disease prevalence is highest in the Democratic Republic of Congo, which has reported several thousand cases a year, and where the monkeypox clade, or variant, in circulation is more deadly. The disease has been reported to have mortality rates of up to 10% in the DRC. Noone has yet reported to have died from the outbreak that has occurred abroad recently – which has been traced to the milder West African clade. Cases of monkeypox in endemic countries between 15 December 2021 to 1 May 2022 Increased circulation of the disease in Africa in recent years has been linked to deforestation – which put wild animals in closer contact with humans, as well as increased agro-food storage, and consequent infestation of food containers by infected rats. Additionally, human travelers as well as the trade in exotic animals has been linked to the appearance of some cases overseas in the past. But the appearance of so many cases abroad is a new phenomenon, where community transmission is now occurring, including among networks of men who have sex with men, WHO said. The changes in ecosystems, trade and travel have been exacerbated by a decline in human immunity to the disease, due to the discontinuation of smallpox vaccination in the 1970s, which was protective against monkeypox as well. Ecological pressures need to be addressed Michael Ryan, WHO Executive Director, Health Emergencies Beyond the immediate health system measures needed to track and trace the spiral of increasing human cases occurring daily, more attention needs to be given to the underlying drivers, and ‘ecological pressure’ that has caused disease outbreaks to expand in size and scope,WHO’s Executive Director of Health Emergencies Mike Ryan told the briefing. “Animals are changing their behavior, humans are changing their behavior. What we’re dealing with is a lot of ecological fragility,” said Ryan. “We’re dealing with the animal-human interface being quite unstable, and the number of times that these diseases cross into humans is increasing, [as well as] that ability to amplify the disease and move it within our communities.” But he did not elaborate on how WHO might address such drivers – beyond saying that they could be a topic of discussion at this week’s R&D meeting convened by the global health agency. Inequity of investment in monkeypox in Europe versus Africa already apparent The current outbreak also highlights once more, the boomerang effect of inequitable investments in health systems and disease control in Africa, where monkeypox has been circulating for decades in countries that lack the tools to track and tackle such infections, Ryan said. “There are thousands and thousands of cases of monkeypox every year in Africa, and there are deaths every year….. And now, we have a concern about this disease spreading in Europe, but I certainly haven’t heard that same level of concern over the last five or ten years.” “Are we in a position to collectively respond? Are we in a position to share resources in order to stop transmission of these diseases within human communities?,” Ryan asked. Already, countries such as the United Kingdom have vaccinated more than 1,000 people at risk of contracting the virus, and the European Union is in discussions to buy smallpox vaccines from Bavarian Nordic, the only maker of the vaccine licensed in Europe, according to media reports. Smallpox vaccines are estimated to be about 85% effective against monkeypox, which is in the same orthopox family of viruses – but there have been no such vaccination campaigns in monkeypox hotspots such as DRC for decades. “It’s a bit uncomfortable that we have a different attitude to the kinds of resources we deploy depending on where cases are,” said Dr Jimmy Whittworth, of the London School of Hygiene and Tropical Medicine, speaking to the Associated Press. “It exposes a moral failing when those interventions aren’t available for the millions of people in Africa who need them.” Stigma against disease may prevent care, increase transmission Tedros Adhanom Ghebreyesus, WHO Director-General Meanwhile, WHO’s Tedros urged people to fight against stigma associated with the transmission of monkeypox in networks of men who have sex with men (MSM) – and underlined that the disease can be transmitted in a range of ways. Those include through contact with: infected saliva and mouth lesions, bedding as well as transmission of pregnant women to their unborn children through the placenta, according to a WHO seminar on the issue Tuesday. Tedros said that MSM advocacy groups “are working hard to inform [members of their community] about the risks of monkeypox and prevent transmission. But all of us must work hard to fight stigma, which is not just wrong. It could also prevent infected individuals from seeking care, making it harder to stop transmission.” “Anyone can be infected with monkeypox if they have close physical contact with someone else who was infected,” he said. The virus was first identified in 1958 in a colony of captive African research monkeys. The first human case was identified in the DRC in 1970, during the period of smallpox elimination campaigns. Even before the current outbreak, there have been limited waves of cases reported in non-endemic countries through channels such as the export of exotic animals, such as infected mice, squirrels, and rats, from Ghana to the United States in 2003, as well as by infected travelers. Misinformation campaign to target monkeypox Maria van Kerkhove, WHO Technical Lead on COVID-19 WHO is also mounting a campaign on disinformation about the disease, said Gabby Stern, WHO Communications Director. WHO is currently working with both social media companies and tech companies, urging them to filter out the misinformation and push out accurate information through their channels and platforms, said She said that misinformation and disinformation was a ‘major priority’ for both WHO and the United Nations. “Misinformation kills, just as these viruses kill, misinformation kills as well,” added Dr Maria van Kerkhove, WHO technical Lead on COVID-19. “This remains a constant challenge, not only COVID-19 across the entire spectrum of interventions and the response that we have. It’s the attacks on science that undermine the effectiveness of our countermeasures.” Image Credits: Tessa Davis/Twitter , Laëtitia Dudous, WHO, Disease Outbreak News, 21 May 2022 . Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Climate Crisis Poses Serious Risk to Mental Health – WHO 03/06/2022 Raisa Santos Climate change poses serious risks to mental health and well-being, concluded a new World Health Organization policy brief, launched on Friday at the Stockholm+50 conference. Natural disasters such as floods, heatwaves, storms, and drought can pose a threat to mental health and psychosocial well-being, exacerbating emotional distress, anxiety, depression, grief, and suicidal behavior. WHO is therefore urging countries to include mental health and psychosocial support in their response to climate change. “The impacts of climate change are increasingly part of our daily lives, and there is very little dedicated mental health support available for people and communities dealing with climate-related hazards and long-term risk,” said Dr Maria Neira, WHO’s Director of Environment, Climate Change, and Health. #ClimateChange poses serious risks to #MentalHealth and well-being – from emotional distress to anxiety, depression, grief, and suicidal behavior: new WHO policy brief https://t.co/ogdEP9iIG6 pic.twitter.com/VRqrMqoixr — World Health Organization (WHO) (@WHO) June 3, 2022 The findings concur with a report made by the Intergovernmental Panel on Climate Change (IPCC) published in February of this year, which revealed that half of the world’s populations live in climate ‘danger zones’ that place “people’s health, lives, and livelihoods” at risk, and this can also include people’s mental health. The two-day conference, hosted by the government of Sweden and convened by the United Nations General Assembly on 2 – 3 June, drew together thousands of participants across government, civil society, and the private sector in an effort to spur urgent action for a healthy planet. The meeting also commemorates 50 years since the 1972 UN Conference on the Human Environment, which made the environment a pressing issue for the first time. Climate change impact on mental health The mental health impacts of climate change are felt disproportionately around the world, with support services unequally distributed as well. While there are nearly 1 billion people living with mental health conditions, 3 out of 4 do not have access to needed services in low- and middle-income countries. A 2021 WHO survey found that out of 95 countries, only 9 have thus far included mental health and psychosocial support in their national health and climate change plans. Additionally, while the annual cost of common mental disorders is $1 trillion, only 2% of government health budgets are spent on mental health. These figures are all exacerbated by climate change. “The impact of climate change is compounding the already extremely challenging situation for mental health and health services globally,” said Devora Kestel, WHO Director of the Department of Mental Health and Substance Abuse. Examples of how climate change can impact mental health include the loss of personally important places, loss of autonomy and control, and exposure to pollution, which is associated with increased risk for mental health conditions. The new policy brief recommends five important approaches for governments to address the mental health impacts of climate change: Integrate climate considerations with mental health programs Integrate mental health support with climate action Build upon global commitments Development of community-based approaches to reduce vulnerabilities to climate change, and Close the funding gap for mental health and psychosocial support “By ramping up mental health and psychosocial support within disaster risk reduction and climate action, countries can do more to help protect those most at risk,” said Kestel. Image Credits: Clay Kaufmann/ Unsplash. After Many Missed Opportunities, Oral Health Gets Long Overdue Attention from WHO 03/06/2022 Ihsane Ben Yahya & Greg Chadwick Dental services, including regular check-ups, were among the most disrupted essential health services during the COVID-19 lockdowns. People´s reticence to visit a dentist during normal times was exacerbated by fear of venturing into an open clinic or simply not being able to, due to restrictions. Dental hesitancy has always been around but over two years into the pandemic, it´s now a lot worse. This hesitancy is also echoed at the policy level. Oral health has, until very recently, been considered the “ugly duckling” of global health efforts. The World Health Organization (WHO) has only ever passed a special resolution on oral health twice in its history: most recently, ironically, in the midst of the COVID-19 pandemic in 2021. The new global oral health strategy, approved by governments at 75th WHO World Health Assembly last week is a step in the right direction, and it is long overdue. 📣The WHO global #OralHealth strategy has officially been approved and adopted at the #WHA75 👏 FDI commends the strategy and tells @WHO that we are ready to support the development of the subsequent action plan and monitoring framework by 2023 ➡️ https://t.co/mTPgDRSB24 pic.twitter.com/MYf1nFap8e — FDI World Dental Federation (@fdiworlddental) May 28, 2022 Oral health is essential for overall health It´s a perfect time to double down on just why responding to the global oral health epidemic is in our broader (health) interests. Getting people back into dental clinics and protecting their oral health is essential to safeguarding their overall health, well-being, and quality of life. All those factors that can make people vulnerable to chronic non-communicable diseases (NCDs) such as cardiovascular disease, cancer, chronic respiratory disease, and diabetes are equally risky for one´s oral health. High sugar consumption, harmful alcohol use and tobacco are just as bad for our bodies as they are for our mouths. The impact in pure numbers is alarming: there were some 3.5 billion cases of oral diseases and other oral conditions in 2017. For the last three decades, the combined global prevalence of dental caries (tooth decay), periodontal (gum) disease and tooth loss has stood at 45% – higher than any other NCD. Ignoring the problem makes no sense, financial or otherwise. Worldwide, oral diseases accounted in 2015 for $ 357 billion in direct costs and US$ 188 billion in indirect costs. In the same year, $96.2 billion was spent on the treatment of oral diseases across the European Union, the third-highest total among NCDs, behind diabetes and cardiovascular diseases. “Without good oral health, you’re not healthy,” former US Surgeon-General David Satcher once said, and he was right. The largely siloed approach to dealing with oral health makes no policy sense either, especially when we consider the evidence. Junk food and tooth decay We know that bacteria and inflammation associated with periodontal disease are linked to cardiovascular disease, rheumatoid arthritis, and adverse effects in pregnancy. We also know that people living with diabetes experience improved blood glucose levels if their periodontal (gum) disease is managed correctly. Knowing what we know about poor oral health – that it is preventable and if addressed can help improve our overall health – only begs the question as to why more is not being done to integrate it into other NCD programmes? The pending ban on television and online advertising of junk food in the UK before 9pm is a great example of encouraging better diet. So too is the campaign by UK footballer Marcus Rashford to promote healthier school lunches. But they are missed opportunities. With forethought, both interventions could have included some key messages for children and parents around the connection between a healthy diet and good oral health. Future campaigns could better highlight the need to prioritize oral health promotion in schools, communities and workplaces as well as ensure access to the millions of people who cannot afford the basics, such as fluoridated toothpaste. We need to globally re-think how we talk about and tackle oral diseases. In the vast majority of countries, even essential oral health services are not part of universal health coverage. Oral diseases are noncommunicable diseases and need to be treated as such. Advocates have long argued that investment in prevention produces strong economic returns and saves millions of lives. COVID-19 has reinforced the huge economic and human cost of not doing so: people living with chronic diseases like diabetes, cancer and cardiovascular were at much higher risk of becoming seriously ill, hospitalized, or dying from SARS‑CoV‑2. At the same time, the pandemic is just a microcosm of the bigger picture: our past failure to address oral disease in a substantive way and to view it as an NCD like any other. Prof Ihsane Ben Yahya Prof Ihsane Ben Yahya is the President of the FDI World Dental Federation and professor at the Dental University in Casablanca, Morocco. Dr Greg Chadwick Dr Greg Chadwick is the President-elect of FDI World Dental Federation and Dean at East Carolina University, School of Dental Medicine, United States. Image Credits: Caroline LM/ Unsplash, FDI World Dental Federation. Shanghai Lockdown is Finally Relaxed But Stringent Testing Still Required 02/06/2022 Raisa Santos Shanghai eased its lockdown restrictions 1 June 2022, following continuous low cases reported. Sixty five days after one of the toughest lockdowns in the world, China has eased COVID-19 restrictions on its financial hub, Shanghai, on Wednesday – finally allowing the majority of its 25 million residents to move freely again. However, at least 890,000 residents are confined at home, in “quarantine” or “control zones”. The announcement to lift restrictions came as official figures showed on Sunday that daily new coronavirus cases fell from 170 to 122 in a 24-hour period. The city reported just 13 cases for Wednesday, and an additional 7 cases on Thursday. This is a marked turnaround from the beginning of April, when tens of thousands of cases were reported daily. “This is a day that we dreamed of for a very long time,” Shanghai government spokeswoman Yin Xin told the BBC. China to maintain ‘zero tolerance’ policy Shanghai residents will be required to hold a negative nucleic acid test result taken within 72 hours of entering public spaces or using public transportation from June But while China seems to have moved into the clear with COVID, the country is keen to maintain its “zero tolerance” policy, and is already preparing for future waves. Beijing municipal officials said Thursday that 12 of its planned 14 ‘transition hubs’ will be used to test and disinfect all imported frozen food before goods are distributed across the city. This follows China’s contention that frozen food could transmit COVID-19 in while the World Health Organization’s independent panel on the virus’s origins favour an unknown animal vector as the most likely cause, while others have pointed to laboratory accident for the spread of the coronavirus first found in bats in China. Tens of thousands of testing booths will also be set up across China’s largest cities, including Beijing, Shanghai, and technological hub Shenzhen, to require testing as often as every 48 hours. New rules in Shanghai will now require residents to show a green health code on their smartphone, with proof of a negative PCR test in the last 72 hours, to leave their residential compounds and enter most places, including banks, malls, and public transportation. However, cinemas, museums, and gyms remain closed, as well as in-person schooling. Restrictions on leaving the city still remain, with anyone traveling to another city facing a quarantine of seven to 14 days upon return. Beijing also lifted its restrictions earlier this week, following similar protocol with some of its public transportation system, malls, and other venues opening up. Shanghai testing centers tested by overcapacity and staff shortages Shanghai testing center Shanghai’s 72-hour rule has tested the capacity of its testing centers, as crowds flocked to the 15,000 stations. While some said their test took only a matter of minutes, others complained that they had to wait over an hour to test. Many testing booths are only open for about three hours each in the morning and afternoon, although some hospitals offer a 24-hour service. Shanghai resident Zhang Zehong told Sixth Tone that she was unable to test Wednesday as the station in her neighborhood closed two hours earlier than shown on the city’s health code app, which features all the testing centers. Instead, she went to a hospital with a 24-hour service Thursday morning, only to find no staff and a line that stretched on for over 100 meters. So many issues need to be fixed,” Zhang said. Chinese microblogging platform Weibo also featured complaints with the stations. “It’s been very hot recently, several people passed out when standing (in line),” one Weibo user wrote. “I visited five sites but each had long queues. This is not really humane enough. Don’t these mobile kiosks cause more people to gather?” another Weibo user wrote. Fifty-point plan to revive Shanghai economy A fifty-point plan has also been drawn up to support Shanghai’s economy, crippled in the wake of closures, quarantines, and lockdowns. New measures include reducing taxes for car buyers, speeding up the issuance of local government bonds, and fast-tracked approval of building projects. Drivers who also switch to an electric vehicle will also be able to claim a $1500 subsidy. Businesses may also be able to delay insurance and rent payments, with subsidies available for utility charges. Image Credits: Appriseug/Twitter , DA Trade Market Securities/Twitter , Don Weinland/Twitter. Eight Countries Compete to Host African Medicines Agency at Crucial African Union Meeting 02/06/2022 Paul Adepoju AMA headquarters host country is expected to be named at the end of an ongoing meeting in Addis Ababa A meeting to decide which African country will be the host country for the African Medicines Agency (AMA) is underway and at the last count, expressions of interest in hosting the agency have been received from Uganda, Algeria, Egypt, Morocco, Rwanda, Tanzania, Tunisia and Zimbabwe. The decision is expected to be one of the outcomes at the ongoing first Ordinary session of the Conference of State Parties (CoSP) of the AMA, in Addis Ababa, Ethiopia from 1 to 3 June 2022. The CoSP is reviewing the AMA assessment report and at the end of their meeting, it will make recommendations on the host country of the AMA Headquarters. A final decision on this recommendation will be made at the next assembly of the African Union. Uganda is one of the countries vying to host the AMA Headquarters and the country’s delegation to the CoSP meeting is led by the country’s Minister of Health, Dr Jane Aceng, and Dr Diana Atwine, a Permanent Secretary in the Ministry of Health. Zimbabwe’s team is a four-member delegation led by the country’s Health and Child Care deputy Minister, Dr John Mangwiro. Sierra Leone is also attending the session led by Minister of Health and Sanitation Dr Austin Demby. In his remark at the official launch of the Africa CDC’s Ministerial Executive Leadership Program (MELP), Dr John Nkengasong, Africa CDC’s outgoing Director General confirmed the CoSP’s outcome would play a critical role in deciding the future of the agency. “The launch of the AMA is really another landmark initiative of the African Union as part of the Agenda 63. I can’t wait to hear the outcome of the deliberations. It’s going to be transformational when the AMA and we are truly excited with that,” Nkengasong said. The three-day ministerial meeting will deliberate on the priorities and next steps to establish the AMA. From Geneva to Addis Ababa At last week’s World Health Assembly, Amref Health Africa’s Desta Lakew, on behalf of the African Medicines Agency Treaty Alliance (AMATA) described AMA as an initiative of the African Union aimed at strengthening the regulatory environment to guarantee access to quality, safe and efficacious medicines, medical products, and technologies on the continent. Countries that have signed the treaty, according to AMATA, are Algeria, Benin, Chad, Ghana, Madagascar, Mali, Morocco, Rwanda, Saharawi Arab Democratic Republic, Senegal, and Tunisia. But about four years after the AU Assembly adopted the AMA Treaty, Lakew noted that some Member States still haven’t given it the authority to fulfill its mandate. “The increased risk of disease outbreaks in the region and globally has made access to medical products a priority. Trade in locally produced medical products, including Personal Protective Equipment, across African countries will be hampered if we do not have a harmonized regulatory environment,” Lakew told WHA 75. At the CoSP meeting, the AU called on all member states to sign the Treaty to see improved regulation and easy flow of medical products and technologies, are expected to be reechoed. Lakew described the call as an urgent matter “for the sake of ensuring that there is equitable access to quality, safe, efficacious medicines and technologies for a healthy Africa”. Last month, Health Policy Watch reported Kenya was preparing to join the AMA alongside thirty-one other African Union member states following the Kenyan cabinet’s decision to approve the ratification of the African Union Treaty. See more about the African Medicines Agency on our special AMA Countdown page: African Medicines Agency Countdown Sex, War, Sustainability and the World Health Assembly – Last Week in Review 02/06/2022 Elaine Ruth Fletcher 75th World Health Assembly Health and peace, sex and war, money and management. Whether in chorus or cacophony – last week’s World Health Assembly of WHO member states played most of the notes in the symphony of global debate over strategies to tackle disease, epidemics and pandemics and bolster health systems. But the root causes of emerging disease threats – in modern environmental health threats and nature gone awry remained under-represented themes. From the opening notes of the WHA, on a health for peace theme, to Saturday’s late night closing and end-run charges over language on sexual orientation – this year’s WHA was a seesaw of successes and setbacks. Highs included the consensus vote Tuesday to increase member states contributions to WHO, followed by a resolution Friday to move ahead on the first real reforms to the International Health Regulations in almost 20 years. And at the same time, unprecedented polarization was evident during Thursday’s debate over a resolution condemning Russia’s invasion of Ukraine, which won approval by a vote of 88 to 12. That was followed by the dispute that emerged Friday and continued until nearly midnight Saturday over references to terms such as “sexual rights” and “men who have sex with men” (MSM) in a WHO strategy on HIV, hepatitis-B and sexually transmitted infections (STIs). That, too, was resolved only by a painful series of rollcall votes, leading to the strategy’s passage by just 60 member states, with twice as many delegates absent or abstaining. Like a bullet train ride Dr Hiroki Nakatani joins in the applause for the resolution’s passage on HIV, Hepatitis B and STIs Dr Hiroki Nakatani, who presided over the committee that faced the thorny final hours of WHA dealing with the clash among nations over sexual health terms that HIV professionals regard as the standard usage, compared this year’s WHA session to a ride on a bullet train. “The train ride was sometimes bumpy but we arrived at our destination,” he said of the first Assembly to be held in person in several years because of the pandemic. Perhaps so, even more so than the war in Ukraine, the exceptionally large number of abstentions in the vote on a new HIV, Hepatitis and STI strategy was a bitter pill to swallow for delegates on both sides of the debate. It highlighted the fact that the battles still being waged in Europe, the Middle East, Asia and Africa over the control of territory are not the only big issues dividing member states. Fissures over social norms shape and guide public health policies run just as deep. Sex & War – Global social divide as deep as territorial conflicts And among those norms, there remains a deep divide around health policies that interface with human sexuality – that other primordial urge that co-exists alongside the urge for power and territory. For WHA delegates, in fact, the series of votes Saturday over sexual terminology may have been even more unsettling than the votes over Russia’s invasion of Ukraine – precisely because they sit in Ministries of Health, not Defence, with day-to-day responsibility for designing and implementing policies on HIV and other STIs. As with the Ukraine conflict, the divide that emerged, however, was not strictly drawn along the lines of global North and South. Saudi delegate in heated WHA debate Saturday over sexual rights and terminology Rather, it was the oil-rich Saudi Arabia that led the charge in the quest to purge references to men who have sex with men from the strategy on HIV treatment, followed by emerging economies of Asia and Africa where conservative views about sexual expression are often protected by law as well as custom. Against that, was Europe, North America, much of Latin America and high-income Asia- where more new attitudes about gender identity and LGBTI terminology have taken root over the past few decades. There were also exceptions, such as South Africa, which voted in favour of the HIV strategy. And European Serbia abstained from the vote as did the Russian Federation. Respect for culture, versus respect for evidence In the aftermath, the abstaining countries pleaded for more understanding of norms guided by tradition and culture. Western delegates, meanwhile, referred to the compass of science – whereby recent research has revealed how oft-marginalized MSM groups often fall through the cracks of programmes for HIV/AIDS prevention, diagnosis and treatment. “We appreciate those member states acted in good faith as part of these deliberations. Unfortunately this has served as a painful reminder of the need to reinforce our focus on evidence, human dignity and decency,” said US Assistant Secretary of State for Global Health Loyce Pace just after the strategy was approved. Loyce Pace, Assistant Secretary of State for Global Health, USA “[But] we should not need to hold a vote on the existence of entire communities of people,” she added. “We have a strategy on critically important global health issues, yes. But at what cost to those we risk leaving behind? “So to gay, lesbian, bisexual, queer, intersex, transgender and gender non-conforming people around the world, the United States government sees you, and will continue to support you. Stay strong.” (Right) Denmark’s EB representative, Søren Brostrøm, Director-General, Danish Health Authority, at the WHO Executive Board meeting 30 May, (left) Loyce Pace Assistant Secretary of State for Global Health, USA Reviewing the issue at Monday’s Executive Board meeting, member states on both sides of the divide expressed concerns over the failure of the WHA to find consensus over such a flagship health strategy – and the “dangerous precedent” that the voting set. “It is important that this does not set a precedent for consideration and adoption of technical documents by the Health Assembly,” said Dr Edwin Dikoloti, Botswana’s Minister of Health and Wellness, speaking on behalf of the African group, saying that greater efforts need to be made to find consensus in future WHAs over such controversial issues. Money – landmark decision on WHO finance – but not a ‘done deal’ Members of the WHO Working Group on Sustainable Finance hammer out the final agreement on increasing member state contributions, Germany’s Björn Kümmel on far left. The holy grail of consensus was restored in other key moments – including around the WHA resolution to increase regular member state contributions to WHO – in a bid to stabilize the agency’s finances The agreement, the fruit of months of grinding backroom diplomacy led by Germany, saw member states commit to increase annual assessments to cover 50% of WHO’s core budget by the end of the decade. However, each stepwise increase up until 2030 will still need endorsement at future WHAs to go forward. And so the vote should not be seen as a blank check either, a senior official in the Department of Health and Human Services, told Health Policy Watch. “I would say that the US, as a big contributor to the WHO, is definitely committed to that [resolution], and we were very happy to join the consensus,” the official said. “But I hope it’s also been clear that that is not a done deal and neither for us as the administration or for Congress.” According to the resolution, final approval of each year’s increase is contingent on progress in WHO internal reforms that are supposed to make the organization more transparent, efficient and well-managed. Those demands include overhaul of WHO’s budget management system, said the senior US official: “The budgets that are adopted by the Health Assembly are not real budgets. They’re just budget space. And creating budgets that are aspirational is very different from programming and reporting on and demonstrating the impact of real budgets.” Management – following election Tedros faces new demands Applause just after WHA re-elects Dr Tedros Adhanom Ghebreyesus to serve a second five-year term as Director-General of the World Health Organization on 24 May. He ran un-opposed. But the expectations go beyond budget reform, pressing newly re-elected Dr Tedros Adhanom Ghebreyesus for changes in WHO’s management culture, including more merit-based appointments of senior WHO staff, such as those serving as heads of WHO country offices, and structural reforms in WHO’s internal justice system. “I think, from our perspective…. there’s a very significant culture change… that needs to happen within the organization,” the official told Health Policy Watch. Further related to that, are demands for a “full resolution” of the ongoing investigation of the cases of sexual harassment and abuse of women in the Democratic Republic of Congo by WHO staff and consultants, whose progress also was reviewed at last week’s WHA and Monday’s EB. Justice – WHO internal justice system lacks independence While the revelations of the DRC sex abuse scandal, which first came to light in 2020, and whose perpetrators have yet to be fully prosecuted, highlight failures of WHO internal justice to date, they also are evidence of a broader and more systematic problem, some WHO insiders maintain. One key problem, highlighted in multiple interviews with both past and present WHO staff, is the fact that WHO’s Internal Oversight Office (IOS) – the legal mechanism that manages staff and management complaints – is housed in the Director-General’s Office and effectively controlled by the Director General himself – rather than at arms length. Politically influential managers or staff with the ear of the DG, may receive different treatment than staff who do not, critics say. The flaws in the current process featured in a WHO Staff Association letter to Monday’s Executive Board. The Staff Association demanded that the WHO Global Board of Appeals, the three-member body that hears cases, and recommends disciplinary action to the Director General, be expanded and also include staff-appointed representatives. “The panel of the Global Board of Appeal (GBA) should have five-members,” stated the Staff Association. “A three-member panel – the current practice – is simply not reassuring staff that GBA deliberations are sufficiently robust,” the Staff Association letter stated.“Furthermore, the staff representatives on each of the GBA panels should be selected by the respective staff association rather than selected by the GBA Chair or Deputy-Chair.” The net result of the current system is that – short of a costly and lengthy appeal to the International Labour Organization – disciplinary cases are heard by a GBA board appointed by senior managers who report directly to Tedros, who also decides on the final outcome of the cases. Dr Boubacar Diallo with WHO Director-General, Dr Tedros Adhanom Ghebreyesus and then-WHO Emergency Response Team leader, Dr Michel Yao in DRC in June 2019; Diallo was among those accused of harassment and Yao was alleged to have ignored those and other reports. With regards to the DRC cases, allegations that high-ranking WHO managers or consultants with ties to Tedros may have turned a blind eye to the reports of abuses going on in the field, have never been publicly resolved. But the concerns extend beyond sexual harrassement, to the need to foster an institutional culture of professionalism free of political interference, critics also say, pointing to other episodes like the suppression of a 2020 WHO report on Italty’s pandemic response, which criticized another senior WHO advisor to Tedros. From a sustainable budget a sustainable planet? While WHO’s financial sustainability received considerable attention at this year’s WHA, there was comparatively little debate on the planet’s sustainability crisis – and how that may be fueling a cascading array of health impacts – from more noncommunicable diseases to emerging outbreaks, such as SARS-CoV2 and more recently a worldwide surge in monkeypox. A new roadmap to accelerate work on noncommunicable diseases fails to give more than a nod to air pollution as one of the leading causes of NCDs – responsible for some 7 million deaths a year from cancers, cardiovascular and lung diseases every year. And that doesn’t even include risks from chemicals exposures that make the total estimate of deaths from pollution closer to 9 million annually, according to a new Lancet Planetary Health Report released on 18 May. Deaths attributable to key “modern” and “traditional” pollution sources for which data is available In a debate over an NCD roadmap that aims to slash NCD risks by one third by 2030, France, speaking on behalf of some European Union member states,called for a more “integrated” approach that includes environmental health and climate change. So far, such approaches have been slow in coming. Despite the rhetoric about air pollution being a leading risk factor for NCDs, there are, as yet, no WHO “Best Buys” for environmental strategies that reduce deadly pollution risks – even if measures like clean public transport and compact cities, built around cycling and walking networks, are regarded by urban planners and transport managers as evidence-based solutions that have a record of demonstrated results. ‘One Health’ and food safety – some new approaches Caged animals held for sale and slaughter in unsanitary conditions at Wuhan’s Huanan Seafood Market, prior to the outbreak of COVID-19, including: (a) King rat snake (Elaphe carinata), (b) Chinese bamboo rat (Rhizomys sinensis), (c) Amur hedgehog (Erinaceus amurensis) (the finger points to a tick), (d) Raccoon dog (Nyctereutes procyonoides), (e) Marmot (Marmota himalayana) (beneath the marmots is a cage containing hedgehogs), and (f) Hog badger (Arctonyx albogularis). On the brigher side, a new WHO Global Strategy for Food Safety was approved by member states. For the first time ever, the strategy makes reference, at least in passing, to the need for a “One Health approach when addressing health risks emerging at the human-animal-ecosystems interface.” A companion decision asks WHO to also update its guidance on Reducing public health risks associated with the sale of live wild animals of mammalian species in traditional food markets. Such guidance emerges out of the SARS-CoV2 pandemic, where peoples’ exposure to SARS-CoV2 infected animals in the Wuhan, China live animal market is considered to be one of the most plausible routes by which SARS-CoV2 initially leaped from animal to human populations in Wuhan, China during 2019. But the caging and slaughter of live, wild animals in areas heavily trafficked by customers are practices common in thousands of traditional markets in Asia and Southeast Asia, as well as parts of Africa, leading to further risks of human exposure to pathogens the animals may harbour. Not nearly enough action to stop pandemics at source The unsafe handling of live animals that are sold for slaughter at traditional markets can risk the spread of foodborne and infectious diseases. Such “One Health” issues need far more deliberate and systematic WHO and member state attention than the nod that they have so far, a growing chorus of “Ecohealth” experts say. In a little-noticed press release issued during WHA, Dr Nigel Sizer, executive director of the consortium Preventing Pandemics at the Source called upon the WHA to do more to address ecosystem risks upstream that increase “spillover risks” of pathogen leap from animal to human populations: “Such actions include shutting down or strictly regulating wildlife trade and markets, stopping deforestation and forest degradation, and providing better health to communities in emerging infectious disease hotspots, as well as strengthened veterinary care and biosecurity in animal husbandry,” said Sizer, an internationally known conservationist, in his statement. “Overall throughout the WHA process and in the preparations for negotiation of a possible global instrument on pandemic prevention and preparedness there has been remarkably little attention given to true pandemic prevention,” Sizer later told Health Policy Watch. “We know where most pandemics come from and we know how to reduce the risk of zoonotic spillover of the vruses that cause them,” he added. “Governments in general and health agencies in particular should embrace these approaches, including One Health efforts. They should also work much more closely with environmental agencies to address spillover risk from tropical deforestation, wildlife exploitation and trade, and intensive animal agriculture. The public health return on investment in such activities would be enormous.” Health and Environment: WHO structures preserve a deep divide Researcher explores evidence around the wildlife-trade- pandemic nexus (Wildlife Conservation Society) There are parallel calls to better incorporate such concerns into any future “pandemic instrument” intended to have a broader scope than the International Health Regulations, and to be the focus of intense negotiations by a WHA Intergovernmental Board (INB) in coming months. However, the yawning chasm environmental groups encounter in trying to to interact with WHO and WHO member states over environmental health and One Health concerns, can sometimes appear as wide as the divide between member states on the terms around sexual health. “It has been exceedingly difficult to engage with the WHA or with the intergovernmental negotiating body’s (INB) process to draft and negotiate a new pandemic instrument,” Christine Franklin, of the Wildlife Conservation Society, another member of the Preventing Pandemics coalition, told Health Policy Watch. The club of non-state actors in ‘official relations’ “Only non-State actors in official relations with the WHO are invited to engage with the WHA,” she remarked. That status of ‘official relations’ not only allows civil society groups the privilege of expounding on their positions at the annual World Health Assembly, it gives them access to lengthy and detailed informal member state consultations and intergovernmental negotiating sessions that are closed to the general public and the media. Some 220 civil society actors hold that coveted status, mostly mainstream medical and health societies as well as pharma groups, but also agro-business foundations, such as CropLife International, as well as the outliers like the World Plumbing Council. A review by Health Policy Watch found nary an environmental or eco-health group on the list, as of February 2022. “So even though Wildlife Conservation Society has been working across the globe for more than 125 years; is the only international conservation organization with an embedded health program, works on the ground in more than 60 countries; and our health program is recognized as a One Health founder and a leader at the nexus of health and the environment, the INB’s public hearing has been the only opportunity we have had to provide input,” Franklin lamented. “Oral testimonies were limited to two minutes and written statements restricted to 250 words. In fact, there are no organizations from the conservation or environment communities in official relations with the WHO and the process to gain status is complex and lengthy.” Image Credits: Germany's UN Mission in Geneva , WHO, Lancet Planetary Health, Nature , Pierce Mill Media, Wildlife Conservation Society . Doubling of Monkeypox Cases Outside of Endemic Countries Raises New Alarm Bells at WHO 01/06/2022 Raisa Santos & Elaine Ruth Fletcher Monkeypox lesions In just a matter of three days, the number of monkeypox cases reported to WHO outside of central and west Africa has doubled – with reports Wednesday of some 550 cases in more than 30 countries outside of the countries where the disease is endemic, WHO Director General, Dr Tedros Adhanom Ghebreyesus told a press briefing on Wednesday. That, as compared to reports of 257 cases outside of Africa, as of Sunday, 30 May. The ‘sudden appearance’ of monkeypox in so many non-endemic countries is prompting new concerns that it could spread to more “vulnerable populations” in countries where it has suddenly emerged, including pregnant women and children, added WHO’s Maria Van Kerkhove, Health Emergencies technical lead. WHO Briefing, 1 June 2022 “Investigations are ongoing, but the sudden appearance of monkeypox in many countries at the same time suggests there may have been undetected transmission for some time,” said WHO Director-General Tedros Adhanom Ghebreyesus during a press briefing Wednesday. “WHO’s priority now is to first provide accurate information to those groups most at risk, and second to prevent further spread among at-risk groups, to advance our understanding of monkeypox.” WHO is organizing two R&D meetings of experts on Thursday and Friday of this week, to further discuss monkeypox and understand the current surge in cases. Ecological pressures prompting rapid disease emergence Gambian pouched rat – rodents are a common animal reservoir for monkeypox Monkeypox has long circulated in 12 countries of central and western Africa, with a rising incidence over time. Disease prevalence is highest in the Democratic Republic of Congo, which has reported several thousand cases a year, and where the monkeypox clade, or variant, in circulation is more deadly. The disease has been reported to have mortality rates of up to 10% in the DRC. Noone has yet reported to have died from the outbreak that has occurred abroad recently – which has been traced to the milder West African clade. Cases of monkeypox in endemic countries between 15 December 2021 to 1 May 2022 Increased circulation of the disease in Africa in recent years has been linked to deforestation – which put wild animals in closer contact with humans, as well as increased agro-food storage, and consequent infestation of food containers by infected rats. Additionally, human travelers as well as the trade in exotic animals has been linked to the appearance of some cases overseas in the past. But the appearance of so many cases abroad is a new phenomenon, where community transmission is now occurring, including among networks of men who have sex with men, WHO said. The changes in ecosystems, trade and travel have been exacerbated by a decline in human immunity to the disease, due to the discontinuation of smallpox vaccination in the 1970s, which was protective against monkeypox as well. Ecological pressures need to be addressed Michael Ryan, WHO Executive Director, Health Emergencies Beyond the immediate health system measures needed to track and trace the spiral of increasing human cases occurring daily, more attention needs to be given to the underlying drivers, and ‘ecological pressure’ that has caused disease outbreaks to expand in size and scope,WHO’s Executive Director of Health Emergencies Mike Ryan told the briefing. “Animals are changing their behavior, humans are changing their behavior. What we’re dealing with is a lot of ecological fragility,” said Ryan. “We’re dealing with the animal-human interface being quite unstable, and the number of times that these diseases cross into humans is increasing, [as well as] that ability to amplify the disease and move it within our communities.” But he did not elaborate on how WHO might address such drivers – beyond saying that they could be a topic of discussion at this week’s R&D meeting convened by the global health agency. Inequity of investment in monkeypox in Europe versus Africa already apparent The current outbreak also highlights once more, the boomerang effect of inequitable investments in health systems and disease control in Africa, where monkeypox has been circulating for decades in countries that lack the tools to track and tackle such infections, Ryan said. “There are thousands and thousands of cases of monkeypox every year in Africa, and there are deaths every year….. And now, we have a concern about this disease spreading in Europe, but I certainly haven’t heard that same level of concern over the last five or ten years.” “Are we in a position to collectively respond? Are we in a position to share resources in order to stop transmission of these diseases within human communities?,” Ryan asked. Already, countries such as the United Kingdom have vaccinated more than 1,000 people at risk of contracting the virus, and the European Union is in discussions to buy smallpox vaccines from Bavarian Nordic, the only maker of the vaccine licensed in Europe, according to media reports. Smallpox vaccines are estimated to be about 85% effective against monkeypox, which is in the same orthopox family of viruses – but there have been no such vaccination campaigns in monkeypox hotspots such as DRC for decades. “It’s a bit uncomfortable that we have a different attitude to the kinds of resources we deploy depending on where cases are,” said Dr Jimmy Whittworth, of the London School of Hygiene and Tropical Medicine, speaking to the Associated Press. “It exposes a moral failing when those interventions aren’t available for the millions of people in Africa who need them.” Stigma against disease may prevent care, increase transmission Tedros Adhanom Ghebreyesus, WHO Director-General Meanwhile, WHO’s Tedros urged people to fight against stigma associated with the transmission of monkeypox in networks of men who have sex with men (MSM) – and underlined that the disease can be transmitted in a range of ways. Those include through contact with: infected saliva and mouth lesions, bedding as well as transmission of pregnant women to their unborn children through the placenta, according to a WHO seminar on the issue Tuesday. Tedros said that MSM advocacy groups “are working hard to inform [members of their community] about the risks of monkeypox and prevent transmission. But all of us must work hard to fight stigma, which is not just wrong. It could also prevent infected individuals from seeking care, making it harder to stop transmission.” “Anyone can be infected with monkeypox if they have close physical contact with someone else who was infected,” he said. The virus was first identified in 1958 in a colony of captive African research monkeys. The first human case was identified in the DRC in 1970, during the period of smallpox elimination campaigns. Even before the current outbreak, there have been limited waves of cases reported in non-endemic countries through channels such as the export of exotic animals, such as infected mice, squirrels, and rats, from Ghana to the United States in 2003, as well as by infected travelers. Misinformation campaign to target monkeypox Maria van Kerkhove, WHO Technical Lead on COVID-19 WHO is also mounting a campaign on disinformation about the disease, said Gabby Stern, WHO Communications Director. WHO is currently working with both social media companies and tech companies, urging them to filter out the misinformation and push out accurate information through their channels and platforms, said She said that misinformation and disinformation was a ‘major priority’ for both WHO and the United Nations. “Misinformation kills, just as these viruses kill, misinformation kills as well,” added Dr Maria van Kerkhove, WHO technical Lead on COVID-19. “This remains a constant challenge, not only COVID-19 across the entire spectrum of interventions and the response that we have. It’s the attacks on science that undermine the effectiveness of our countermeasures.” Image Credits: Tessa Davis/Twitter , Laëtitia Dudous, WHO, Disease Outbreak News, 21 May 2022 . Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
After Many Missed Opportunities, Oral Health Gets Long Overdue Attention from WHO 03/06/2022 Ihsane Ben Yahya & Greg Chadwick Dental services, including regular check-ups, were among the most disrupted essential health services during the COVID-19 lockdowns. People´s reticence to visit a dentist during normal times was exacerbated by fear of venturing into an open clinic or simply not being able to, due to restrictions. Dental hesitancy has always been around but over two years into the pandemic, it´s now a lot worse. This hesitancy is also echoed at the policy level. Oral health has, until very recently, been considered the “ugly duckling” of global health efforts. The World Health Organization (WHO) has only ever passed a special resolution on oral health twice in its history: most recently, ironically, in the midst of the COVID-19 pandemic in 2021. The new global oral health strategy, approved by governments at 75th WHO World Health Assembly last week is a step in the right direction, and it is long overdue. 📣The WHO global #OralHealth strategy has officially been approved and adopted at the #WHA75 👏 FDI commends the strategy and tells @WHO that we are ready to support the development of the subsequent action plan and monitoring framework by 2023 ➡️ https://t.co/mTPgDRSB24 pic.twitter.com/MYf1nFap8e — FDI World Dental Federation (@fdiworlddental) May 28, 2022 Oral health is essential for overall health It´s a perfect time to double down on just why responding to the global oral health epidemic is in our broader (health) interests. Getting people back into dental clinics and protecting their oral health is essential to safeguarding their overall health, well-being, and quality of life. All those factors that can make people vulnerable to chronic non-communicable diseases (NCDs) such as cardiovascular disease, cancer, chronic respiratory disease, and diabetes are equally risky for one´s oral health. High sugar consumption, harmful alcohol use and tobacco are just as bad for our bodies as they are for our mouths. The impact in pure numbers is alarming: there were some 3.5 billion cases of oral diseases and other oral conditions in 2017. For the last three decades, the combined global prevalence of dental caries (tooth decay), periodontal (gum) disease and tooth loss has stood at 45% – higher than any other NCD. Ignoring the problem makes no sense, financial or otherwise. Worldwide, oral diseases accounted in 2015 for $ 357 billion in direct costs and US$ 188 billion in indirect costs. In the same year, $96.2 billion was spent on the treatment of oral diseases across the European Union, the third-highest total among NCDs, behind diabetes and cardiovascular diseases. “Without good oral health, you’re not healthy,” former US Surgeon-General David Satcher once said, and he was right. The largely siloed approach to dealing with oral health makes no policy sense either, especially when we consider the evidence. Junk food and tooth decay We know that bacteria and inflammation associated with periodontal disease are linked to cardiovascular disease, rheumatoid arthritis, and adverse effects in pregnancy. We also know that people living with diabetes experience improved blood glucose levels if their periodontal (gum) disease is managed correctly. Knowing what we know about poor oral health – that it is preventable and if addressed can help improve our overall health – only begs the question as to why more is not being done to integrate it into other NCD programmes? The pending ban on television and online advertising of junk food in the UK before 9pm is a great example of encouraging better diet. So too is the campaign by UK footballer Marcus Rashford to promote healthier school lunches. But they are missed opportunities. With forethought, both interventions could have included some key messages for children and parents around the connection between a healthy diet and good oral health. Future campaigns could better highlight the need to prioritize oral health promotion in schools, communities and workplaces as well as ensure access to the millions of people who cannot afford the basics, such as fluoridated toothpaste. We need to globally re-think how we talk about and tackle oral diseases. In the vast majority of countries, even essential oral health services are not part of universal health coverage. Oral diseases are noncommunicable diseases and need to be treated as such. Advocates have long argued that investment in prevention produces strong economic returns and saves millions of lives. COVID-19 has reinforced the huge economic and human cost of not doing so: people living with chronic diseases like diabetes, cancer and cardiovascular were at much higher risk of becoming seriously ill, hospitalized, or dying from SARS‑CoV‑2. At the same time, the pandemic is just a microcosm of the bigger picture: our past failure to address oral disease in a substantive way and to view it as an NCD like any other. Prof Ihsane Ben Yahya Prof Ihsane Ben Yahya is the President of the FDI World Dental Federation and professor at the Dental University in Casablanca, Morocco. Dr Greg Chadwick Dr Greg Chadwick is the President-elect of FDI World Dental Federation and Dean at East Carolina University, School of Dental Medicine, United States. Image Credits: Caroline LM/ Unsplash, FDI World Dental Federation. Shanghai Lockdown is Finally Relaxed But Stringent Testing Still Required 02/06/2022 Raisa Santos Shanghai eased its lockdown restrictions 1 June 2022, following continuous low cases reported. Sixty five days after one of the toughest lockdowns in the world, China has eased COVID-19 restrictions on its financial hub, Shanghai, on Wednesday – finally allowing the majority of its 25 million residents to move freely again. However, at least 890,000 residents are confined at home, in “quarantine” or “control zones”. The announcement to lift restrictions came as official figures showed on Sunday that daily new coronavirus cases fell from 170 to 122 in a 24-hour period. The city reported just 13 cases for Wednesday, and an additional 7 cases on Thursday. This is a marked turnaround from the beginning of April, when tens of thousands of cases were reported daily. “This is a day that we dreamed of for a very long time,” Shanghai government spokeswoman Yin Xin told the BBC. China to maintain ‘zero tolerance’ policy Shanghai residents will be required to hold a negative nucleic acid test result taken within 72 hours of entering public spaces or using public transportation from June But while China seems to have moved into the clear with COVID, the country is keen to maintain its “zero tolerance” policy, and is already preparing for future waves. Beijing municipal officials said Thursday that 12 of its planned 14 ‘transition hubs’ will be used to test and disinfect all imported frozen food before goods are distributed across the city. This follows China’s contention that frozen food could transmit COVID-19 in while the World Health Organization’s independent panel on the virus’s origins favour an unknown animal vector as the most likely cause, while others have pointed to laboratory accident for the spread of the coronavirus first found in bats in China. Tens of thousands of testing booths will also be set up across China’s largest cities, including Beijing, Shanghai, and technological hub Shenzhen, to require testing as often as every 48 hours. New rules in Shanghai will now require residents to show a green health code on their smartphone, with proof of a negative PCR test in the last 72 hours, to leave their residential compounds and enter most places, including banks, malls, and public transportation. However, cinemas, museums, and gyms remain closed, as well as in-person schooling. Restrictions on leaving the city still remain, with anyone traveling to another city facing a quarantine of seven to 14 days upon return. Beijing also lifted its restrictions earlier this week, following similar protocol with some of its public transportation system, malls, and other venues opening up. Shanghai testing centers tested by overcapacity and staff shortages Shanghai testing center Shanghai’s 72-hour rule has tested the capacity of its testing centers, as crowds flocked to the 15,000 stations. While some said their test took only a matter of minutes, others complained that they had to wait over an hour to test. Many testing booths are only open for about three hours each in the morning and afternoon, although some hospitals offer a 24-hour service. Shanghai resident Zhang Zehong told Sixth Tone that she was unable to test Wednesday as the station in her neighborhood closed two hours earlier than shown on the city’s health code app, which features all the testing centers. Instead, she went to a hospital with a 24-hour service Thursday morning, only to find no staff and a line that stretched on for over 100 meters. So many issues need to be fixed,” Zhang said. Chinese microblogging platform Weibo also featured complaints with the stations. “It’s been very hot recently, several people passed out when standing (in line),” one Weibo user wrote. “I visited five sites but each had long queues. This is not really humane enough. Don’t these mobile kiosks cause more people to gather?” another Weibo user wrote. Fifty-point plan to revive Shanghai economy A fifty-point plan has also been drawn up to support Shanghai’s economy, crippled in the wake of closures, quarantines, and lockdowns. New measures include reducing taxes for car buyers, speeding up the issuance of local government bonds, and fast-tracked approval of building projects. Drivers who also switch to an electric vehicle will also be able to claim a $1500 subsidy. Businesses may also be able to delay insurance and rent payments, with subsidies available for utility charges. Image Credits: Appriseug/Twitter , DA Trade Market Securities/Twitter , Don Weinland/Twitter. Eight Countries Compete to Host African Medicines Agency at Crucial African Union Meeting 02/06/2022 Paul Adepoju AMA headquarters host country is expected to be named at the end of an ongoing meeting in Addis Ababa A meeting to decide which African country will be the host country for the African Medicines Agency (AMA) is underway and at the last count, expressions of interest in hosting the agency have been received from Uganda, Algeria, Egypt, Morocco, Rwanda, Tanzania, Tunisia and Zimbabwe. The decision is expected to be one of the outcomes at the ongoing first Ordinary session of the Conference of State Parties (CoSP) of the AMA, in Addis Ababa, Ethiopia from 1 to 3 June 2022. The CoSP is reviewing the AMA assessment report and at the end of their meeting, it will make recommendations on the host country of the AMA Headquarters. A final decision on this recommendation will be made at the next assembly of the African Union. Uganda is one of the countries vying to host the AMA Headquarters and the country’s delegation to the CoSP meeting is led by the country’s Minister of Health, Dr Jane Aceng, and Dr Diana Atwine, a Permanent Secretary in the Ministry of Health. Zimbabwe’s team is a four-member delegation led by the country’s Health and Child Care deputy Minister, Dr John Mangwiro. Sierra Leone is also attending the session led by Minister of Health and Sanitation Dr Austin Demby. In his remark at the official launch of the Africa CDC’s Ministerial Executive Leadership Program (MELP), Dr John Nkengasong, Africa CDC’s outgoing Director General confirmed the CoSP’s outcome would play a critical role in deciding the future of the agency. “The launch of the AMA is really another landmark initiative of the African Union as part of the Agenda 63. I can’t wait to hear the outcome of the deliberations. It’s going to be transformational when the AMA and we are truly excited with that,” Nkengasong said. The three-day ministerial meeting will deliberate on the priorities and next steps to establish the AMA. From Geneva to Addis Ababa At last week’s World Health Assembly, Amref Health Africa’s Desta Lakew, on behalf of the African Medicines Agency Treaty Alliance (AMATA) described AMA as an initiative of the African Union aimed at strengthening the regulatory environment to guarantee access to quality, safe and efficacious medicines, medical products, and technologies on the continent. Countries that have signed the treaty, according to AMATA, are Algeria, Benin, Chad, Ghana, Madagascar, Mali, Morocco, Rwanda, Saharawi Arab Democratic Republic, Senegal, and Tunisia. But about four years after the AU Assembly adopted the AMA Treaty, Lakew noted that some Member States still haven’t given it the authority to fulfill its mandate. “The increased risk of disease outbreaks in the region and globally has made access to medical products a priority. Trade in locally produced medical products, including Personal Protective Equipment, across African countries will be hampered if we do not have a harmonized regulatory environment,” Lakew told WHA 75. At the CoSP meeting, the AU called on all member states to sign the Treaty to see improved regulation and easy flow of medical products and technologies, are expected to be reechoed. Lakew described the call as an urgent matter “for the sake of ensuring that there is equitable access to quality, safe, efficacious medicines and technologies for a healthy Africa”. Last month, Health Policy Watch reported Kenya was preparing to join the AMA alongside thirty-one other African Union member states following the Kenyan cabinet’s decision to approve the ratification of the African Union Treaty. See more about the African Medicines Agency on our special AMA Countdown page: African Medicines Agency Countdown Sex, War, Sustainability and the World Health Assembly – Last Week in Review 02/06/2022 Elaine Ruth Fletcher 75th World Health Assembly Health and peace, sex and war, money and management. Whether in chorus or cacophony – last week’s World Health Assembly of WHO member states played most of the notes in the symphony of global debate over strategies to tackle disease, epidemics and pandemics and bolster health systems. But the root causes of emerging disease threats – in modern environmental health threats and nature gone awry remained under-represented themes. From the opening notes of the WHA, on a health for peace theme, to Saturday’s late night closing and end-run charges over language on sexual orientation – this year’s WHA was a seesaw of successes and setbacks. Highs included the consensus vote Tuesday to increase member states contributions to WHO, followed by a resolution Friday to move ahead on the first real reforms to the International Health Regulations in almost 20 years. And at the same time, unprecedented polarization was evident during Thursday’s debate over a resolution condemning Russia’s invasion of Ukraine, which won approval by a vote of 88 to 12. That was followed by the dispute that emerged Friday and continued until nearly midnight Saturday over references to terms such as “sexual rights” and “men who have sex with men” (MSM) in a WHO strategy on HIV, hepatitis-B and sexually transmitted infections (STIs). That, too, was resolved only by a painful series of rollcall votes, leading to the strategy’s passage by just 60 member states, with twice as many delegates absent or abstaining. Like a bullet train ride Dr Hiroki Nakatani joins in the applause for the resolution’s passage on HIV, Hepatitis B and STIs Dr Hiroki Nakatani, who presided over the committee that faced the thorny final hours of WHA dealing with the clash among nations over sexual health terms that HIV professionals regard as the standard usage, compared this year’s WHA session to a ride on a bullet train. “The train ride was sometimes bumpy but we arrived at our destination,” he said of the first Assembly to be held in person in several years because of the pandemic. Perhaps so, even more so than the war in Ukraine, the exceptionally large number of abstentions in the vote on a new HIV, Hepatitis and STI strategy was a bitter pill to swallow for delegates on both sides of the debate. It highlighted the fact that the battles still being waged in Europe, the Middle East, Asia and Africa over the control of territory are not the only big issues dividing member states. Fissures over social norms shape and guide public health policies run just as deep. Sex & War – Global social divide as deep as territorial conflicts And among those norms, there remains a deep divide around health policies that interface with human sexuality – that other primordial urge that co-exists alongside the urge for power and territory. For WHA delegates, in fact, the series of votes Saturday over sexual terminology may have been even more unsettling than the votes over Russia’s invasion of Ukraine – precisely because they sit in Ministries of Health, not Defence, with day-to-day responsibility for designing and implementing policies on HIV and other STIs. As with the Ukraine conflict, the divide that emerged, however, was not strictly drawn along the lines of global North and South. Saudi delegate in heated WHA debate Saturday over sexual rights and terminology Rather, it was the oil-rich Saudi Arabia that led the charge in the quest to purge references to men who have sex with men from the strategy on HIV treatment, followed by emerging economies of Asia and Africa where conservative views about sexual expression are often protected by law as well as custom. Against that, was Europe, North America, much of Latin America and high-income Asia- where more new attitudes about gender identity and LGBTI terminology have taken root over the past few decades. There were also exceptions, such as South Africa, which voted in favour of the HIV strategy. And European Serbia abstained from the vote as did the Russian Federation. Respect for culture, versus respect for evidence In the aftermath, the abstaining countries pleaded for more understanding of norms guided by tradition and culture. Western delegates, meanwhile, referred to the compass of science – whereby recent research has revealed how oft-marginalized MSM groups often fall through the cracks of programmes for HIV/AIDS prevention, diagnosis and treatment. “We appreciate those member states acted in good faith as part of these deliberations. Unfortunately this has served as a painful reminder of the need to reinforce our focus on evidence, human dignity and decency,” said US Assistant Secretary of State for Global Health Loyce Pace just after the strategy was approved. Loyce Pace, Assistant Secretary of State for Global Health, USA “[But] we should not need to hold a vote on the existence of entire communities of people,” she added. “We have a strategy on critically important global health issues, yes. But at what cost to those we risk leaving behind? “So to gay, lesbian, bisexual, queer, intersex, transgender and gender non-conforming people around the world, the United States government sees you, and will continue to support you. Stay strong.” (Right) Denmark’s EB representative, Søren Brostrøm, Director-General, Danish Health Authority, at the WHO Executive Board meeting 30 May, (left) Loyce Pace Assistant Secretary of State for Global Health, USA Reviewing the issue at Monday’s Executive Board meeting, member states on both sides of the divide expressed concerns over the failure of the WHA to find consensus over such a flagship health strategy – and the “dangerous precedent” that the voting set. “It is important that this does not set a precedent for consideration and adoption of technical documents by the Health Assembly,” said Dr Edwin Dikoloti, Botswana’s Minister of Health and Wellness, speaking on behalf of the African group, saying that greater efforts need to be made to find consensus in future WHAs over such controversial issues. Money – landmark decision on WHO finance – but not a ‘done deal’ Members of the WHO Working Group on Sustainable Finance hammer out the final agreement on increasing member state contributions, Germany’s Björn Kümmel on far left. The holy grail of consensus was restored in other key moments – including around the WHA resolution to increase regular member state contributions to WHO – in a bid to stabilize the agency’s finances The agreement, the fruit of months of grinding backroom diplomacy led by Germany, saw member states commit to increase annual assessments to cover 50% of WHO’s core budget by the end of the decade. However, each stepwise increase up until 2030 will still need endorsement at future WHAs to go forward. And so the vote should not be seen as a blank check either, a senior official in the Department of Health and Human Services, told Health Policy Watch. “I would say that the US, as a big contributor to the WHO, is definitely committed to that [resolution], and we were very happy to join the consensus,” the official said. “But I hope it’s also been clear that that is not a done deal and neither for us as the administration or for Congress.” According to the resolution, final approval of each year’s increase is contingent on progress in WHO internal reforms that are supposed to make the organization more transparent, efficient and well-managed. Those demands include overhaul of WHO’s budget management system, said the senior US official: “The budgets that are adopted by the Health Assembly are not real budgets. They’re just budget space. And creating budgets that are aspirational is very different from programming and reporting on and demonstrating the impact of real budgets.” Management – following election Tedros faces new demands Applause just after WHA re-elects Dr Tedros Adhanom Ghebreyesus to serve a second five-year term as Director-General of the World Health Organization on 24 May. He ran un-opposed. But the expectations go beyond budget reform, pressing newly re-elected Dr Tedros Adhanom Ghebreyesus for changes in WHO’s management culture, including more merit-based appointments of senior WHO staff, such as those serving as heads of WHO country offices, and structural reforms in WHO’s internal justice system. “I think, from our perspective…. there’s a very significant culture change… that needs to happen within the organization,” the official told Health Policy Watch. Further related to that, are demands for a “full resolution” of the ongoing investigation of the cases of sexual harassment and abuse of women in the Democratic Republic of Congo by WHO staff and consultants, whose progress also was reviewed at last week’s WHA and Monday’s EB. Justice – WHO internal justice system lacks independence While the revelations of the DRC sex abuse scandal, which first came to light in 2020, and whose perpetrators have yet to be fully prosecuted, highlight failures of WHO internal justice to date, they also are evidence of a broader and more systematic problem, some WHO insiders maintain. One key problem, highlighted in multiple interviews with both past and present WHO staff, is the fact that WHO’s Internal Oversight Office (IOS) – the legal mechanism that manages staff and management complaints – is housed in the Director-General’s Office and effectively controlled by the Director General himself – rather than at arms length. Politically influential managers or staff with the ear of the DG, may receive different treatment than staff who do not, critics say. The flaws in the current process featured in a WHO Staff Association letter to Monday’s Executive Board. The Staff Association demanded that the WHO Global Board of Appeals, the three-member body that hears cases, and recommends disciplinary action to the Director General, be expanded and also include staff-appointed representatives. “The panel of the Global Board of Appeal (GBA) should have five-members,” stated the Staff Association. “A three-member panel – the current practice – is simply not reassuring staff that GBA deliberations are sufficiently robust,” the Staff Association letter stated.“Furthermore, the staff representatives on each of the GBA panels should be selected by the respective staff association rather than selected by the GBA Chair or Deputy-Chair.” The net result of the current system is that – short of a costly and lengthy appeal to the International Labour Organization – disciplinary cases are heard by a GBA board appointed by senior managers who report directly to Tedros, who also decides on the final outcome of the cases. Dr Boubacar Diallo with WHO Director-General, Dr Tedros Adhanom Ghebreyesus and then-WHO Emergency Response Team leader, Dr Michel Yao in DRC in June 2019; Diallo was among those accused of harassment and Yao was alleged to have ignored those and other reports. With regards to the DRC cases, allegations that high-ranking WHO managers or consultants with ties to Tedros may have turned a blind eye to the reports of abuses going on in the field, have never been publicly resolved. But the concerns extend beyond sexual harrassement, to the need to foster an institutional culture of professionalism free of political interference, critics also say, pointing to other episodes like the suppression of a 2020 WHO report on Italty’s pandemic response, which criticized another senior WHO advisor to Tedros. From a sustainable budget a sustainable planet? While WHO’s financial sustainability received considerable attention at this year’s WHA, there was comparatively little debate on the planet’s sustainability crisis – and how that may be fueling a cascading array of health impacts – from more noncommunicable diseases to emerging outbreaks, such as SARS-CoV2 and more recently a worldwide surge in monkeypox. A new roadmap to accelerate work on noncommunicable diseases fails to give more than a nod to air pollution as one of the leading causes of NCDs – responsible for some 7 million deaths a year from cancers, cardiovascular and lung diseases every year. And that doesn’t even include risks from chemicals exposures that make the total estimate of deaths from pollution closer to 9 million annually, according to a new Lancet Planetary Health Report released on 18 May. Deaths attributable to key “modern” and “traditional” pollution sources for which data is available In a debate over an NCD roadmap that aims to slash NCD risks by one third by 2030, France, speaking on behalf of some European Union member states,called for a more “integrated” approach that includes environmental health and climate change. So far, such approaches have been slow in coming. Despite the rhetoric about air pollution being a leading risk factor for NCDs, there are, as yet, no WHO “Best Buys” for environmental strategies that reduce deadly pollution risks – even if measures like clean public transport and compact cities, built around cycling and walking networks, are regarded by urban planners and transport managers as evidence-based solutions that have a record of demonstrated results. ‘One Health’ and food safety – some new approaches Caged animals held for sale and slaughter in unsanitary conditions at Wuhan’s Huanan Seafood Market, prior to the outbreak of COVID-19, including: (a) King rat snake (Elaphe carinata), (b) Chinese bamboo rat (Rhizomys sinensis), (c) Amur hedgehog (Erinaceus amurensis) (the finger points to a tick), (d) Raccoon dog (Nyctereutes procyonoides), (e) Marmot (Marmota himalayana) (beneath the marmots is a cage containing hedgehogs), and (f) Hog badger (Arctonyx albogularis). On the brigher side, a new WHO Global Strategy for Food Safety was approved by member states. For the first time ever, the strategy makes reference, at least in passing, to the need for a “One Health approach when addressing health risks emerging at the human-animal-ecosystems interface.” A companion decision asks WHO to also update its guidance on Reducing public health risks associated with the sale of live wild animals of mammalian species in traditional food markets. Such guidance emerges out of the SARS-CoV2 pandemic, where peoples’ exposure to SARS-CoV2 infected animals in the Wuhan, China live animal market is considered to be one of the most plausible routes by which SARS-CoV2 initially leaped from animal to human populations in Wuhan, China during 2019. But the caging and slaughter of live, wild animals in areas heavily trafficked by customers are practices common in thousands of traditional markets in Asia and Southeast Asia, as well as parts of Africa, leading to further risks of human exposure to pathogens the animals may harbour. Not nearly enough action to stop pandemics at source The unsafe handling of live animals that are sold for slaughter at traditional markets can risk the spread of foodborne and infectious diseases. Such “One Health” issues need far more deliberate and systematic WHO and member state attention than the nod that they have so far, a growing chorus of “Ecohealth” experts say. In a little-noticed press release issued during WHA, Dr Nigel Sizer, executive director of the consortium Preventing Pandemics at the Source called upon the WHA to do more to address ecosystem risks upstream that increase “spillover risks” of pathogen leap from animal to human populations: “Such actions include shutting down or strictly regulating wildlife trade and markets, stopping deforestation and forest degradation, and providing better health to communities in emerging infectious disease hotspots, as well as strengthened veterinary care and biosecurity in animal husbandry,” said Sizer, an internationally known conservationist, in his statement. “Overall throughout the WHA process and in the preparations for negotiation of a possible global instrument on pandemic prevention and preparedness there has been remarkably little attention given to true pandemic prevention,” Sizer later told Health Policy Watch. “We know where most pandemics come from and we know how to reduce the risk of zoonotic spillover of the vruses that cause them,” he added. “Governments in general and health agencies in particular should embrace these approaches, including One Health efforts. They should also work much more closely with environmental agencies to address spillover risk from tropical deforestation, wildlife exploitation and trade, and intensive animal agriculture. The public health return on investment in such activities would be enormous.” Health and Environment: WHO structures preserve a deep divide Researcher explores evidence around the wildlife-trade- pandemic nexus (Wildlife Conservation Society) There are parallel calls to better incorporate such concerns into any future “pandemic instrument” intended to have a broader scope than the International Health Regulations, and to be the focus of intense negotiations by a WHA Intergovernmental Board (INB) in coming months. However, the yawning chasm environmental groups encounter in trying to to interact with WHO and WHO member states over environmental health and One Health concerns, can sometimes appear as wide as the divide between member states on the terms around sexual health. “It has been exceedingly difficult to engage with the WHA or with the intergovernmental negotiating body’s (INB) process to draft and negotiate a new pandemic instrument,” Christine Franklin, of the Wildlife Conservation Society, another member of the Preventing Pandemics coalition, told Health Policy Watch. The club of non-state actors in ‘official relations’ “Only non-State actors in official relations with the WHO are invited to engage with the WHA,” she remarked. That status of ‘official relations’ not only allows civil society groups the privilege of expounding on their positions at the annual World Health Assembly, it gives them access to lengthy and detailed informal member state consultations and intergovernmental negotiating sessions that are closed to the general public and the media. Some 220 civil society actors hold that coveted status, mostly mainstream medical and health societies as well as pharma groups, but also agro-business foundations, such as CropLife International, as well as the outliers like the World Plumbing Council. A review by Health Policy Watch found nary an environmental or eco-health group on the list, as of February 2022. “So even though Wildlife Conservation Society has been working across the globe for more than 125 years; is the only international conservation organization with an embedded health program, works on the ground in more than 60 countries; and our health program is recognized as a One Health founder and a leader at the nexus of health and the environment, the INB’s public hearing has been the only opportunity we have had to provide input,” Franklin lamented. “Oral testimonies were limited to two minutes and written statements restricted to 250 words. In fact, there are no organizations from the conservation or environment communities in official relations with the WHO and the process to gain status is complex and lengthy.” Image Credits: Germany's UN Mission in Geneva , WHO, Lancet Planetary Health, Nature , Pierce Mill Media, Wildlife Conservation Society . Doubling of Monkeypox Cases Outside of Endemic Countries Raises New Alarm Bells at WHO 01/06/2022 Raisa Santos & Elaine Ruth Fletcher Monkeypox lesions In just a matter of three days, the number of monkeypox cases reported to WHO outside of central and west Africa has doubled – with reports Wednesday of some 550 cases in more than 30 countries outside of the countries where the disease is endemic, WHO Director General, Dr Tedros Adhanom Ghebreyesus told a press briefing on Wednesday. That, as compared to reports of 257 cases outside of Africa, as of Sunday, 30 May. The ‘sudden appearance’ of monkeypox in so many non-endemic countries is prompting new concerns that it could spread to more “vulnerable populations” in countries where it has suddenly emerged, including pregnant women and children, added WHO’s Maria Van Kerkhove, Health Emergencies technical lead. WHO Briefing, 1 June 2022 “Investigations are ongoing, but the sudden appearance of monkeypox in many countries at the same time suggests there may have been undetected transmission for some time,” said WHO Director-General Tedros Adhanom Ghebreyesus during a press briefing Wednesday. “WHO’s priority now is to first provide accurate information to those groups most at risk, and second to prevent further spread among at-risk groups, to advance our understanding of monkeypox.” WHO is organizing two R&D meetings of experts on Thursday and Friday of this week, to further discuss monkeypox and understand the current surge in cases. Ecological pressures prompting rapid disease emergence Gambian pouched rat – rodents are a common animal reservoir for monkeypox Monkeypox has long circulated in 12 countries of central and western Africa, with a rising incidence over time. Disease prevalence is highest in the Democratic Republic of Congo, which has reported several thousand cases a year, and where the monkeypox clade, or variant, in circulation is more deadly. The disease has been reported to have mortality rates of up to 10% in the DRC. Noone has yet reported to have died from the outbreak that has occurred abroad recently – which has been traced to the milder West African clade. Cases of monkeypox in endemic countries between 15 December 2021 to 1 May 2022 Increased circulation of the disease in Africa in recent years has been linked to deforestation – which put wild animals in closer contact with humans, as well as increased agro-food storage, and consequent infestation of food containers by infected rats. Additionally, human travelers as well as the trade in exotic animals has been linked to the appearance of some cases overseas in the past. But the appearance of so many cases abroad is a new phenomenon, where community transmission is now occurring, including among networks of men who have sex with men, WHO said. The changes in ecosystems, trade and travel have been exacerbated by a decline in human immunity to the disease, due to the discontinuation of smallpox vaccination in the 1970s, which was protective against monkeypox as well. Ecological pressures need to be addressed Michael Ryan, WHO Executive Director, Health Emergencies Beyond the immediate health system measures needed to track and trace the spiral of increasing human cases occurring daily, more attention needs to be given to the underlying drivers, and ‘ecological pressure’ that has caused disease outbreaks to expand in size and scope,WHO’s Executive Director of Health Emergencies Mike Ryan told the briefing. “Animals are changing their behavior, humans are changing their behavior. What we’re dealing with is a lot of ecological fragility,” said Ryan. “We’re dealing with the animal-human interface being quite unstable, and the number of times that these diseases cross into humans is increasing, [as well as] that ability to amplify the disease and move it within our communities.” But he did not elaborate on how WHO might address such drivers – beyond saying that they could be a topic of discussion at this week’s R&D meeting convened by the global health agency. Inequity of investment in monkeypox in Europe versus Africa already apparent The current outbreak also highlights once more, the boomerang effect of inequitable investments in health systems and disease control in Africa, where monkeypox has been circulating for decades in countries that lack the tools to track and tackle such infections, Ryan said. “There are thousands and thousands of cases of monkeypox every year in Africa, and there are deaths every year….. And now, we have a concern about this disease spreading in Europe, but I certainly haven’t heard that same level of concern over the last five or ten years.” “Are we in a position to collectively respond? Are we in a position to share resources in order to stop transmission of these diseases within human communities?,” Ryan asked. Already, countries such as the United Kingdom have vaccinated more than 1,000 people at risk of contracting the virus, and the European Union is in discussions to buy smallpox vaccines from Bavarian Nordic, the only maker of the vaccine licensed in Europe, according to media reports. Smallpox vaccines are estimated to be about 85% effective against monkeypox, which is in the same orthopox family of viruses – but there have been no such vaccination campaigns in monkeypox hotspots such as DRC for decades. “It’s a bit uncomfortable that we have a different attitude to the kinds of resources we deploy depending on where cases are,” said Dr Jimmy Whittworth, of the London School of Hygiene and Tropical Medicine, speaking to the Associated Press. “It exposes a moral failing when those interventions aren’t available for the millions of people in Africa who need them.” Stigma against disease may prevent care, increase transmission Tedros Adhanom Ghebreyesus, WHO Director-General Meanwhile, WHO’s Tedros urged people to fight against stigma associated with the transmission of monkeypox in networks of men who have sex with men (MSM) – and underlined that the disease can be transmitted in a range of ways. Those include through contact with: infected saliva and mouth lesions, bedding as well as transmission of pregnant women to their unborn children through the placenta, according to a WHO seminar on the issue Tuesday. Tedros said that MSM advocacy groups “are working hard to inform [members of their community] about the risks of monkeypox and prevent transmission. But all of us must work hard to fight stigma, which is not just wrong. It could also prevent infected individuals from seeking care, making it harder to stop transmission.” “Anyone can be infected with monkeypox if they have close physical contact with someone else who was infected,” he said. The virus was first identified in 1958 in a colony of captive African research monkeys. The first human case was identified in the DRC in 1970, during the period of smallpox elimination campaigns. Even before the current outbreak, there have been limited waves of cases reported in non-endemic countries through channels such as the export of exotic animals, such as infected mice, squirrels, and rats, from Ghana to the United States in 2003, as well as by infected travelers. Misinformation campaign to target monkeypox Maria van Kerkhove, WHO Technical Lead on COVID-19 WHO is also mounting a campaign on disinformation about the disease, said Gabby Stern, WHO Communications Director. WHO is currently working with both social media companies and tech companies, urging them to filter out the misinformation and push out accurate information through their channels and platforms, said She said that misinformation and disinformation was a ‘major priority’ for both WHO and the United Nations. “Misinformation kills, just as these viruses kill, misinformation kills as well,” added Dr Maria van Kerkhove, WHO technical Lead on COVID-19. “This remains a constant challenge, not only COVID-19 across the entire spectrum of interventions and the response that we have. It’s the attacks on science that undermine the effectiveness of our countermeasures.” Image Credits: Tessa Davis/Twitter , Laëtitia Dudous, WHO, Disease Outbreak News, 21 May 2022 . Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Shanghai Lockdown is Finally Relaxed But Stringent Testing Still Required 02/06/2022 Raisa Santos Shanghai eased its lockdown restrictions 1 June 2022, following continuous low cases reported. Sixty five days after one of the toughest lockdowns in the world, China has eased COVID-19 restrictions on its financial hub, Shanghai, on Wednesday – finally allowing the majority of its 25 million residents to move freely again. However, at least 890,000 residents are confined at home, in “quarantine” or “control zones”. The announcement to lift restrictions came as official figures showed on Sunday that daily new coronavirus cases fell from 170 to 122 in a 24-hour period. The city reported just 13 cases for Wednesday, and an additional 7 cases on Thursday. This is a marked turnaround from the beginning of April, when tens of thousands of cases were reported daily. “This is a day that we dreamed of for a very long time,” Shanghai government spokeswoman Yin Xin told the BBC. China to maintain ‘zero tolerance’ policy Shanghai residents will be required to hold a negative nucleic acid test result taken within 72 hours of entering public spaces or using public transportation from June But while China seems to have moved into the clear with COVID, the country is keen to maintain its “zero tolerance” policy, and is already preparing for future waves. Beijing municipal officials said Thursday that 12 of its planned 14 ‘transition hubs’ will be used to test and disinfect all imported frozen food before goods are distributed across the city. This follows China’s contention that frozen food could transmit COVID-19 in while the World Health Organization’s independent panel on the virus’s origins favour an unknown animal vector as the most likely cause, while others have pointed to laboratory accident for the spread of the coronavirus first found in bats in China. Tens of thousands of testing booths will also be set up across China’s largest cities, including Beijing, Shanghai, and technological hub Shenzhen, to require testing as often as every 48 hours. New rules in Shanghai will now require residents to show a green health code on their smartphone, with proof of a negative PCR test in the last 72 hours, to leave their residential compounds and enter most places, including banks, malls, and public transportation. However, cinemas, museums, and gyms remain closed, as well as in-person schooling. Restrictions on leaving the city still remain, with anyone traveling to another city facing a quarantine of seven to 14 days upon return. Beijing also lifted its restrictions earlier this week, following similar protocol with some of its public transportation system, malls, and other venues opening up. Shanghai testing centers tested by overcapacity and staff shortages Shanghai testing center Shanghai’s 72-hour rule has tested the capacity of its testing centers, as crowds flocked to the 15,000 stations. While some said their test took only a matter of minutes, others complained that they had to wait over an hour to test. Many testing booths are only open for about three hours each in the morning and afternoon, although some hospitals offer a 24-hour service. Shanghai resident Zhang Zehong told Sixth Tone that she was unable to test Wednesday as the station in her neighborhood closed two hours earlier than shown on the city’s health code app, which features all the testing centers. Instead, she went to a hospital with a 24-hour service Thursday morning, only to find no staff and a line that stretched on for over 100 meters. So many issues need to be fixed,” Zhang said. Chinese microblogging platform Weibo also featured complaints with the stations. “It’s been very hot recently, several people passed out when standing (in line),” one Weibo user wrote. “I visited five sites but each had long queues. This is not really humane enough. Don’t these mobile kiosks cause more people to gather?” another Weibo user wrote. Fifty-point plan to revive Shanghai economy A fifty-point plan has also been drawn up to support Shanghai’s economy, crippled in the wake of closures, quarantines, and lockdowns. New measures include reducing taxes for car buyers, speeding up the issuance of local government bonds, and fast-tracked approval of building projects. Drivers who also switch to an electric vehicle will also be able to claim a $1500 subsidy. Businesses may also be able to delay insurance and rent payments, with subsidies available for utility charges. Image Credits: Appriseug/Twitter , DA Trade Market Securities/Twitter , Don Weinland/Twitter. Eight Countries Compete to Host African Medicines Agency at Crucial African Union Meeting 02/06/2022 Paul Adepoju AMA headquarters host country is expected to be named at the end of an ongoing meeting in Addis Ababa A meeting to decide which African country will be the host country for the African Medicines Agency (AMA) is underway and at the last count, expressions of interest in hosting the agency have been received from Uganda, Algeria, Egypt, Morocco, Rwanda, Tanzania, Tunisia and Zimbabwe. The decision is expected to be one of the outcomes at the ongoing first Ordinary session of the Conference of State Parties (CoSP) of the AMA, in Addis Ababa, Ethiopia from 1 to 3 June 2022. The CoSP is reviewing the AMA assessment report and at the end of their meeting, it will make recommendations on the host country of the AMA Headquarters. A final decision on this recommendation will be made at the next assembly of the African Union. Uganda is one of the countries vying to host the AMA Headquarters and the country’s delegation to the CoSP meeting is led by the country’s Minister of Health, Dr Jane Aceng, and Dr Diana Atwine, a Permanent Secretary in the Ministry of Health. Zimbabwe’s team is a four-member delegation led by the country’s Health and Child Care deputy Minister, Dr John Mangwiro. Sierra Leone is also attending the session led by Minister of Health and Sanitation Dr Austin Demby. In his remark at the official launch of the Africa CDC’s Ministerial Executive Leadership Program (MELP), Dr John Nkengasong, Africa CDC’s outgoing Director General confirmed the CoSP’s outcome would play a critical role in deciding the future of the agency. “The launch of the AMA is really another landmark initiative of the African Union as part of the Agenda 63. I can’t wait to hear the outcome of the deliberations. It’s going to be transformational when the AMA and we are truly excited with that,” Nkengasong said. The three-day ministerial meeting will deliberate on the priorities and next steps to establish the AMA. From Geneva to Addis Ababa At last week’s World Health Assembly, Amref Health Africa’s Desta Lakew, on behalf of the African Medicines Agency Treaty Alliance (AMATA) described AMA as an initiative of the African Union aimed at strengthening the regulatory environment to guarantee access to quality, safe and efficacious medicines, medical products, and technologies on the continent. Countries that have signed the treaty, according to AMATA, are Algeria, Benin, Chad, Ghana, Madagascar, Mali, Morocco, Rwanda, Saharawi Arab Democratic Republic, Senegal, and Tunisia. But about four years after the AU Assembly adopted the AMA Treaty, Lakew noted that some Member States still haven’t given it the authority to fulfill its mandate. “The increased risk of disease outbreaks in the region and globally has made access to medical products a priority. Trade in locally produced medical products, including Personal Protective Equipment, across African countries will be hampered if we do not have a harmonized regulatory environment,” Lakew told WHA 75. At the CoSP meeting, the AU called on all member states to sign the Treaty to see improved regulation and easy flow of medical products and technologies, are expected to be reechoed. Lakew described the call as an urgent matter “for the sake of ensuring that there is equitable access to quality, safe, efficacious medicines and technologies for a healthy Africa”. Last month, Health Policy Watch reported Kenya was preparing to join the AMA alongside thirty-one other African Union member states following the Kenyan cabinet’s decision to approve the ratification of the African Union Treaty. See more about the African Medicines Agency on our special AMA Countdown page: African Medicines Agency Countdown Sex, War, Sustainability and the World Health Assembly – Last Week in Review 02/06/2022 Elaine Ruth Fletcher 75th World Health Assembly Health and peace, sex and war, money and management. Whether in chorus or cacophony – last week’s World Health Assembly of WHO member states played most of the notes in the symphony of global debate over strategies to tackle disease, epidemics and pandemics and bolster health systems. But the root causes of emerging disease threats – in modern environmental health threats and nature gone awry remained under-represented themes. From the opening notes of the WHA, on a health for peace theme, to Saturday’s late night closing and end-run charges over language on sexual orientation – this year’s WHA was a seesaw of successes and setbacks. Highs included the consensus vote Tuesday to increase member states contributions to WHO, followed by a resolution Friday to move ahead on the first real reforms to the International Health Regulations in almost 20 years. And at the same time, unprecedented polarization was evident during Thursday’s debate over a resolution condemning Russia’s invasion of Ukraine, which won approval by a vote of 88 to 12. That was followed by the dispute that emerged Friday and continued until nearly midnight Saturday over references to terms such as “sexual rights” and “men who have sex with men” (MSM) in a WHO strategy on HIV, hepatitis-B and sexually transmitted infections (STIs). That, too, was resolved only by a painful series of rollcall votes, leading to the strategy’s passage by just 60 member states, with twice as many delegates absent or abstaining. Like a bullet train ride Dr Hiroki Nakatani joins in the applause for the resolution’s passage on HIV, Hepatitis B and STIs Dr Hiroki Nakatani, who presided over the committee that faced the thorny final hours of WHA dealing with the clash among nations over sexual health terms that HIV professionals regard as the standard usage, compared this year’s WHA session to a ride on a bullet train. “The train ride was sometimes bumpy but we arrived at our destination,” he said of the first Assembly to be held in person in several years because of the pandemic. Perhaps so, even more so than the war in Ukraine, the exceptionally large number of abstentions in the vote on a new HIV, Hepatitis and STI strategy was a bitter pill to swallow for delegates on both sides of the debate. It highlighted the fact that the battles still being waged in Europe, the Middle East, Asia and Africa over the control of territory are not the only big issues dividing member states. Fissures over social norms shape and guide public health policies run just as deep. Sex & War – Global social divide as deep as territorial conflicts And among those norms, there remains a deep divide around health policies that interface with human sexuality – that other primordial urge that co-exists alongside the urge for power and territory. For WHA delegates, in fact, the series of votes Saturday over sexual terminology may have been even more unsettling than the votes over Russia’s invasion of Ukraine – precisely because they sit in Ministries of Health, not Defence, with day-to-day responsibility for designing and implementing policies on HIV and other STIs. As with the Ukraine conflict, the divide that emerged, however, was not strictly drawn along the lines of global North and South. Saudi delegate in heated WHA debate Saturday over sexual rights and terminology Rather, it was the oil-rich Saudi Arabia that led the charge in the quest to purge references to men who have sex with men from the strategy on HIV treatment, followed by emerging economies of Asia and Africa where conservative views about sexual expression are often protected by law as well as custom. Against that, was Europe, North America, much of Latin America and high-income Asia- where more new attitudes about gender identity and LGBTI terminology have taken root over the past few decades. There were also exceptions, such as South Africa, which voted in favour of the HIV strategy. And European Serbia abstained from the vote as did the Russian Federation. Respect for culture, versus respect for evidence In the aftermath, the abstaining countries pleaded for more understanding of norms guided by tradition and culture. Western delegates, meanwhile, referred to the compass of science – whereby recent research has revealed how oft-marginalized MSM groups often fall through the cracks of programmes for HIV/AIDS prevention, diagnosis and treatment. “We appreciate those member states acted in good faith as part of these deliberations. Unfortunately this has served as a painful reminder of the need to reinforce our focus on evidence, human dignity and decency,” said US Assistant Secretary of State for Global Health Loyce Pace just after the strategy was approved. Loyce Pace, Assistant Secretary of State for Global Health, USA “[But] we should not need to hold a vote on the existence of entire communities of people,” she added. “We have a strategy on critically important global health issues, yes. But at what cost to those we risk leaving behind? “So to gay, lesbian, bisexual, queer, intersex, transgender and gender non-conforming people around the world, the United States government sees you, and will continue to support you. Stay strong.” (Right) Denmark’s EB representative, Søren Brostrøm, Director-General, Danish Health Authority, at the WHO Executive Board meeting 30 May, (left) Loyce Pace Assistant Secretary of State for Global Health, USA Reviewing the issue at Monday’s Executive Board meeting, member states on both sides of the divide expressed concerns over the failure of the WHA to find consensus over such a flagship health strategy – and the “dangerous precedent” that the voting set. “It is important that this does not set a precedent for consideration and adoption of technical documents by the Health Assembly,” said Dr Edwin Dikoloti, Botswana’s Minister of Health and Wellness, speaking on behalf of the African group, saying that greater efforts need to be made to find consensus in future WHAs over such controversial issues. Money – landmark decision on WHO finance – but not a ‘done deal’ Members of the WHO Working Group on Sustainable Finance hammer out the final agreement on increasing member state contributions, Germany’s Björn Kümmel on far left. The holy grail of consensus was restored in other key moments – including around the WHA resolution to increase regular member state contributions to WHO – in a bid to stabilize the agency’s finances The agreement, the fruit of months of grinding backroom diplomacy led by Germany, saw member states commit to increase annual assessments to cover 50% of WHO’s core budget by the end of the decade. However, each stepwise increase up until 2030 will still need endorsement at future WHAs to go forward. And so the vote should not be seen as a blank check either, a senior official in the Department of Health and Human Services, told Health Policy Watch. “I would say that the US, as a big contributor to the WHO, is definitely committed to that [resolution], and we were very happy to join the consensus,” the official said. “But I hope it’s also been clear that that is not a done deal and neither for us as the administration or for Congress.” According to the resolution, final approval of each year’s increase is contingent on progress in WHO internal reforms that are supposed to make the organization more transparent, efficient and well-managed. Those demands include overhaul of WHO’s budget management system, said the senior US official: “The budgets that are adopted by the Health Assembly are not real budgets. They’re just budget space. And creating budgets that are aspirational is very different from programming and reporting on and demonstrating the impact of real budgets.” Management – following election Tedros faces new demands Applause just after WHA re-elects Dr Tedros Adhanom Ghebreyesus to serve a second five-year term as Director-General of the World Health Organization on 24 May. He ran un-opposed. But the expectations go beyond budget reform, pressing newly re-elected Dr Tedros Adhanom Ghebreyesus for changes in WHO’s management culture, including more merit-based appointments of senior WHO staff, such as those serving as heads of WHO country offices, and structural reforms in WHO’s internal justice system. “I think, from our perspective…. there’s a very significant culture change… that needs to happen within the organization,” the official told Health Policy Watch. Further related to that, are demands for a “full resolution” of the ongoing investigation of the cases of sexual harassment and abuse of women in the Democratic Republic of Congo by WHO staff and consultants, whose progress also was reviewed at last week’s WHA and Monday’s EB. Justice – WHO internal justice system lacks independence While the revelations of the DRC sex abuse scandal, which first came to light in 2020, and whose perpetrators have yet to be fully prosecuted, highlight failures of WHO internal justice to date, they also are evidence of a broader and more systematic problem, some WHO insiders maintain. One key problem, highlighted in multiple interviews with both past and present WHO staff, is the fact that WHO’s Internal Oversight Office (IOS) – the legal mechanism that manages staff and management complaints – is housed in the Director-General’s Office and effectively controlled by the Director General himself – rather than at arms length. Politically influential managers or staff with the ear of the DG, may receive different treatment than staff who do not, critics say. The flaws in the current process featured in a WHO Staff Association letter to Monday’s Executive Board. The Staff Association demanded that the WHO Global Board of Appeals, the three-member body that hears cases, and recommends disciplinary action to the Director General, be expanded and also include staff-appointed representatives. “The panel of the Global Board of Appeal (GBA) should have five-members,” stated the Staff Association. “A three-member panel – the current practice – is simply not reassuring staff that GBA deliberations are sufficiently robust,” the Staff Association letter stated.“Furthermore, the staff representatives on each of the GBA panels should be selected by the respective staff association rather than selected by the GBA Chair or Deputy-Chair.” The net result of the current system is that – short of a costly and lengthy appeal to the International Labour Organization – disciplinary cases are heard by a GBA board appointed by senior managers who report directly to Tedros, who also decides on the final outcome of the cases. Dr Boubacar Diallo with WHO Director-General, Dr Tedros Adhanom Ghebreyesus and then-WHO Emergency Response Team leader, Dr Michel Yao in DRC in June 2019; Diallo was among those accused of harassment and Yao was alleged to have ignored those and other reports. With regards to the DRC cases, allegations that high-ranking WHO managers or consultants with ties to Tedros may have turned a blind eye to the reports of abuses going on in the field, have never been publicly resolved. But the concerns extend beyond sexual harrassement, to the need to foster an institutional culture of professionalism free of political interference, critics also say, pointing to other episodes like the suppression of a 2020 WHO report on Italty’s pandemic response, which criticized another senior WHO advisor to Tedros. From a sustainable budget a sustainable planet? While WHO’s financial sustainability received considerable attention at this year’s WHA, there was comparatively little debate on the planet’s sustainability crisis – and how that may be fueling a cascading array of health impacts – from more noncommunicable diseases to emerging outbreaks, such as SARS-CoV2 and more recently a worldwide surge in monkeypox. A new roadmap to accelerate work on noncommunicable diseases fails to give more than a nod to air pollution as one of the leading causes of NCDs – responsible for some 7 million deaths a year from cancers, cardiovascular and lung diseases every year. And that doesn’t even include risks from chemicals exposures that make the total estimate of deaths from pollution closer to 9 million annually, according to a new Lancet Planetary Health Report released on 18 May. Deaths attributable to key “modern” and “traditional” pollution sources for which data is available In a debate over an NCD roadmap that aims to slash NCD risks by one third by 2030, France, speaking on behalf of some European Union member states,called for a more “integrated” approach that includes environmental health and climate change. So far, such approaches have been slow in coming. Despite the rhetoric about air pollution being a leading risk factor for NCDs, there are, as yet, no WHO “Best Buys” for environmental strategies that reduce deadly pollution risks – even if measures like clean public transport and compact cities, built around cycling and walking networks, are regarded by urban planners and transport managers as evidence-based solutions that have a record of demonstrated results. ‘One Health’ and food safety – some new approaches Caged animals held for sale and slaughter in unsanitary conditions at Wuhan’s Huanan Seafood Market, prior to the outbreak of COVID-19, including: (a) King rat snake (Elaphe carinata), (b) Chinese bamboo rat (Rhizomys sinensis), (c) Amur hedgehog (Erinaceus amurensis) (the finger points to a tick), (d) Raccoon dog (Nyctereutes procyonoides), (e) Marmot (Marmota himalayana) (beneath the marmots is a cage containing hedgehogs), and (f) Hog badger (Arctonyx albogularis). On the brigher side, a new WHO Global Strategy for Food Safety was approved by member states. For the first time ever, the strategy makes reference, at least in passing, to the need for a “One Health approach when addressing health risks emerging at the human-animal-ecosystems interface.” A companion decision asks WHO to also update its guidance on Reducing public health risks associated with the sale of live wild animals of mammalian species in traditional food markets. Such guidance emerges out of the SARS-CoV2 pandemic, where peoples’ exposure to SARS-CoV2 infected animals in the Wuhan, China live animal market is considered to be one of the most plausible routes by which SARS-CoV2 initially leaped from animal to human populations in Wuhan, China during 2019. But the caging and slaughter of live, wild animals in areas heavily trafficked by customers are practices common in thousands of traditional markets in Asia and Southeast Asia, as well as parts of Africa, leading to further risks of human exposure to pathogens the animals may harbour. Not nearly enough action to stop pandemics at source The unsafe handling of live animals that are sold for slaughter at traditional markets can risk the spread of foodborne and infectious diseases. Such “One Health” issues need far more deliberate and systematic WHO and member state attention than the nod that they have so far, a growing chorus of “Ecohealth” experts say. In a little-noticed press release issued during WHA, Dr Nigel Sizer, executive director of the consortium Preventing Pandemics at the Source called upon the WHA to do more to address ecosystem risks upstream that increase “spillover risks” of pathogen leap from animal to human populations: “Such actions include shutting down or strictly regulating wildlife trade and markets, stopping deforestation and forest degradation, and providing better health to communities in emerging infectious disease hotspots, as well as strengthened veterinary care and biosecurity in animal husbandry,” said Sizer, an internationally known conservationist, in his statement. “Overall throughout the WHA process and in the preparations for negotiation of a possible global instrument on pandemic prevention and preparedness there has been remarkably little attention given to true pandemic prevention,” Sizer later told Health Policy Watch. “We know where most pandemics come from and we know how to reduce the risk of zoonotic spillover of the vruses that cause them,” he added. “Governments in general and health agencies in particular should embrace these approaches, including One Health efforts. They should also work much more closely with environmental agencies to address spillover risk from tropical deforestation, wildlife exploitation and trade, and intensive animal agriculture. The public health return on investment in such activities would be enormous.” Health and Environment: WHO structures preserve a deep divide Researcher explores evidence around the wildlife-trade- pandemic nexus (Wildlife Conservation Society) There are parallel calls to better incorporate such concerns into any future “pandemic instrument” intended to have a broader scope than the International Health Regulations, and to be the focus of intense negotiations by a WHA Intergovernmental Board (INB) in coming months. However, the yawning chasm environmental groups encounter in trying to to interact with WHO and WHO member states over environmental health and One Health concerns, can sometimes appear as wide as the divide between member states on the terms around sexual health. “It has been exceedingly difficult to engage with the WHA or with the intergovernmental negotiating body’s (INB) process to draft and negotiate a new pandemic instrument,” Christine Franklin, of the Wildlife Conservation Society, another member of the Preventing Pandemics coalition, told Health Policy Watch. The club of non-state actors in ‘official relations’ “Only non-State actors in official relations with the WHO are invited to engage with the WHA,” she remarked. That status of ‘official relations’ not only allows civil society groups the privilege of expounding on their positions at the annual World Health Assembly, it gives them access to lengthy and detailed informal member state consultations and intergovernmental negotiating sessions that are closed to the general public and the media. Some 220 civil society actors hold that coveted status, mostly mainstream medical and health societies as well as pharma groups, but also agro-business foundations, such as CropLife International, as well as the outliers like the World Plumbing Council. A review by Health Policy Watch found nary an environmental or eco-health group on the list, as of February 2022. “So even though Wildlife Conservation Society has been working across the globe for more than 125 years; is the only international conservation organization with an embedded health program, works on the ground in more than 60 countries; and our health program is recognized as a One Health founder and a leader at the nexus of health and the environment, the INB’s public hearing has been the only opportunity we have had to provide input,” Franklin lamented. “Oral testimonies were limited to two minutes and written statements restricted to 250 words. In fact, there are no organizations from the conservation or environment communities in official relations with the WHO and the process to gain status is complex and lengthy.” Image Credits: Germany's UN Mission in Geneva , WHO, Lancet Planetary Health, Nature , Pierce Mill Media, Wildlife Conservation Society . Doubling of Monkeypox Cases Outside of Endemic Countries Raises New Alarm Bells at WHO 01/06/2022 Raisa Santos & Elaine Ruth Fletcher Monkeypox lesions In just a matter of three days, the number of monkeypox cases reported to WHO outside of central and west Africa has doubled – with reports Wednesday of some 550 cases in more than 30 countries outside of the countries where the disease is endemic, WHO Director General, Dr Tedros Adhanom Ghebreyesus told a press briefing on Wednesday. That, as compared to reports of 257 cases outside of Africa, as of Sunday, 30 May. The ‘sudden appearance’ of monkeypox in so many non-endemic countries is prompting new concerns that it could spread to more “vulnerable populations” in countries where it has suddenly emerged, including pregnant women and children, added WHO’s Maria Van Kerkhove, Health Emergencies technical lead. WHO Briefing, 1 June 2022 “Investigations are ongoing, but the sudden appearance of monkeypox in many countries at the same time suggests there may have been undetected transmission for some time,” said WHO Director-General Tedros Adhanom Ghebreyesus during a press briefing Wednesday. “WHO’s priority now is to first provide accurate information to those groups most at risk, and second to prevent further spread among at-risk groups, to advance our understanding of monkeypox.” WHO is organizing two R&D meetings of experts on Thursday and Friday of this week, to further discuss monkeypox and understand the current surge in cases. Ecological pressures prompting rapid disease emergence Gambian pouched rat – rodents are a common animal reservoir for monkeypox Monkeypox has long circulated in 12 countries of central and western Africa, with a rising incidence over time. Disease prevalence is highest in the Democratic Republic of Congo, which has reported several thousand cases a year, and where the monkeypox clade, or variant, in circulation is more deadly. The disease has been reported to have mortality rates of up to 10% in the DRC. Noone has yet reported to have died from the outbreak that has occurred abroad recently – which has been traced to the milder West African clade. Cases of monkeypox in endemic countries between 15 December 2021 to 1 May 2022 Increased circulation of the disease in Africa in recent years has been linked to deforestation – which put wild animals in closer contact with humans, as well as increased agro-food storage, and consequent infestation of food containers by infected rats. Additionally, human travelers as well as the trade in exotic animals has been linked to the appearance of some cases overseas in the past. But the appearance of so many cases abroad is a new phenomenon, where community transmission is now occurring, including among networks of men who have sex with men, WHO said. The changes in ecosystems, trade and travel have been exacerbated by a decline in human immunity to the disease, due to the discontinuation of smallpox vaccination in the 1970s, which was protective against monkeypox as well. Ecological pressures need to be addressed Michael Ryan, WHO Executive Director, Health Emergencies Beyond the immediate health system measures needed to track and trace the spiral of increasing human cases occurring daily, more attention needs to be given to the underlying drivers, and ‘ecological pressure’ that has caused disease outbreaks to expand in size and scope,WHO’s Executive Director of Health Emergencies Mike Ryan told the briefing. “Animals are changing their behavior, humans are changing their behavior. What we’re dealing with is a lot of ecological fragility,” said Ryan. “We’re dealing with the animal-human interface being quite unstable, and the number of times that these diseases cross into humans is increasing, [as well as] that ability to amplify the disease and move it within our communities.” But he did not elaborate on how WHO might address such drivers – beyond saying that they could be a topic of discussion at this week’s R&D meeting convened by the global health agency. Inequity of investment in monkeypox in Europe versus Africa already apparent The current outbreak also highlights once more, the boomerang effect of inequitable investments in health systems and disease control in Africa, where monkeypox has been circulating for decades in countries that lack the tools to track and tackle such infections, Ryan said. “There are thousands and thousands of cases of monkeypox every year in Africa, and there are deaths every year….. And now, we have a concern about this disease spreading in Europe, but I certainly haven’t heard that same level of concern over the last five or ten years.” “Are we in a position to collectively respond? Are we in a position to share resources in order to stop transmission of these diseases within human communities?,” Ryan asked. Already, countries such as the United Kingdom have vaccinated more than 1,000 people at risk of contracting the virus, and the European Union is in discussions to buy smallpox vaccines from Bavarian Nordic, the only maker of the vaccine licensed in Europe, according to media reports. Smallpox vaccines are estimated to be about 85% effective against monkeypox, which is in the same orthopox family of viruses – but there have been no such vaccination campaigns in monkeypox hotspots such as DRC for decades. “It’s a bit uncomfortable that we have a different attitude to the kinds of resources we deploy depending on where cases are,” said Dr Jimmy Whittworth, of the London School of Hygiene and Tropical Medicine, speaking to the Associated Press. “It exposes a moral failing when those interventions aren’t available for the millions of people in Africa who need them.” Stigma against disease may prevent care, increase transmission Tedros Adhanom Ghebreyesus, WHO Director-General Meanwhile, WHO’s Tedros urged people to fight against stigma associated with the transmission of monkeypox in networks of men who have sex with men (MSM) – and underlined that the disease can be transmitted in a range of ways. Those include through contact with: infected saliva and mouth lesions, bedding as well as transmission of pregnant women to their unborn children through the placenta, according to a WHO seminar on the issue Tuesday. Tedros said that MSM advocacy groups “are working hard to inform [members of their community] about the risks of monkeypox and prevent transmission. But all of us must work hard to fight stigma, which is not just wrong. It could also prevent infected individuals from seeking care, making it harder to stop transmission.” “Anyone can be infected with monkeypox if they have close physical contact with someone else who was infected,” he said. The virus was first identified in 1958 in a colony of captive African research monkeys. The first human case was identified in the DRC in 1970, during the period of smallpox elimination campaigns. Even before the current outbreak, there have been limited waves of cases reported in non-endemic countries through channels such as the export of exotic animals, such as infected mice, squirrels, and rats, from Ghana to the United States in 2003, as well as by infected travelers. Misinformation campaign to target monkeypox Maria van Kerkhove, WHO Technical Lead on COVID-19 WHO is also mounting a campaign on disinformation about the disease, said Gabby Stern, WHO Communications Director. WHO is currently working with both social media companies and tech companies, urging them to filter out the misinformation and push out accurate information through their channels and platforms, said She said that misinformation and disinformation was a ‘major priority’ for both WHO and the United Nations. “Misinformation kills, just as these viruses kill, misinformation kills as well,” added Dr Maria van Kerkhove, WHO technical Lead on COVID-19. “This remains a constant challenge, not only COVID-19 across the entire spectrum of interventions and the response that we have. It’s the attacks on science that undermine the effectiveness of our countermeasures.” Image Credits: Tessa Davis/Twitter , Laëtitia Dudous, WHO, Disease Outbreak News, 21 May 2022 . Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Eight Countries Compete to Host African Medicines Agency at Crucial African Union Meeting 02/06/2022 Paul Adepoju AMA headquarters host country is expected to be named at the end of an ongoing meeting in Addis Ababa A meeting to decide which African country will be the host country for the African Medicines Agency (AMA) is underway and at the last count, expressions of interest in hosting the agency have been received from Uganda, Algeria, Egypt, Morocco, Rwanda, Tanzania, Tunisia and Zimbabwe. The decision is expected to be one of the outcomes at the ongoing first Ordinary session of the Conference of State Parties (CoSP) of the AMA, in Addis Ababa, Ethiopia from 1 to 3 June 2022. The CoSP is reviewing the AMA assessment report and at the end of their meeting, it will make recommendations on the host country of the AMA Headquarters. A final decision on this recommendation will be made at the next assembly of the African Union. Uganda is one of the countries vying to host the AMA Headquarters and the country’s delegation to the CoSP meeting is led by the country’s Minister of Health, Dr Jane Aceng, and Dr Diana Atwine, a Permanent Secretary in the Ministry of Health. Zimbabwe’s team is a four-member delegation led by the country’s Health and Child Care deputy Minister, Dr John Mangwiro. Sierra Leone is also attending the session led by Minister of Health and Sanitation Dr Austin Demby. In his remark at the official launch of the Africa CDC’s Ministerial Executive Leadership Program (MELP), Dr John Nkengasong, Africa CDC’s outgoing Director General confirmed the CoSP’s outcome would play a critical role in deciding the future of the agency. “The launch of the AMA is really another landmark initiative of the African Union as part of the Agenda 63. I can’t wait to hear the outcome of the deliberations. It’s going to be transformational when the AMA and we are truly excited with that,” Nkengasong said. The three-day ministerial meeting will deliberate on the priorities and next steps to establish the AMA. From Geneva to Addis Ababa At last week’s World Health Assembly, Amref Health Africa’s Desta Lakew, on behalf of the African Medicines Agency Treaty Alliance (AMATA) described AMA as an initiative of the African Union aimed at strengthening the regulatory environment to guarantee access to quality, safe and efficacious medicines, medical products, and technologies on the continent. Countries that have signed the treaty, according to AMATA, are Algeria, Benin, Chad, Ghana, Madagascar, Mali, Morocco, Rwanda, Saharawi Arab Democratic Republic, Senegal, and Tunisia. But about four years after the AU Assembly adopted the AMA Treaty, Lakew noted that some Member States still haven’t given it the authority to fulfill its mandate. “The increased risk of disease outbreaks in the region and globally has made access to medical products a priority. Trade in locally produced medical products, including Personal Protective Equipment, across African countries will be hampered if we do not have a harmonized regulatory environment,” Lakew told WHA 75. At the CoSP meeting, the AU called on all member states to sign the Treaty to see improved regulation and easy flow of medical products and technologies, are expected to be reechoed. Lakew described the call as an urgent matter “for the sake of ensuring that there is equitable access to quality, safe, efficacious medicines and technologies for a healthy Africa”. Last month, Health Policy Watch reported Kenya was preparing to join the AMA alongside thirty-one other African Union member states following the Kenyan cabinet’s decision to approve the ratification of the African Union Treaty. See more about the African Medicines Agency on our special AMA Countdown page: African Medicines Agency Countdown Sex, War, Sustainability and the World Health Assembly – Last Week in Review 02/06/2022 Elaine Ruth Fletcher 75th World Health Assembly Health and peace, sex and war, money and management. Whether in chorus or cacophony – last week’s World Health Assembly of WHO member states played most of the notes in the symphony of global debate over strategies to tackle disease, epidemics and pandemics and bolster health systems. But the root causes of emerging disease threats – in modern environmental health threats and nature gone awry remained under-represented themes. From the opening notes of the WHA, on a health for peace theme, to Saturday’s late night closing and end-run charges over language on sexual orientation – this year’s WHA was a seesaw of successes and setbacks. Highs included the consensus vote Tuesday to increase member states contributions to WHO, followed by a resolution Friday to move ahead on the first real reforms to the International Health Regulations in almost 20 years. And at the same time, unprecedented polarization was evident during Thursday’s debate over a resolution condemning Russia’s invasion of Ukraine, which won approval by a vote of 88 to 12. That was followed by the dispute that emerged Friday and continued until nearly midnight Saturday over references to terms such as “sexual rights” and “men who have sex with men” (MSM) in a WHO strategy on HIV, hepatitis-B and sexually transmitted infections (STIs). That, too, was resolved only by a painful series of rollcall votes, leading to the strategy’s passage by just 60 member states, with twice as many delegates absent or abstaining. Like a bullet train ride Dr Hiroki Nakatani joins in the applause for the resolution’s passage on HIV, Hepatitis B and STIs Dr Hiroki Nakatani, who presided over the committee that faced the thorny final hours of WHA dealing with the clash among nations over sexual health terms that HIV professionals regard as the standard usage, compared this year’s WHA session to a ride on a bullet train. “The train ride was sometimes bumpy but we arrived at our destination,” he said of the first Assembly to be held in person in several years because of the pandemic. Perhaps so, even more so than the war in Ukraine, the exceptionally large number of abstentions in the vote on a new HIV, Hepatitis and STI strategy was a bitter pill to swallow for delegates on both sides of the debate. It highlighted the fact that the battles still being waged in Europe, the Middle East, Asia and Africa over the control of territory are not the only big issues dividing member states. Fissures over social norms shape and guide public health policies run just as deep. Sex & War – Global social divide as deep as territorial conflicts And among those norms, there remains a deep divide around health policies that interface with human sexuality – that other primordial urge that co-exists alongside the urge for power and territory. For WHA delegates, in fact, the series of votes Saturday over sexual terminology may have been even more unsettling than the votes over Russia’s invasion of Ukraine – precisely because they sit in Ministries of Health, not Defence, with day-to-day responsibility for designing and implementing policies on HIV and other STIs. As with the Ukraine conflict, the divide that emerged, however, was not strictly drawn along the lines of global North and South. Saudi delegate in heated WHA debate Saturday over sexual rights and terminology Rather, it was the oil-rich Saudi Arabia that led the charge in the quest to purge references to men who have sex with men from the strategy on HIV treatment, followed by emerging economies of Asia and Africa where conservative views about sexual expression are often protected by law as well as custom. Against that, was Europe, North America, much of Latin America and high-income Asia- where more new attitudes about gender identity and LGBTI terminology have taken root over the past few decades. There were also exceptions, such as South Africa, which voted in favour of the HIV strategy. And European Serbia abstained from the vote as did the Russian Federation. Respect for culture, versus respect for evidence In the aftermath, the abstaining countries pleaded for more understanding of norms guided by tradition and culture. Western delegates, meanwhile, referred to the compass of science – whereby recent research has revealed how oft-marginalized MSM groups often fall through the cracks of programmes for HIV/AIDS prevention, diagnosis and treatment. “We appreciate those member states acted in good faith as part of these deliberations. Unfortunately this has served as a painful reminder of the need to reinforce our focus on evidence, human dignity and decency,” said US Assistant Secretary of State for Global Health Loyce Pace just after the strategy was approved. Loyce Pace, Assistant Secretary of State for Global Health, USA “[But] we should not need to hold a vote on the existence of entire communities of people,” she added. “We have a strategy on critically important global health issues, yes. But at what cost to those we risk leaving behind? “So to gay, lesbian, bisexual, queer, intersex, transgender and gender non-conforming people around the world, the United States government sees you, and will continue to support you. Stay strong.” (Right) Denmark’s EB representative, Søren Brostrøm, Director-General, Danish Health Authority, at the WHO Executive Board meeting 30 May, (left) Loyce Pace Assistant Secretary of State for Global Health, USA Reviewing the issue at Monday’s Executive Board meeting, member states on both sides of the divide expressed concerns over the failure of the WHA to find consensus over such a flagship health strategy – and the “dangerous precedent” that the voting set. “It is important that this does not set a precedent for consideration and adoption of technical documents by the Health Assembly,” said Dr Edwin Dikoloti, Botswana’s Minister of Health and Wellness, speaking on behalf of the African group, saying that greater efforts need to be made to find consensus in future WHAs over such controversial issues. Money – landmark decision on WHO finance – but not a ‘done deal’ Members of the WHO Working Group on Sustainable Finance hammer out the final agreement on increasing member state contributions, Germany’s Björn Kümmel on far left. The holy grail of consensus was restored in other key moments – including around the WHA resolution to increase regular member state contributions to WHO – in a bid to stabilize the agency’s finances The agreement, the fruit of months of grinding backroom diplomacy led by Germany, saw member states commit to increase annual assessments to cover 50% of WHO’s core budget by the end of the decade. However, each stepwise increase up until 2030 will still need endorsement at future WHAs to go forward. And so the vote should not be seen as a blank check either, a senior official in the Department of Health and Human Services, told Health Policy Watch. “I would say that the US, as a big contributor to the WHO, is definitely committed to that [resolution], and we were very happy to join the consensus,” the official said. “But I hope it’s also been clear that that is not a done deal and neither for us as the administration or for Congress.” According to the resolution, final approval of each year’s increase is contingent on progress in WHO internal reforms that are supposed to make the organization more transparent, efficient and well-managed. Those demands include overhaul of WHO’s budget management system, said the senior US official: “The budgets that are adopted by the Health Assembly are not real budgets. They’re just budget space. And creating budgets that are aspirational is very different from programming and reporting on and demonstrating the impact of real budgets.” Management – following election Tedros faces new demands Applause just after WHA re-elects Dr Tedros Adhanom Ghebreyesus to serve a second five-year term as Director-General of the World Health Organization on 24 May. He ran un-opposed. But the expectations go beyond budget reform, pressing newly re-elected Dr Tedros Adhanom Ghebreyesus for changes in WHO’s management culture, including more merit-based appointments of senior WHO staff, such as those serving as heads of WHO country offices, and structural reforms in WHO’s internal justice system. “I think, from our perspective…. there’s a very significant culture change… that needs to happen within the organization,” the official told Health Policy Watch. Further related to that, are demands for a “full resolution” of the ongoing investigation of the cases of sexual harassment and abuse of women in the Democratic Republic of Congo by WHO staff and consultants, whose progress also was reviewed at last week’s WHA and Monday’s EB. Justice – WHO internal justice system lacks independence While the revelations of the DRC sex abuse scandal, which first came to light in 2020, and whose perpetrators have yet to be fully prosecuted, highlight failures of WHO internal justice to date, they also are evidence of a broader and more systematic problem, some WHO insiders maintain. One key problem, highlighted in multiple interviews with both past and present WHO staff, is the fact that WHO’s Internal Oversight Office (IOS) – the legal mechanism that manages staff and management complaints – is housed in the Director-General’s Office and effectively controlled by the Director General himself – rather than at arms length. Politically influential managers or staff with the ear of the DG, may receive different treatment than staff who do not, critics say. The flaws in the current process featured in a WHO Staff Association letter to Monday’s Executive Board. The Staff Association demanded that the WHO Global Board of Appeals, the three-member body that hears cases, and recommends disciplinary action to the Director General, be expanded and also include staff-appointed representatives. “The panel of the Global Board of Appeal (GBA) should have five-members,” stated the Staff Association. “A three-member panel – the current practice – is simply not reassuring staff that GBA deliberations are sufficiently robust,” the Staff Association letter stated.“Furthermore, the staff representatives on each of the GBA panels should be selected by the respective staff association rather than selected by the GBA Chair or Deputy-Chair.” The net result of the current system is that – short of a costly and lengthy appeal to the International Labour Organization – disciplinary cases are heard by a GBA board appointed by senior managers who report directly to Tedros, who also decides on the final outcome of the cases. Dr Boubacar Diallo with WHO Director-General, Dr Tedros Adhanom Ghebreyesus and then-WHO Emergency Response Team leader, Dr Michel Yao in DRC in June 2019; Diallo was among those accused of harassment and Yao was alleged to have ignored those and other reports. With regards to the DRC cases, allegations that high-ranking WHO managers or consultants with ties to Tedros may have turned a blind eye to the reports of abuses going on in the field, have never been publicly resolved. But the concerns extend beyond sexual harrassement, to the need to foster an institutional culture of professionalism free of political interference, critics also say, pointing to other episodes like the suppression of a 2020 WHO report on Italty’s pandemic response, which criticized another senior WHO advisor to Tedros. From a sustainable budget a sustainable planet? While WHO’s financial sustainability received considerable attention at this year’s WHA, there was comparatively little debate on the planet’s sustainability crisis – and how that may be fueling a cascading array of health impacts – from more noncommunicable diseases to emerging outbreaks, such as SARS-CoV2 and more recently a worldwide surge in monkeypox. A new roadmap to accelerate work on noncommunicable diseases fails to give more than a nod to air pollution as one of the leading causes of NCDs – responsible for some 7 million deaths a year from cancers, cardiovascular and lung diseases every year. And that doesn’t even include risks from chemicals exposures that make the total estimate of deaths from pollution closer to 9 million annually, according to a new Lancet Planetary Health Report released on 18 May. Deaths attributable to key “modern” and “traditional” pollution sources for which data is available In a debate over an NCD roadmap that aims to slash NCD risks by one third by 2030, France, speaking on behalf of some European Union member states,called for a more “integrated” approach that includes environmental health and climate change. So far, such approaches have been slow in coming. Despite the rhetoric about air pollution being a leading risk factor for NCDs, there are, as yet, no WHO “Best Buys” for environmental strategies that reduce deadly pollution risks – even if measures like clean public transport and compact cities, built around cycling and walking networks, are regarded by urban planners and transport managers as evidence-based solutions that have a record of demonstrated results. ‘One Health’ and food safety – some new approaches Caged animals held for sale and slaughter in unsanitary conditions at Wuhan’s Huanan Seafood Market, prior to the outbreak of COVID-19, including: (a) King rat snake (Elaphe carinata), (b) Chinese bamboo rat (Rhizomys sinensis), (c) Amur hedgehog (Erinaceus amurensis) (the finger points to a tick), (d) Raccoon dog (Nyctereutes procyonoides), (e) Marmot (Marmota himalayana) (beneath the marmots is a cage containing hedgehogs), and (f) Hog badger (Arctonyx albogularis). On the brigher side, a new WHO Global Strategy for Food Safety was approved by member states. For the first time ever, the strategy makes reference, at least in passing, to the need for a “One Health approach when addressing health risks emerging at the human-animal-ecosystems interface.” A companion decision asks WHO to also update its guidance on Reducing public health risks associated with the sale of live wild animals of mammalian species in traditional food markets. Such guidance emerges out of the SARS-CoV2 pandemic, where peoples’ exposure to SARS-CoV2 infected animals in the Wuhan, China live animal market is considered to be one of the most plausible routes by which SARS-CoV2 initially leaped from animal to human populations in Wuhan, China during 2019. But the caging and slaughter of live, wild animals in areas heavily trafficked by customers are practices common in thousands of traditional markets in Asia and Southeast Asia, as well as parts of Africa, leading to further risks of human exposure to pathogens the animals may harbour. Not nearly enough action to stop pandemics at source The unsafe handling of live animals that are sold for slaughter at traditional markets can risk the spread of foodborne and infectious diseases. Such “One Health” issues need far more deliberate and systematic WHO and member state attention than the nod that they have so far, a growing chorus of “Ecohealth” experts say. In a little-noticed press release issued during WHA, Dr Nigel Sizer, executive director of the consortium Preventing Pandemics at the Source called upon the WHA to do more to address ecosystem risks upstream that increase “spillover risks” of pathogen leap from animal to human populations: “Such actions include shutting down or strictly regulating wildlife trade and markets, stopping deforestation and forest degradation, and providing better health to communities in emerging infectious disease hotspots, as well as strengthened veterinary care and biosecurity in animal husbandry,” said Sizer, an internationally known conservationist, in his statement. “Overall throughout the WHA process and in the preparations for negotiation of a possible global instrument on pandemic prevention and preparedness there has been remarkably little attention given to true pandemic prevention,” Sizer later told Health Policy Watch. “We know where most pandemics come from and we know how to reduce the risk of zoonotic spillover of the vruses that cause them,” he added. “Governments in general and health agencies in particular should embrace these approaches, including One Health efforts. They should also work much more closely with environmental agencies to address spillover risk from tropical deforestation, wildlife exploitation and trade, and intensive animal agriculture. The public health return on investment in such activities would be enormous.” Health and Environment: WHO structures preserve a deep divide Researcher explores evidence around the wildlife-trade- pandemic nexus (Wildlife Conservation Society) There are parallel calls to better incorporate such concerns into any future “pandemic instrument” intended to have a broader scope than the International Health Regulations, and to be the focus of intense negotiations by a WHA Intergovernmental Board (INB) in coming months. However, the yawning chasm environmental groups encounter in trying to to interact with WHO and WHO member states over environmental health and One Health concerns, can sometimes appear as wide as the divide between member states on the terms around sexual health. “It has been exceedingly difficult to engage with the WHA or with the intergovernmental negotiating body’s (INB) process to draft and negotiate a new pandemic instrument,” Christine Franklin, of the Wildlife Conservation Society, another member of the Preventing Pandemics coalition, told Health Policy Watch. The club of non-state actors in ‘official relations’ “Only non-State actors in official relations with the WHO are invited to engage with the WHA,” she remarked. That status of ‘official relations’ not only allows civil society groups the privilege of expounding on their positions at the annual World Health Assembly, it gives them access to lengthy and detailed informal member state consultations and intergovernmental negotiating sessions that are closed to the general public and the media. Some 220 civil society actors hold that coveted status, mostly mainstream medical and health societies as well as pharma groups, but also agro-business foundations, such as CropLife International, as well as the outliers like the World Plumbing Council. A review by Health Policy Watch found nary an environmental or eco-health group on the list, as of February 2022. “So even though Wildlife Conservation Society has been working across the globe for more than 125 years; is the only international conservation organization with an embedded health program, works on the ground in more than 60 countries; and our health program is recognized as a One Health founder and a leader at the nexus of health and the environment, the INB’s public hearing has been the only opportunity we have had to provide input,” Franklin lamented. “Oral testimonies were limited to two minutes and written statements restricted to 250 words. In fact, there are no organizations from the conservation or environment communities in official relations with the WHO and the process to gain status is complex and lengthy.” Image Credits: Germany's UN Mission in Geneva , WHO, Lancet Planetary Health, Nature , Pierce Mill Media, Wildlife Conservation Society . Doubling of Monkeypox Cases Outside of Endemic Countries Raises New Alarm Bells at WHO 01/06/2022 Raisa Santos & Elaine Ruth Fletcher Monkeypox lesions In just a matter of three days, the number of monkeypox cases reported to WHO outside of central and west Africa has doubled – with reports Wednesday of some 550 cases in more than 30 countries outside of the countries where the disease is endemic, WHO Director General, Dr Tedros Adhanom Ghebreyesus told a press briefing on Wednesday. That, as compared to reports of 257 cases outside of Africa, as of Sunday, 30 May. The ‘sudden appearance’ of monkeypox in so many non-endemic countries is prompting new concerns that it could spread to more “vulnerable populations” in countries where it has suddenly emerged, including pregnant women and children, added WHO’s Maria Van Kerkhove, Health Emergencies technical lead. WHO Briefing, 1 June 2022 “Investigations are ongoing, but the sudden appearance of monkeypox in many countries at the same time suggests there may have been undetected transmission for some time,” said WHO Director-General Tedros Adhanom Ghebreyesus during a press briefing Wednesday. “WHO’s priority now is to first provide accurate information to those groups most at risk, and second to prevent further spread among at-risk groups, to advance our understanding of monkeypox.” WHO is organizing two R&D meetings of experts on Thursday and Friday of this week, to further discuss monkeypox and understand the current surge in cases. Ecological pressures prompting rapid disease emergence Gambian pouched rat – rodents are a common animal reservoir for monkeypox Monkeypox has long circulated in 12 countries of central and western Africa, with a rising incidence over time. Disease prevalence is highest in the Democratic Republic of Congo, which has reported several thousand cases a year, and where the monkeypox clade, or variant, in circulation is more deadly. The disease has been reported to have mortality rates of up to 10% in the DRC. Noone has yet reported to have died from the outbreak that has occurred abroad recently – which has been traced to the milder West African clade. Cases of monkeypox in endemic countries between 15 December 2021 to 1 May 2022 Increased circulation of the disease in Africa in recent years has been linked to deforestation – which put wild animals in closer contact with humans, as well as increased agro-food storage, and consequent infestation of food containers by infected rats. Additionally, human travelers as well as the trade in exotic animals has been linked to the appearance of some cases overseas in the past. But the appearance of so many cases abroad is a new phenomenon, where community transmission is now occurring, including among networks of men who have sex with men, WHO said. The changes in ecosystems, trade and travel have been exacerbated by a decline in human immunity to the disease, due to the discontinuation of smallpox vaccination in the 1970s, which was protective against monkeypox as well. Ecological pressures need to be addressed Michael Ryan, WHO Executive Director, Health Emergencies Beyond the immediate health system measures needed to track and trace the spiral of increasing human cases occurring daily, more attention needs to be given to the underlying drivers, and ‘ecological pressure’ that has caused disease outbreaks to expand in size and scope,WHO’s Executive Director of Health Emergencies Mike Ryan told the briefing. “Animals are changing their behavior, humans are changing their behavior. What we’re dealing with is a lot of ecological fragility,” said Ryan. “We’re dealing with the animal-human interface being quite unstable, and the number of times that these diseases cross into humans is increasing, [as well as] that ability to amplify the disease and move it within our communities.” But he did not elaborate on how WHO might address such drivers – beyond saying that they could be a topic of discussion at this week’s R&D meeting convened by the global health agency. Inequity of investment in monkeypox in Europe versus Africa already apparent The current outbreak also highlights once more, the boomerang effect of inequitable investments in health systems and disease control in Africa, where monkeypox has been circulating for decades in countries that lack the tools to track and tackle such infections, Ryan said. “There are thousands and thousands of cases of monkeypox every year in Africa, and there are deaths every year….. And now, we have a concern about this disease spreading in Europe, but I certainly haven’t heard that same level of concern over the last five or ten years.” “Are we in a position to collectively respond? Are we in a position to share resources in order to stop transmission of these diseases within human communities?,” Ryan asked. Already, countries such as the United Kingdom have vaccinated more than 1,000 people at risk of contracting the virus, and the European Union is in discussions to buy smallpox vaccines from Bavarian Nordic, the only maker of the vaccine licensed in Europe, according to media reports. Smallpox vaccines are estimated to be about 85% effective against monkeypox, which is in the same orthopox family of viruses – but there have been no such vaccination campaigns in monkeypox hotspots such as DRC for decades. “It’s a bit uncomfortable that we have a different attitude to the kinds of resources we deploy depending on where cases are,” said Dr Jimmy Whittworth, of the London School of Hygiene and Tropical Medicine, speaking to the Associated Press. “It exposes a moral failing when those interventions aren’t available for the millions of people in Africa who need them.” Stigma against disease may prevent care, increase transmission Tedros Adhanom Ghebreyesus, WHO Director-General Meanwhile, WHO’s Tedros urged people to fight against stigma associated with the transmission of monkeypox in networks of men who have sex with men (MSM) – and underlined that the disease can be transmitted in a range of ways. Those include through contact with: infected saliva and mouth lesions, bedding as well as transmission of pregnant women to their unborn children through the placenta, according to a WHO seminar on the issue Tuesday. Tedros said that MSM advocacy groups “are working hard to inform [members of their community] about the risks of monkeypox and prevent transmission. But all of us must work hard to fight stigma, which is not just wrong. It could also prevent infected individuals from seeking care, making it harder to stop transmission.” “Anyone can be infected with monkeypox if they have close physical contact with someone else who was infected,” he said. The virus was first identified in 1958 in a colony of captive African research monkeys. The first human case was identified in the DRC in 1970, during the period of smallpox elimination campaigns. Even before the current outbreak, there have been limited waves of cases reported in non-endemic countries through channels such as the export of exotic animals, such as infected mice, squirrels, and rats, from Ghana to the United States in 2003, as well as by infected travelers. Misinformation campaign to target monkeypox Maria van Kerkhove, WHO Technical Lead on COVID-19 WHO is also mounting a campaign on disinformation about the disease, said Gabby Stern, WHO Communications Director. WHO is currently working with both social media companies and tech companies, urging them to filter out the misinformation and push out accurate information through their channels and platforms, said She said that misinformation and disinformation was a ‘major priority’ for both WHO and the United Nations. “Misinformation kills, just as these viruses kill, misinformation kills as well,” added Dr Maria van Kerkhove, WHO technical Lead on COVID-19. “This remains a constant challenge, not only COVID-19 across the entire spectrum of interventions and the response that we have. It’s the attacks on science that undermine the effectiveness of our countermeasures.” Image Credits: Tessa Davis/Twitter , Laëtitia Dudous, WHO, Disease Outbreak News, 21 May 2022 . Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Sex, War, Sustainability and the World Health Assembly – Last Week in Review 02/06/2022 Elaine Ruth Fletcher 75th World Health Assembly Health and peace, sex and war, money and management. Whether in chorus or cacophony – last week’s World Health Assembly of WHO member states played most of the notes in the symphony of global debate over strategies to tackle disease, epidemics and pandemics and bolster health systems. But the root causes of emerging disease threats – in modern environmental health threats and nature gone awry remained under-represented themes. From the opening notes of the WHA, on a health for peace theme, to Saturday’s late night closing and end-run charges over language on sexual orientation – this year’s WHA was a seesaw of successes and setbacks. Highs included the consensus vote Tuesday to increase member states contributions to WHO, followed by a resolution Friday to move ahead on the first real reforms to the International Health Regulations in almost 20 years. And at the same time, unprecedented polarization was evident during Thursday’s debate over a resolution condemning Russia’s invasion of Ukraine, which won approval by a vote of 88 to 12. That was followed by the dispute that emerged Friday and continued until nearly midnight Saturday over references to terms such as “sexual rights” and “men who have sex with men” (MSM) in a WHO strategy on HIV, hepatitis-B and sexually transmitted infections (STIs). That, too, was resolved only by a painful series of rollcall votes, leading to the strategy’s passage by just 60 member states, with twice as many delegates absent or abstaining. Like a bullet train ride Dr Hiroki Nakatani joins in the applause for the resolution’s passage on HIV, Hepatitis B and STIs Dr Hiroki Nakatani, who presided over the committee that faced the thorny final hours of WHA dealing with the clash among nations over sexual health terms that HIV professionals regard as the standard usage, compared this year’s WHA session to a ride on a bullet train. “The train ride was sometimes bumpy but we arrived at our destination,” he said of the first Assembly to be held in person in several years because of the pandemic. Perhaps so, even more so than the war in Ukraine, the exceptionally large number of abstentions in the vote on a new HIV, Hepatitis and STI strategy was a bitter pill to swallow for delegates on both sides of the debate. It highlighted the fact that the battles still being waged in Europe, the Middle East, Asia and Africa over the control of territory are not the only big issues dividing member states. Fissures over social norms shape and guide public health policies run just as deep. Sex & War – Global social divide as deep as territorial conflicts And among those norms, there remains a deep divide around health policies that interface with human sexuality – that other primordial urge that co-exists alongside the urge for power and territory. For WHA delegates, in fact, the series of votes Saturday over sexual terminology may have been even more unsettling than the votes over Russia’s invasion of Ukraine – precisely because they sit in Ministries of Health, not Defence, with day-to-day responsibility for designing and implementing policies on HIV and other STIs. As with the Ukraine conflict, the divide that emerged, however, was not strictly drawn along the lines of global North and South. Saudi delegate in heated WHA debate Saturday over sexual rights and terminology Rather, it was the oil-rich Saudi Arabia that led the charge in the quest to purge references to men who have sex with men from the strategy on HIV treatment, followed by emerging economies of Asia and Africa where conservative views about sexual expression are often protected by law as well as custom. Against that, was Europe, North America, much of Latin America and high-income Asia- where more new attitudes about gender identity and LGBTI terminology have taken root over the past few decades. There were also exceptions, such as South Africa, which voted in favour of the HIV strategy. And European Serbia abstained from the vote as did the Russian Federation. Respect for culture, versus respect for evidence In the aftermath, the abstaining countries pleaded for more understanding of norms guided by tradition and culture. Western delegates, meanwhile, referred to the compass of science – whereby recent research has revealed how oft-marginalized MSM groups often fall through the cracks of programmes for HIV/AIDS prevention, diagnosis and treatment. “We appreciate those member states acted in good faith as part of these deliberations. Unfortunately this has served as a painful reminder of the need to reinforce our focus on evidence, human dignity and decency,” said US Assistant Secretary of State for Global Health Loyce Pace just after the strategy was approved. Loyce Pace, Assistant Secretary of State for Global Health, USA “[But] we should not need to hold a vote on the existence of entire communities of people,” she added. “We have a strategy on critically important global health issues, yes. But at what cost to those we risk leaving behind? “So to gay, lesbian, bisexual, queer, intersex, transgender and gender non-conforming people around the world, the United States government sees you, and will continue to support you. Stay strong.” (Right) Denmark’s EB representative, Søren Brostrøm, Director-General, Danish Health Authority, at the WHO Executive Board meeting 30 May, (left) Loyce Pace Assistant Secretary of State for Global Health, USA Reviewing the issue at Monday’s Executive Board meeting, member states on both sides of the divide expressed concerns over the failure of the WHA to find consensus over such a flagship health strategy – and the “dangerous precedent” that the voting set. “It is important that this does not set a precedent for consideration and adoption of technical documents by the Health Assembly,” said Dr Edwin Dikoloti, Botswana’s Minister of Health and Wellness, speaking on behalf of the African group, saying that greater efforts need to be made to find consensus in future WHAs over such controversial issues. Money – landmark decision on WHO finance – but not a ‘done deal’ Members of the WHO Working Group on Sustainable Finance hammer out the final agreement on increasing member state contributions, Germany’s Björn Kümmel on far left. The holy grail of consensus was restored in other key moments – including around the WHA resolution to increase regular member state contributions to WHO – in a bid to stabilize the agency’s finances The agreement, the fruit of months of grinding backroom diplomacy led by Germany, saw member states commit to increase annual assessments to cover 50% of WHO’s core budget by the end of the decade. However, each stepwise increase up until 2030 will still need endorsement at future WHAs to go forward. And so the vote should not be seen as a blank check either, a senior official in the Department of Health and Human Services, told Health Policy Watch. “I would say that the US, as a big contributor to the WHO, is definitely committed to that [resolution], and we were very happy to join the consensus,” the official said. “But I hope it’s also been clear that that is not a done deal and neither for us as the administration or for Congress.” According to the resolution, final approval of each year’s increase is contingent on progress in WHO internal reforms that are supposed to make the organization more transparent, efficient and well-managed. Those demands include overhaul of WHO’s budget management system, said the senior US official: “The budgets that are adopted by the Health Assembly are not real budgets. They’re just budget space. And creating budgets that are aspirational is very different from programming and reporting on and demonstrating the impact of real budgets.” Management – following election Tedros faces new demands Applause just after WHA re-elects Dr Tedros Adhanom Ghebreyesus to serve a second five-year term as Director-General of the World Health Organization on 24 May. He ran un-opposed. But the expectations go beyond budget reform, pressing newly re-elected Dr Tedros Adhanom Ghebreyesus for changes in WHO’s management culture, including more merit-based appointments of senior WHO staff, such as those serving as heads of WHO country offices, and structural reforms in WHO’s internal justice system. “I think, from our perspective…. there’s a very significant culture change… that needs to happen within the organization,” the official told Health Policy Watch. Further related to that, are demands for a “full resolution” of the ongoing investigation of the cases of sexual harassment and abuse of women in the Democratic Republic of Congo by WHO staff and consultants, whose progress also was reviewed at last week’s WHA and Monday’s EB. Justice – WHO internal justice system lacks independence While the revelations of the DRC sex abuse scandal, which first came to light in 2020, and whose perpetrators have yet to be fully prosecuted, highlight failures of WHO internal justice to date, they also are evidence of a broader and more systematic problem, some WHO insiders maintain. One key problem, highlighted in multiple interviews with both past and present WHO staff, is the fact that WHO’s Internal Oversight Office (IOS) – the legal mechanism that manages staff and management complaints – is housed in the Director-General’s Office and effectively controlled by the Director General himself – rather than at arms length. Politically influential managers or staff with the ear of the DG, may receive different treatment than staff who do not, critics say. The flaws in the current process featured in a WHO Staff Association letter to Monday’s Executive Board. The Staff Association demanded that the WHO Global Board of Appeals, the three-member body that hears cases, and recommends disciplinary action to the Director General, be expanded and also include staff-appointed representatives. “The panel of the Global Board of Appeal (GBA) should have five-members,” stated the Staff Association. “A three-member panel – the current practice – is simply not reassuring staff that GBA deliberations are sufficiently robust,” the Staff Association letter stated.“Furthermore, the staff representatives on each of the GBA panels should be selected by the respective staff association rather than selected by the GBA Chair or Deputy-Chair.” The net result of the current system is that – short of a costly and lengthy appeal to the International Labour Organization – disciplinary cases are heard by a GBA board appointed by senior managers who report directly to Tedros, who also decides on the final outcome of the cases. Dr Boubacar Diallo with WHO Director-General, Dr Tedros Adhanom Ghebreyesus and then-WHO Emergency Response Team leader, Dr Michel Yao in DRC in June 2019; Diallo was among those accused of harassment and Yao was alleged to have ignored those and other reports. With regards to the DRC cases, allegations that high-ranking WHO managers or consultants with ties to Tedros may have turned a blind eye to the reports of abuses going on in the field, have never been publicly resolved. But the concerns extend beyond sexual harrassement, to the need to foster an institutional culture of professionalism free of political interference, critics also say, pointing to other episodes like the suppression of a 2020 WHO report on Italty’s pandemic response, which criticized another senior WHO advisor to Tedros. From a sustainable budget a sustainable planet? While WHO’s financial sustainability received considerable attention at this year’s WHA, there was comparatively little debate on the planet’s sustainability crisis – and how that may be fueling a cascading array of health impacts – from more noncommunicable diseases to emerging outbreaks, such as SARS-CoV2 and more recently a worldwide surge in monkeypox. A new roadmap to accelerate work on noncommunicable diseases fails to give more than a nod to air pollution as one of the leading causes of NCDs – responsible for some 7 million deaths a year from cancers, cardiovascular and lung diseases every year. And that doesn’t even include risks from chemicals exposures that make the total estimate of deaths from pollution closer to 9 million annually, according to a new Lancet Planetary Health Report released on 18 May. Deaths attributable to key “modern” and “traditional” pollution sources for which data is available In a debate over an NCD roadmap that aims to slash NCD risks by one third by 2030, France, speaking on behalf of some European Union member states,called for a more “integrated” approach that includes environmental health and climate change. So far, such approaches have been slow in coming. Despite the rhetoric about air pollution being a leading risk factor for NCDs, there are, as yet, no WHO “Best Buys” for environmental strategies that reduce deadly pollution risks – even if measures like clean public transport and compact cities, built around cycling and walking networks, are regarded by urban planners and transport managers as evidence-based solutions that have a record of demonstrated results. ‘One Health’ and food safety – some new approaches Caged animals held for sale and slaughter in unsanitary conditions at Wuhan’s Huanan Seafood Market, prior to the outbreak of COVID-19, including: (a) King rat snake (Elaphe carinata), (b) Chinese bamboo rat (Rhizomys sinensis), (c) Amur hedgehog (Erinaceus amurensis) (the finger points to a tick), (d) Raccoon dog (Nyctereutes procyonoides), (e) Marmot (Marmota himalayana) (beneath the marmots is a cage containing hedgehogs), and (f) Hog badger (Arctonyx albogularis). On the brigher side, a new WHO Global Strategy for Food Safety was approved by member states. For the first time ever, the strategy makes reference, at least in passing, to the need for a “One Health approach when addressing health risks emerging at the human-animal-ecosystems interface.” A companion decision asks WHO to also update its guidance on Reducing public health risks associated with the sale of live wild animals of mammalian species in traditional food markets. Such guidance emerges out of the SARS-CoV2 pandemic, where peoples’ exposure to SARS-CoV2 infected animals in the Wuhan, China live animal market is considered to be one of the most plausible routes by which SARS-CoV2 initially leaped from animal to human populations in Wuhan, China during 2019. But the caging and slaughter of live, wild animals in areas heavily trafficked by customers are practices common in thousands of traditional markets in Asia and Southeast Asia, as well as parts of Africa, leading to further risks of human exposure to pathogens the animals may harbour. Not nearly enough action to stop pandemics at source The unsafe handling of live animals that are sold for slaughter at traditional markets can risk the spread of foodborne and infectious diseases. Such “One Health” issues need far more deliberate and systematic WHO and member state attention than the nod that they have so far, a growing chorus of “Ecohealth” experts say. In a little-noticed press release issued during WHA, Dr Nigel Sizer, executive director of the consortium Preventing Pandemics at the Source called upon the WHA to do more to address ecosystem risks upstream that increase “spillover risks” of pathogen leap from animal to human populations: “Such actions include shutting down or strictly regulating wildlife trade and markets, stopping deforestation and forest degradation, and providing better health to communities in emerging infectious disease hotspots, as well as strengthened veterinary care and biosecurity in animal husbandry,” said Sizer, an internationally known conservationist, in his statement. “Overall throughout the WHA process and in the preparations for negotiation of a possible global instrument on pandemic prevention and preparedness there has been remarkably little attention given to true pandemic prevention,” Sizer later told Health Policy Watch. “We know where most pandemics come from and we know how to reduce the risk of zoonotic spillover of the vruses that cause them,” he added. “Governments in general and health agencies in particular should embrace these approaches, including One Health efforts. They should also work much more closely with environmental agencies to address spillover risk from tropical deforestation, wildlife exploitation and trade, and intensive animal agriculture. The public health return on investment in such activities would be enormous.” Health and Environment: WHO structures preserve a deep divide Researcher explores evidence around the wildlife-trade- pandemic nexus (Wildlife Conservation Society) There are parallel calls to better incorporate such concerns into any future “pandemic instrument” intended to have a broader scope than the International Health Regulations, and to be the focus of intense negotiations by a WHA Intergovernmental Board (INB) in coming months. However, the yawning chasm environmental groups encounter in trying to to interact with WHO and WHO member states over environmental health and One Health concerns, can sometimes appear as wide as the divide between member states on the terms around sexual health. “It has been exceedingly difficult to engage with the WHA or with the intergovernmental negotiating body’s (INB) process to draft and negotiate a new pandemic instrument,” Christine Franklin, of the Wildlife Conservation Society, another member of the Preventing Pandemics coalition, told Health Policy Watch. The club of non-state actors in ‘official relations’ “Only non-State actors in official relations with the WHO are invited to engage with the WHA,” she remarked. That status of ‘official relations’ not only allows civil society groups the privilege of expounding on their positions at the annual World Health Assembly, it gives them access to lengthy and detailed informal member state consultations and intergovernmental negotiating sessions that are closed to the general public and the media. Some 220 civil society actors hold that coveted status, mostly mainstream medical and health societies as well as pharma groups, but also agro-business foundations, such as CropLife International, as well as the outliers like the World Plumbing Council. A review by Health Policy Watch found nary an environmental or eco-health group on the list, as of February 2022. “So even though Wildlife Conservation Society has been working across the globe for more than 125 years; is the only international conservation organization with an embedded health program, works on the ground in more than 60 countries; and our health program is recognized as a One Health founder and a leader at the nexus of health and the environment, the INB’s public hearing has been the only opportunity we have had to provide input,” Franklin lamented. “Oral testimonies were limited to two minutes and written statements restricted to 250 words. In fact, there are no organizations from the conservation or environment communities in official relations with the WHO and the process to gain status is complex and lengthy.” Image Credits: Germany's UN Mission in Geneva , WHO, Lancet Planetary Health, Nature , Pierce Mill Media, Wildlife Conservation Society . Doubling of Monkeypox Cases Outside of Endemic Countries Raises New Alarm Bells at WHO 01/06/2022 Raisa Santos & Elaine Ruth Fletcher Monkeypox lesions In just a matter of three days, the number of monkeypox cases reported to WHO outside of central and west Africa has doubled – with reports Wednesday of some 550 cases in more than 30 countries outside of the countries where the disease is endemic, WHO Director General, Dr Tedros Adhanom Ghebreyesus told a press briefing on Wednesday. That, as compared to reports of 257 cases outside of Africa, as of Sunday, 30 May. The ‘sudden appearance’ of monkeypox in so many non-endemic countries is prompting new concerns that it could spread to more “vulnerable populations” in countries where it has suddenly emerged, including pregnant women and children, added WHO’s Maria Van Kerkhove, Health Emergencies technical lead. WHO Briefing, 1 June 2022 “Investigations are ongoing, but the sudden appearance of monkeypox in many countries at the same time suggests there may have been undetected transmission for some time,” said WHO Director-General Tedros Adhanom Ghebreyesus during a press briefing Wednesday. “WHO’s priority now is to first provide accurate information to those groups most at risk, and second to prevent further spread among at-risk groups, to advance our understanding of monkeypox.” WHO is organizing two R&D meetings of experts on Thursday and Friday of this week, to further discuss monkeypox and understand the current surge in cases. Ecological pressures prompting rapid disease emergence Gambian pouched rat – rodents are a common animal reservoir for monkeypox Monkeypox has long circulated in 12 countries of central and western Africa, with a rising incidence over time. Disease prevalence is highest in the Democratic Republic of Congo, which has reported several thousand cases a year, and where the monkeypox clade, or variant, in circulation is more deadly. The disease has been reported to have mortality rates of up to 10% in the DRC. Noone has yet reported to have died from the outbreak that has occurred abroad recently – which has been traced to the milder West African clade. Cases of monkeypox in endemic countries between 15 December 2021 to 1 May 2022 Increased circulation of the disease in Africa in recent years has been linked to deforestation – which put wild animals in closer contact with humans, as well as increased agro-food storage, and consequent infestation of food containers by infected rats. Additionally, human travelers as well as the trade in exotic animals has been linked to the appearance of some cases overseas in the past. But the appearance of so many cases abroad is a new phenomenon, where community transmission is now occurring, including among networks of men who have sex with men, WHO said. The changes in ecosystems, trade and travel have been exacerbated by a decline in human immunity to the disease, due to the discontinuation of smallpox vaccination in the 1970s, which was protective against monkeypox as well. Ecological pressures need to be addressed Michael Ryan, WHO Executive Director, Health Emergencies Beyond the immediate health system measures needed to track and trace the spiral of increasing human cases occurring daily, more attention needs to be given to the underlying drivers, and ‘ecological pressure’ that has caused disease outbreaks to expand in size and scope,WHO’s Executive Director of Health Emergencies Mike Ryan told the briefing. “Animals are changing their behavior, humans are changing their behavior. What we’re dealing with is a lot of ecological fragility,” said Ryan. “We’re dealing with the animal-human interface being quite unstable, and the number of times that these diseases cross into humans is increasing, [as well as] that ability to amplify the disease and move it within our communities.” But he did not elaborate on how WHO might address such drivers – beyond saying that they could be a topic of discussion at this week’s R&D meeting convened by the global health agency. Inequity of investment in monkeypox in Europe versus Africa already apparent The current outbreak also highlights once more, the boomerang effect of inequitable investments in health systems and disease control in Africa, where monkeypox has been circulating for decades in countries that lack the tools to track and tackle such infections, Ryan said. “There are thousands and thousands of cases of monkeypox every year in Africa, and there are deaths every year….. And now, we have a concern about this disease spreading in Europe, but I certainly haven’t heard that same level of concern over the last five or ten years.” “Are we in a position to collectively respond? Are we in a position to share resources in order to stop transmission of these diseases within human communities?,” Ryan asked. Already, countries such as the United Kingdom have vaccinated more than 1,000 people at risk of contracting the virus, and the European Union is in discussions to buy smallpox vaccines from Bavarian Nordic, the only maker of the vaccine licensed in Europe, according to media reports. Smallpox vaccines are estimated to be about 85% effective against monkeypox, which is in the same orthopox family of viruses – but there have been no such vaccination campaigns in monkeypox hotspots such as DRC for decades. “It’s a bit uncomfortable that we have a different attitude to the kinds of resources we deploy depending on where cases are,” said Dr Jimmy Whittworth, of the London School of Hygiene and Tropical Medicine, speaking to the Associated Press. “It exposes a moral failing when those interventions aren’t available for the millions of people in Africa who need them.” Stigma against disease may prevent care, increase transmission Tedros Adhanom Ghebreyesus, WHO Director-General Meanwhile, WHO’s Tedros urged people to fight against stigma associated with the transmission of monkeypox in networks of men who have sex with men (MSM) – and underlined that the disease can be transmitted in a range of ways. Those include through contact with: infected saliva and mouth lesions, bedding as well as transmission of pregnant women to their unborn children through the placenta, according to a WHO seminar on the issue Tuesday. Tedros said that MSM advocacy groups “are working hard to inform [members of their community] about the risks of monkeypox and prevent transmission. But all of us must work hard to fight stigma, which is not just wrong. It could also prevent infected individuals from seeking care, making it harder to stop transmission.” “Anyone can be infected with monkeypox if they have close physical contact with someone else who was infected,” he said. The virus was first identified in 1958 in a colony of captive African research monkeys. The first human case was identified in the DRC in 1970, during the period of smallpox elimination campaigns. Even before the current outbreak, there have been limited waves of cases reported in non-endemic countries through channels such as the export of exotic animals, such as infected mice, squirrels, and rats, from Ghana to the United States in 2003, as well as by infected travelers. Misinformation campaign to target monkeypox Maria van Kerkhove, WHO Technical Lead on COVID-19 WHO is also mounting a campaign on disinformation about the disease, said Gabby Stern, WHO Communications Director. WHO is currently working with both social media companies and tech companies, urging them to filter out the misinformation and push out accurate information through their channels and platforms, said She said that misinformation and disinformation was a ‘major priority’ for both WHO and the United Nations. “Misinformation kills, just as these viruses kill, misinformation kills as well,” added Dr Maria van Kerkhove, WHO technical Lead on COVID-19. “This remains a constant challenge, not only COVID-19 across the entire spectrum of interventions and the response that we have. It’s the attacks on science that undermine the effectiveness of our countermeasures.” Image Credits: Tessa Davis/Twitter , Laëtitia Dudous, WHO, Disease Outbreak News, 21 May 2022 . Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Doubling of Monkeypox Cases Outside of Endemic Countries Raises New Alarm Bells at WHO 01/06/2022 Raisa Santos & Elaine Ruth Fletcher Monkeypox lesions In just a matter of three days, the number of monkeypox cases reported to WHO outside of central and west Africa has doubled – with reports Wednesday of some 550 cases in more than 30 countries outside of the countries where the disease is endemic, WHO Director General, Dr Tedros Adhanom Ghebreyesus told a press briefing on Wednesday. That, as compared to reports of 257 cases outside of Africa, as of Sunday, 30 May. The ‘sudden appearance’ of monkeypox in so many non-endemic countries is prompting new concerns that it could spread to more “vulnerable populations” in countries where it has suddenly emerged, including pregnant women and children, added WHO’s Maria Van Kerkhove, Health Emergencies technical lead. WHO Briefing, 1 June 2022 “Investigations are ongoing, but the sudden appearance of monkeypox in many countries at the same time suggests there may have been undetected transmission for some time,” said WHO Director-General Tedros Adhanom Ghebreyesus during a press briefing Wednesday. “WHO’s priority now is to first provide accurate information to those groups most at risk, and second to prevent further spread among at-risk groups, to advance our understanding of monkeypox.” WHO is organizing two R&D meetings of experts on Thursday and Friday of this week, to further discuss monkeypox and understand the current surge in cases. Ecological pressures prompting rapid disease emergence Gambian pouched rat – rodents are a common animal reservoir for monkeypox Monkeypox has long circulated in 12 countries of central and western Africa, with a rising incidence over time. Disease prevalence is highest in the Democratic Republic of Congo, which has reported several thousand cases a year, and where the monkeypox clade, or variant, in circulation is more deadly. The disease has been reported to have mortality rates of up to 10% in the DRC. Noone has yet reported to have died from the outbreak that has occurred abroad recently – which has been traced to the milder West African clade. Cases of monkeypox in endemic countries between 15 December 2021 to 1 May 2022 Increased circulation of the disease in Africa in recent years has been linked to deforestation – which put wild animals in closer contact with humans, as well as increased agro-food storage, and consequent infestation of food containers by infected rats. Additionally, human travelers as well as the trade in exotic animals has been linked to the appearance of some cases overseas in the past. But the appearance of so many cases abroad is a new phenomenon, where community transmission is now occurring, including among networks of men who have sex with men, WHO said. The changes in ecosystems, trade and travel have been exacerbated by a decline in human immunity to the disease, due to the discontinuation of smallpox vaccination in the 1970s, which was protective against monkeypox as well. Ecological pressures need to be addressed Michael Ryan, WHO Executive Director, Health Emergencies Beyond the immediate health system measures needed to track and trace the spiral of increasing human cases occurring daily, more attention needs to be given to the underlying drivers, and ‘ecological pressure’ that has caused disease outbreaks to expand in size and scope,WHO’s Executive Director of Health Emergencies Mike Ryan told the briefing. “Animals are changing their behavior, humans are changing their behavior. What we’re dealing with is a lot of ecological fragility,” said Ryan. “We’re dealing with the animal-human interface being quite unstable, and the number of times that these diseases cross into humans is increasing, [as well as] that ability to amplify the disease and move it within our communities.” But he did not elaborate on how WHO might address such drivers – beyond saying that they could be a topic of discussion at this week’s R&D meeting convened by the global health agency. Inequity of investment in monkeypox in Europe versus Africa already apparent The current outbreak also highlights once more, the boomerang effect of inequitable investments in health systems and disease control in Africa, where monkeypox has been circulating for decades in countries that lack the tools to track and tackle such infections, Ryan said. “There are thousands and thousands of cases of monkeypox every year in Africa, and there are deaths every year….. And now, we have a concern about this disease spreading in Europe, but I certainly haven’t heard that same level of concern over the last five or ten years.” “Are we in a position to collectively respond? Are we in a position to share resources in order to stop transmission of these diseases within human communities?,” Ryan asked. Already, countries such as the United Kingdom have vaccinated more than 1,000 people at risk of contracting the virus, and the European Union is in discussions to buy smallpox vaccines from Bavarian Nordic, the only maker of the vaccine licensed in Europe, according to media reports. Smallpox vaccines are estimated to be about 85% effective against monkeypox, which is in the same orthopox family of viruses – but there have been no such vaccination campaigns in monkeypox hotspots such as DRC for decades. “It’s a bit uncomfortable that we have a different attitude to the kinds of resources we deploy depending on where cases are,” said Dr Jimmy Whittworth, of the London School of Hygiene and Tropical Medicine, speaking to the Associated Press. “It exposes a moral failing when those interventions aren’t available for the millions of people in Africa who need them.” Stigma against disease may prevent care, increase transmission Tedros Adhanom Ghebreyesus, WHO Director-General Meanwhile, WHO’s Tedros urged people to fight against stigma associated with the transmission of monkeypox in networks of men who have sex with men (MSM) – and underlined that the disease can be transmitted in a range of ways. Those include through contact with: infected saliva and mouth lesions, bedding as well as transmission of pregnant women to their unborn children through the placenta, according to a WHO seminar on the issue Tuesday. Tedros said that MSM advocacy groups “are working hard to inform [members of their community] about the risks of monkeypox and prevent transmission. But all of us must work hard to fight stigma, which is not just wrong. It could also prevent infected individuals from seeking care, making it harder to stop transmission.” “Anyone can be infected with monkeypox if they have close physical contact with someone else who was infected,” he said. The virus was first identified in 1958 in a colony of captive African research monkeys. The first human case was identified in the DRC in 1970, during the period of smallpox elimination campaigns. Even before the current outbreak, there have been limited waves of cases reported in non-endemic countries through channels such as the export of exotic animals, such as infected mice, squirrels, and rats, from Ghana to the United States in 2003, as well as by infected travelers. Misinformation campaign to target monkeypox Maria van Kerkhove, WHO Technical Lead on COVID-19 WHO is also mounting a campaign on disinformation about the disease, said Gabby Stern, WHO Communications Director. WHO is currently working with both social media companies and tech companies, urging them to filter out the misinformation and push out accurate information through their channels and platforms, said She said that misinformation and disinformation was a ‘major priority’ for both WHO and the United Nations. “Misinformation kills, just as these viruses kill, misinformation kills as well,” added Dr Maria van Kerkhove, WHO technical Lead on COVID-19. “This remains a constant challenge, not only COVID-19 across the entire spectrum of interventions and the response that we have. It’s the attacks on science that undermine the effectiveness of our countermeasures.” Image Credits: Tessa Davis/Twitter , Laëtitia Dudous, WHO, Disease Outbreak News, 21 May 2022 . Posts navigation Older postsNewer posts